( (TITLE (S (NP-SBJ (NN Pten) (NN Dose)) (VP (VBZ Dictates) (NP (NN Cancer) (NN Progression)) (PP-LOC (IN in) (NP (DT the) (NN Prostate)))))) )
( (HEADING (NP (NN Abstract))) )
( (S (NP-SBJ (NP (JJ Complete) (NN inactivation)) (PP (IN of) (NP (DT the) (NN PTEN) (NML (NN tumor) (NN suppressor)) (NN gene)))) (VP (VBZ is) (ADJP-PRD (RB extremely) (JJ common)) (PP-LOC (IN in) (NP (NP (JJ advanced) (NN cancer)) (, ,) (PP (VBG including) (NP (NP (NN prostate) (NN cancer)) (-LRB- -LRB-) (NP (NN CaP))))))) (-RRB- -RRB-) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ-1 (CD one) (NN PTEN) (NN allele)) (VP (VBZ is) (ADVP-TMP (RB already)) (VP (VBN lost) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (JJ vast) (NN majority)) (PP (IN of) (NP (NNS CaPs))))) (PP-TMP (IN at) (NP (NN presentation))))) (. .)) )
( (S (S-PRP (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO To) (VP (VB determine) (NP (NP (DT the) (NN consequence)) (PP (IN of) (NP (NML (NN PTEN) (NN dose)) (NNS variations))) (PP (IN on) (NP (NN cancer) (NN progression))))))) (, ,) (NP-SBJ-2 (PRP we)) (VP (VBP have) (VP (VBN generated) (PP-MNR (IN by) (NP (JJ homologous) (NN recombination))) (NP (NP (DT a) (JJ hypomorphic) (NN Pten) (NN mouse) (JJ mutant) (NN series)) (PP (IN with) (NP (NP (VBG decreasing) (NN Pten) (NN activity)) (: :) (NP (NP (NN Ptenhy) (HYPH /) (SYM +)) (ADJP (SYM >) (NP (NP (NN Pten) (SYM +) (HYPH /) (SYM −)) (ADJP (SYM >) (NP (NP (NN Ptenhy) (HYPH /) (SYM −)) (PRN (-LRB- -LRB-) (NP (NP (NNS mutants)) (SBAR (WHPP-1 (IN in) (WHNP (WDT which))) (S (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN rescued) (NP (DT the) (JJ embryonic) (NN lethality)) (PP-PRP (IN due) (IN to) (NP (JJ complete) (NN Pten) (NN inactivation))) (PP-1 (-NONE- *T*))))))) (-RRB- -RRB-)) (ADJP (SYM >) (NP (NML (NML (NN Pten) (NN prostate) (JJ conditional) (NN knockout)) (-LRB- -LRB-) (NML (NN Ptenpc))) (-RRB- -RRB-) (NNS mutants))))))))))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (PRP we)) (VP (VBP have) (VP (VP (VBN generated) (NP-3 (-NONE- *RNR*))) (CC and) (VP (ADVP (RB comparatively)) (VBD analyzed) (NP-3 (-NONE- *RNR*))) (NP-3 (NP (CD two) (JJ distinct) (NN Ptenpc) (NNS mutants)) (SBAR (WHPP-1 (IN in) (WHNP (WDT which))) (S (NP-SBJ-2 (NN Pten)) (VP (VBZ is) (VP (VBN inactivated) (NP-2 (-NONE- *)) (UCP (ADVP (RB focally)) (CC or) (PP-LOC (IN throughout) (NP (DT the) (JJ entire) (JJ prostatic) (NN epithelium)))) (PP-1 (-NONE- *T*))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP find) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN extent)) (PP (IN of) (NP (NN Pten) (NN inactivation)))) (VP (VBP dictate) (PP-MNR (IN in) (NP (DT an) (JJ exquisite) (ADJP (NN dose) (HYPH -) (JJ dependent)) (NN fashion))) (NP (NP (NN CaP) (NN progression)) (, ,) (NP (PRP$ its) (NML (NN incidence) (, ,) (NN latency) (, ,) (CC and) (NN biology)))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN dose)) (PP (IN of) (NP (NN Pten)))) (VP (VBZ affects) (NP (NP (JJ key) (JJ downstream) (NNS targets)) (PP (JJ such) (IN as) (NP (NN Akt) (, ,) (NN p27Kip1) (, ,) (NN mTOR) (, ,) (CC and) (NN FOXO3))))) (. .)) )
( (S (NP-SBJ (PRP$ Our) (NNS results)) (VP (VBP provide) (NP (NP (JJ conclusive) (JJ genetic) (NN support)) (PP (IN for) (NP (DT the) (NN notion) (SBAR (SBAR (IN that) (S (NP-SBJ (NN PTEN)) (VP (VBZ is) (ADJP-PRD (JJ haploinsufficient)) (PP (IN in) (NP (NN tumor) (NN suppression)))))) (CC and) (SBAR (IN that) (S (NP-SBJ (PRP$ its) (NN dose)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ key) (NN determinant)) (PP (IN in) (NP (NN cancer) (NN progression)))))))))))) (. .)) )
( (HEADING (NP (NN Introduction))) )
( (S (NP-SBJ-1 (DT The) (NML (NML (NN PTEN)) (NML (-LRB- -LRB-) (NML (NML (NN phosphatase) (CC and) (NN tensin)) (NN homolog)) (VP (VBN deleted) (NP (-NONE- *)) (PP-LOC (IN on) (NP (NN chromosome) (CD 10)))) (-RRB- -RRB-))) (NML (NN tumor) (NN suppressor)) (NN gene)) (VP (VBZ is) (VP (VBN located) (NP-1 (-NONE- *)) (PP-LOC (IN on) (NP (NP (NN chromosome) (CD 10q23)) (, ,) (NP (NP (DT a) (JJ genomic) (NN region)) (VP (ADVP-TMP (RB frequently)) (VBN lost) (NP (-NONE- *)) (PP (IN in) (NP (JJ human) (NNS cancers))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Somatic) (NML (NNS deletions) (CC or) (NNS mutations))) (PP (IN of) (NP (DT this) (NN gene)))) (VP (VBP have) (VP (VBN been) (VP (VBN identified) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT a) (JJ large) (NN fraction)) (PP (IN of) (NP (NNS tumors))))) (, ,) (PP (ADVP-TMP (RB frequently)) (IN in) (NP (NP (NN prostate) (NN cancer)) (-LRB- -LRB-) (NP (NN CaP)))) (-RRB- -RRB-) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG placing) (NP (NN PTEN)) (PP (IN among) (NP (NP (DT the) (ADJP (ADVP (RBS most) (RB commonly)) (VBN mutated)) (NML (NN tumor) (NN suppressor)) (NNS genes)) (PP (IN in) (NP (JJ human) (NN cancer))))) (CIT (-LRB- -LRB-) (NNP Cantley) (CC and) (NNP Neel) (CD 1999) (: ;) (NNP Di) (NNP Cristofano) (CC and) (NNP Pandolfi) (CD 2000) (-RRB- -RRB-))))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN dictated) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NNP Knudson) (POS 's)) (`` “) (NML (CD two) (HYPH -) (NN hit)) ('' ”) (NN hypothesis))) (CIT (-LRB- -LRB-) (NNP Knudson) (CD 1971) (-RRB- -RRB-))))) (, ,) (ADVP (RB however)) (, ,) (NP-SBJ-2 (NP (DT the) (NN analysis)) (PP (IN of) (NP (NN cancer) (NNS samples))) (PP (IN for) (NP (NP (NNS mutations)) (PP (IN in) (NP (NN PTEN)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN performed) (NP-2 (-NONE- *)) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG searching) (PP (IN for) (NP (NP (NP (JJ biallelic) (NN inactivation)) (PP (IN of) (NP (DT the) (NN gene)))) (, ,) (SBAR (WHNP-3 (WDT which)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBD pointed) (PP (IN at) (NP (NP (JJ complete) (NN PTEN) (NN inactivation)) (PP (IN as) (NP (NP (DT a) (JJ late) (NN event)) (PP (IN in) (NP (NN cancer) (NN progression))))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN consequence)) (PP (IN of) (NP (NP (NN loss) (CC or) (NN mutation)) (PP-LOC (IN in) (NP (CD one) (NN PTEN) (NN allele))) (PP-LOC (IN in) (NP (NNS carcinomas))) (UCP (ADVP (FW in) (FW situ)) (CC or) (PP-LOC (IN in) (NP (JJ primary) (NNS cancers))))))) (VP (MD may) (VP (VB have) (VP (VBN been) (VP (VBN underestimated) (NP-1 (-NONE- *)))))) (. .)) )
( (S (NP-SBJ-2 (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (MD could) (VP (VB be) (VP (VBN postulated) (NP-2 (-NONE- *)) (SBAR-1 (IN that) (S (SBAR-ADV (IN if) (S (NP-SBJ (NN PTEN)) (VP (VBD were) (S-PRD (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ haploinsufficient)) (PP (IN for) (NP (NP (DT some)) (PP (IN of) (NP (PRP$ its) (ADJP (NN tumor) (HYPH -) (JJ suppressive)) (NNS functions))))))))))) (, ,) (NP-SBJ (NP (NN loss)) (PP (IN of) (NP (NP (CD one) (NN PTEN) (NN allele)) (CC or) (NP (NP (NN reduction)) (PP (IN in) (NP (PRP$ its) (NN expression))))))) (VP (MD may) (VP (VB be) (VP (VBG playing) (NP (DT a) (JJ key) (NN role)) (PP (IN in) (NP (NN tumor) (NN initiation))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NP (JJ further) (NN reduction)) (PP (IN of) (NP (PRP$ its) (NML (NN function) (HYPH /) (NN expression))))) (VP (MD may) (VP (VB favor) (NP (NP (NN invasion)) (CC and) (NP (ADVP (RB possibly)) (NN tumor) (NN metastasis))) (PP-LOC (IN in) (NP (VBN advanced) (NNS cancers))))))))))))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN agreement)) (PP (IN with) (NP (DT this) (NN hypothesis))))) (, ,) (NP-SBJ-2 (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (NP-2 (-NONE- *)) (SBAR-1 (IN that) (S (NP-SBJ (JJ primary) (NNS tumors)) (ADVP-TMP (RB often)) (VP (VBP show) (NP (NP (NN loss) (CC or) (NN alteration)) (PP (IN of) (NP (QP (RB at) (RBS least) (CD one)) (NN PTEN) (NN allele) (PRN (-LRB- -LRB-) (NP (ADVP (FW e.g.)) (, ,) (NP (CD 70) (NN %)) (PP (SYM –) (NP (CD 80) (NN %))) (PP (IN of) (NP (JJ primary) (NNS CaPs))))))))))) (CIT (: ;) (NNP Gray) (FW et) (FW al.) (CD 1998) (: ;) (NNP Whang) (FW et) (FW al.) (CD 1998) (-RRB- -RRB-)) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NP (JJ homozygous) (NN inactivation)) (PP (IN of) (NP (NN PTEN)))) (VP (VBZ is) (ADJP-PRD (RB generally) (JJ associated) (PP (IN with) (NP (NP (JJ advanced) (NN cancer)) (CC and) (NP (NN metastasis))))) (CIT (-LRB- -LRB-) (NNP Cantley) (CC and) (NNP Neel) (CD 1999) (: ;) (NNP Di) (NNP Cristofano) (CC and) (NNP Pandolfi) (CD 2000) (-RRB- -RRB-)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG supporting) (NP (NP (DT a) (JJ possible) (JJ key) (NN role)) (PP (IN for) (NP (JJ progressive) (NN PTEN) (JJ functional) (NN loss))) (PP (IN in) (NP (NN tumor) (NN progression)))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN elucidation)) (PP (IN of) (NP (NP (DT the) (JJ molecular) (NN basis)) (PP (IN for) (NP (NP (NN tumor) (NML (NN initiation) (CC and) (NN progression))) (PP-LOC (IN in) (NP (JJS most) (JJ epithelial) (NNS neoplasms)))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN hindered) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NN lack)) (PP (IN of) (NP (NP (JJ suitable) (UCP (NN laboratory) (CC and) (JJ preclinical)) (NNS models)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (ADVP (RB accurately)) (VP (VBP reflect) (NP (NP (DT the) (ADJP (JJ genetic) (CC and) (JJ histopathological)) (NN progression)) (PP (IN of) (NP (DT these) (NNS cancers)))))))))))))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ-1 (NP (DT the) (NN outcome)) (PP (IN of) (NP (DT a) (JJ progressive) (NN dose) (NN reduction))) (PP (IN in) (NP (NML (NN tumor) (NN suppressor)) (NN function)))) (VP (VBZ has) (VP (VBN been) (ADVP-TMP (RB rarely)) (VP (VBN assessed) (NP-1 (-NONE- *)) (ADVP-LOC (FW in) (FW vivo)) (PP-LOC (IN in) (NP (DT the) (NN mouse)))))) (. .)) )
( (S (NP-SBJ (NML (NML (JJ Small) (VBG interfering) (NN RNA)) (-LRB- -LRB-) (NML (NN siRNA))) (-RRB- -RRB-) (NN technology)) (VP (VBZ has) (ADVP-TMP (RBR more) (RB recently)) (VP (VBN allowed) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG testing) (NP (NP (DT the) (NN consequence)) (PP (IN of) (NP (NP (NN knockdown)) (PP (IN of) (NP (NP (DT a) (NN tumor) (NN suppressor)) (PP (JJ such) (IN as) (NP (NN p53)))))))) (PP-LOC (IN in) (NP (NP (JJ specific) (NN cell) (NNS types)) (PP (JJ such) (IN as) (NP (JJ hemopoietic) (NN stem) (NNS cells))))) (, ,) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG generating) (NP (NP (ADJP (JJ epi) (HYPH -) (JJ allelic)) (NNS series)) (PP (IN of) (NP (NP (NNS hypomorphs)) (VP (VBN created) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NML (NML (JJ stable) (NN RNA) (NN interference)) (-LRB- -LRB-) (NML (NN RNAi))) (-RRB- -RRB-) (NN transduction)))))))))))) (CIT (-LRB- -LRB-) (NNP Hemann) (FW et) (FW al.) (CD 2003) (-RRB- -RRB-)))) (. .)) )
( (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN Pten))))) (, ,) (NP-SBJ-1 (DT this) (NN analysis)) (VP (VBZ is) (ADVP (RB further)) (VP (VBN complicated) (NP-1 (-NONE- *)) (SBAR-PRP (IN since) (S (NP-SBJ (NP (JJ complete) (NN inactivation)) (PP (IN of) (NP (DT the) (NN gene)))) (VP (VBZ results) (PP (IN in) (NP (NP (ADJP (JJ early) (JJ embryonic)) (NN lethality)) (CC and) (NP (JJ aberrant) (JJ developmental) (NNS programs))))))) (CIT (-LRB- -LRB-) (NNP Di) (NNP Cristofano) (FW et) (FW al.) (CD 1998) (, ,) (CD 2001a) (: ;) (NNP Suzuki) (FW et) (FW al.) (CD 1998) (: ;) (NNP Podsypanina) (FW et) (FW al.) (CD 1999) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (NP (DT a) (JJ further) (JJ unrestricted) (NN reduction)) (PP (IN of) (NP (DT the) (NN Pten) (NN dose)))) (VP (MD could) (ADVP-TMP (RB still)) (VP (VB result) (PP (IN in) (NP (JJ embryonic) (NN lethality))))) (. .)) )
( (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP-SBJ (NP (DT the) (NN consequence)) (PP (IN of) (NP (NP (JJ complete) (NN Pten) (NN inactivation)) (, ,) (SBAR (ADVP (RB even)) (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN restricted) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT a) (JJ specific) (NML (NN organ) (HYPH /) (NN tissue)))) (ADVP-TMP-2 (-NONE- *T*)))))))) (, ,) (VP (MD could) (ADVP-TMP (RB still)) (VP (VB affect) (NP (NP (DT the) (JJ developmental) (NN program)) (PP (IN of) (NP (DT that) (NN organ)))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NP (JJ complete) (JJ somatic) (NN loss)) (PP (IN of) (NP (NN Pten))) (PP-LOC (IN in) (NP (DT an) (JJ adult) (NN organ)))) (VP (MD would) (ADVP (RBR better)) (VP (VB approximate) (SBAR-NOM (WHNP-3 (WP what)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBZ is) (ADVP (RB normally)) (VP (VBN observed) (NP-3 (-NONE- *)) (PP-LOC (IN in) (NP (JJ human) (NN cancer))))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN addressed) (NP (DT these) (NNS issues)) (PP (IN for) (NP (NN Pten))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ (PRP we)) (VP (VBP describe) (PP (IN in) (NP (DT this) (NN article)))))) (, ,) (PP-MNR (IN through) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (NP (LST (-LRB- -LRB-) (LS i) (-RRB- -RRB-)) (JJ hypomorphic) (NN mouse) (NNS mutants)) (CC and) (NP (LST (-LRB- -LRB-) (LS ii) (-RRB- -RRB-)) (JJ conditional) (NNS mutants)))) (PP (IN for) (NP (NP (JJ complete) (ADJP (NN prostate) (HYPH -) (JJ specific)) (NN Pten) (NN inactivation)) (PP-TMP (IN after) (NP (NN puberty))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (ADVP-TMP (RB previously)) (VP (VBD reported) (SBAR (IN that) (S (NP-SBJ-1 (NML (NML (NN Pten) (JJ heterozygous)) (-LRB- -LRB-) (NML (NN Pten) (SYM +) (HYPH /) (SYM −))) (-RRB- -RRB-) (NNS mutants)) (VP (VBP are) (ADJP-PRD (JJ prone) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB develop) (NP (NP (NNS neoplasms)) (PP (IN of) (NP (JJ various) (JJ histological) (NNS origins))) (, ,) (PP (VBG including) (NP (NP (JJ prostatic) (JJ intraepithelial) (NNS neoplasias)) (NP (-LRB- -LRB-) (NN PIN)) (-RRB- -RRB-)))) (PP (PP-TMP (IN after) (NP (NP (DT a) (JJ long) (NN latency)) (-LRB- -LRB-) (NP (QP (SYM >) (CD 14)) (NN mo)) (-RRB- -RRB-))) (CC and) (PP (IN at) (NP (NP (JJ incomplete) (NN penetrance)) (-LRB- -LRB-) (NP (CD 40) (NN %)) (-RRB- -RRB-)))) (CIT (-LRB- -LRB-) (NNP Di) (NNP Cristofano) (FW et) (FW al.) (CD 2001a) (-RRB- -RRB-)))))))))) (. .)) )
( (S (NP-SBJ (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (NNS mutants)) (, ,) (ADVP (RB however)) (, ,) (ADVP-TMP (RB never)) (VP (VBP develop) (NP (JJ invasive) (NNS CaPs))) (. .)) )
( (S (NP-SBJ-1 (JJ Invasive) (NNS CaPs)) (VP (VBD were) (, ,) (PP (IN by) (NP (NN contrast))) (, ,) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN compound) (NML (NML (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (SYM /) (NML (NN p27Kip1) (SYM +) (HYPH /) (SYM −))) (CC or) (NML (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (SYM /) (NML (NN p27Kip1) (SYM −) (HYPH /) (SYM −)))) (NNS mutants))) (CIT (-LRB- -LRB-) (NNP Di) (NNP Cristofano) (FW et) (FW al.) (CD 2001a) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (DT These) (NNS lesions)) (VP (VBD appeared) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB originate) (PP-LOC (IN in) (NP (NP (NN PIN) (NNS lesions)) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (ADVP-TMP (RB then)) (VP (VBP become) (ADJP-PRD (JJ invasive))))))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ-1 (DT no) (JJ metastatic) (NN CaP)) (VP (VBD was) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN in) (NP (DT this) (NN model))) (, ,) (PP (ADVP (RB also)) (IN in) (NP (NP (NN view)) (PP (IN of) (NP (NP (JJ early) (NN lethality)) (PP (IN due) (IN to) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NP (JJ concomitant) (NNS tumors)) (PP (IN of) (NP (JJ various) (NN histogenesis))))))))))))) (. .)) )
( (S (NP-SBJ (NP (NN Analysis)) (PP (IN of) (NP (NNS tumors) (, ,) (NN PIN) (, ,) (CC and) (NN CaP))) (PP-LOC (IN in) (NP (NP (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (CC and) (NP (NML (NN Pten) (SYM /) (NN p27Kip1)) (NN compound) (NNS mutants))))) (ADVP (RB strongly)) (VP (VBD suggested) (SBAR (IN that) (S (NP-SBJ (NN Pten)) (VP (MD may) (VP (VB be) (ADJP-PRD (JJ haploinsufficient) (PP (IN in) (NP (NML (NN prostate) (NN tumor)) (NN suppression)))))))) (SBAR-PRP (IN since) (S (NP-SBJ-1 (NML (NN Pten) (NN protein)) (NN expression)) (VP (VBD was) (ADVP-TMP (RB never)) (VP (VBN lost) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT these) (NNS lesions)))))))) (. .)) )
( (S (SBAR-ADV (IN If) (S (NP-SBJ (DT this)) (VP (VBD was) (ADVP (RB indeed)) (NP-PRD (DT the) (NN case))))) (, ,) (NP-SBJ (NP (DT a) (JJ further) (NN reduction)) (PP (IN in) (NP (DT the) (NN Pten) (NN dose))) (PP (IN with) (NP (NP (NN respect)) (PP (IN to) (NP (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (NNS mutants)))))) (VP (MD should) (VP (VB impact) (PP (IN on) (NP (NP (NN tumorigenesis)) (CC and) (NP (NN tumor) (NN progression)))))) (. .)) )
( (S (PP (IN By) (NP (NN contrast))) (, ,) (SBAR-ADV (IN in) (NN case) (S (NP-SBJ-1 (NN Pten)) (VP (VBN needed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADVP (RB completely)) (VP (VBN lost) (NP-1 (-NONE- *)))))) (SBAR-PRP (IN for) (S (NP-SBJ (JJ phenotypic) (NNS consequences)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ manifest))))))))) (, ,) (NP-SBJ (RB only) (DT a) (JJ complete) (NN Pten) (NN inactivation)) (VP (MD would) (VP (VB hasten) (NP (DT the) (JJ neoplastic) (NN process)))) (. .)) )
( (S (NP-SBJ (DT The) (NN discovery) (SBAR (IN that) (S (NP-SBJ (NP (NN phosphatidylinositol) (CD 3) (, ,) (CD 4) (, ,) (CD 5) (HYPH -) (NN trisphosphate)) (-LRB- -LRB-) (NP (NN PIP3))) (-RRB- -RRB-) (VP (VBZ is) (NP-PRD (NP (DT the) (JJ main) (ADJP (FW in) (FW vivo)) (NN substrate)) (PP (IN of) (NP (NN PTEN)))) (CIT (-LRB- -LRB-) (NNP Maehama) (CC and) (NNP Dixon) (CD 1998) (-RRB- -RRB-)))))) (VP (VBD placed) (NP (DT this) (NN phosphatase)) (PP (IN into) (NP (DT a) (ADJP (RB well) (HYPH -) (JJ defined)) (NN pathway))) (CIT (-LRB- -LRB-) (VBN reviewed) (IN in) (NNP Vivanco) (CC and) (NNP Sawyers) (CD 2002) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NN PIP3) (NNS levels)) (VP (VP (VBP are) (ADJP-PRD (RB very) (JJ low)) (PP-LOC (IN in) (NP (JJ quiescent) (NNS cells)))) (, ,) (CC but) (VP (ADVP-TMP (RB rapidly)) (VBP increase) (PP-TMP (IN upon) (NP (NP (NN stimulation)) (PP (IN by) (NP (NN growth) (NNS factors))))) (, ,) (PP-MNR (IN through) (NP (NML (NML (NN phosphoinositide) (CD 3) (HYPH -) (NN kinase)) (-LRB- -LRB-) (NML (NN PI3K))) (-RRB- -RRB-) (NN activation))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN role)) (PP (IN of) (NP (NN PTEN)))) (VP (VBZ is) (S-PRD (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB keep) (NP-1 (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN PIP3)))) (S-CLR (NP-SBJ-1 (-NONE- *PRO*)) (ADJP-PRD (JJ low))) (PP-MNR (IN by) (NP (NP (NN dephosphorylation)) (PP-LOC (IN at) (NP (DT the) (NN D3) (NN position))))))))) (. .)) )
( (S (NP-SBJ (NP (NN Loss)) (PP (IN of) (NP (NN PTEN) (NN function)))) (VP (VBZ results) (PP (IN in) (NP (NP (VBN increased) (NN PIP3) (NNS levels)) (CC and) (NP (JJ subsequent) (NN Akt) (NML (NN hyperactivation) (HYPH /) (NN phosphorylation))))) (CIT (-LRB- -LRB-) (NNP Stambolic) (FW et) (FW al.) (CD 1998) (: ;) (NNP Di) (NNP Cristofano) (FW et) (FW al.) (CD 1999) (: ;) (NNP Backman) (FW et) (FW al.) (CD 2002) (: ;) (NNP Vivanco) (CC and) (NNP Sawyers) (CD 2002) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-2 (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN proposed) (NP-2 (-NONE- *)) (SBAR-1 (IN that) (S (NP-SBJ (NP (DT a) (JJ progressive) (NN reduction)) (PP (IN in) (NP (DT the) (NN Pten) (NN dose)))) (VP (MD could) (ADVP (RB simply)) (VP (VB result) (PP (IN in) (NP (NP (DT a) (JJ concomitant) (JJ progressive) (ADJP (NN dose) (HYPH -) (JJ dependent)) (NN increase)) (PP (IN in) (NP (NP (NN Akt) (NN activation)) (CC and) (NP (PRP$ its) (JJ downstream) (JJ molecular) (JJ biological) (NNS consequences))))))))))))) (. .)) )
( (S (ADVP (RB Alternatively)) (, ,) (NP-SBJ (NN Pten) (NN expression) (NNS levels)) (VP (MD may) (VP (VB constitute) (NP (NP (JJ discrete) (JJ biochemical) (NNS thresholds)) (SBAR (WHPP-1 (IN below) (WHNP (WDT which))) (S (NP-SBJ (JJ qualitative) (JJ functional) (NNS changes)) (VP (MD would) (VP (VB occur) (PP-1 (-NONE- *T*)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG contributing) (PP (IN to) (NP (NN tumor) (NML (NN progression) (CC and) (NN invasion))))))))))))) (. .)) )
( (S (NP-SBJ (NN CaP)) (VP (VBZ is) (NP-PRD (DT the) (ADJP (RBS most) (JJ common)) (NN non-skin) (NN malignancy)) (PP (IN among) (NP (JJ Western) (JJ adult) (NNS males)))) (. .)) )
( (S (NP-SBJ-2 (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (VP (VBN estimated) (NP-2 (-NONE- *)) (SBAR-1 (IN that) (S (PP-TMP (IN in) (NP (CD 2003))) (, ,) (NP-SBJ (NP (QP (RB approximately) (CD 220,900)) (JJ new) (NNS cases)) (CC and) (NP (CD 28,900) (ADJP (NN CaP) (HYPH -) (VBN related)) (NNS deaths))) (VP (MD will) (VP (VB occur) (PP-LOC (IN in) (NP (DT the) (NNP United) (NNP States))))))))) (. .)) )
( (S (NP-SBJ (NP (QP (RB Approximately) (CD 70)) (NN %)) (PP (IN of) (NP (NN CaP) (NNS patients)))) (VP (MD will) (VP (VP (VB harbor) (NP (NN mutation))) (CC or) (VP (VB display) (NP (NP (NP (NN loss)) (PP (IN of) (NP (NP (QP (RB at) (RBS least) (CD one)) (NN allele)) (PP (IN of) (NP (NN PTEN)))))) (VP (VBG ensuing) (PP (IN in) (NP (NP (DT the) (JJ constitutive) (NN activation)) (PP (IN of) (NP (DT the) (NML (NN PI3K) (HYPH /) (NN mTOR)) (NN pathway)))))))) (CIT (-LRB- -LRB-) (NNP Gray) (FW et) (FW al.) (CD 1998) (: ;) (NNP Whang) (FW et) (FW al.) (CD 1998) (: ;) (NNP Di) (NNP Cristofano) (CC and) (NNP Pandolfi) (CD 2000) (-RRB- -RRB-)))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN aforementioned) (NP-1 (-NONE- *))))) (, ,) (NP-SBJ (DT those) (NNS mutations)) (VP (VBP are) (PP-PRD (IN in) (NP (NP (JJ positive) (NN correlation)) (PP (IN with) (NP (NN tumor) (NML (NN stage) (CC and) (NN grade)))))) (, ,) (S-ADV (NP-SBJ-2 (NN PTEN)) (VP (VBG being) (ADVP (RB completely)) (VP (VBN lost) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NP (QP (RB approximately) (CD 40)) (NN %)) (PP (IN of) (NP (JJ metastatic) (NNS CaPs)))))))) (CIT (-LRB- -LRB-) (NNP Gray) (FW et) (FW al.) (CD 1998) (: ;) (NNP Whang) (FW et) (FW al.) (CD 1998) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (PRP We)) (ADVP (RB therefore)) (VP (VBD decided) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB focus) (PP (IN on) (NP (DT the) (NN prostate))) (PP (IN as) (NP (DT an) (JJ important) (NN model) (NN system))) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (ADVP-MNR (RB genetically)) (SBAR (IN whether) (CC and) (WHADVP-2 (WRB how)) (S (NP-SBJ (NP (DT the) (NN dose)) (PP (IN of) (NP (NN Pten)))) (VP (VBZ dictates) (NP (NN tumor) (NML (NN initiation) (CC and) (NN progression))) (ADVP-2 (-NONE- *T*)))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP demonstrate) (ADVP-LOC (FW in) (FW vivo)) (, ,) (PP (IN in) (NP (DT a) (NML (JJ hypomorphic) (NN mouse) (NN mutant)) (NN series))) (, ,) (SBAR (SBAR (IN that) (S (NP-SBJ (NN Pten)) (VP (VBZ plays) (NP (DT a) (JJ crucial) (ADJP (NN dose) (HYPH -) (JJ dependent)) (NN role)) (PP (IN in) (NP (NN CaP) (NN tumor) (NN suppression)))))) (CC and) (SBAR (IN that) (S (NP-SBJ (NN Pten) (JJ progressive) (NN inactivation)) (VP (VBZ leads) (PP (IN to) (NP (NP (ADJP (CC both) (JJ quantitative) (CC and) (JJ qualitative)) (ADJP (JJ molecular) (CC and) (JJ biological)) (NNS changes)) (PP (IN towards) (NP (ADJP (JJ full) (HYPH -) (JJ blown)) (NN tumorigenesis)))))))))) (. .)) )
( (HEADING (NP (NNS Results))) )
( (HEADING (NP (NP (NN Generation)) (PP (IN of) (NP (DT a) (NML (JJ Hypomorphic) (NN Pten) (NN Mutant)) (NN Series))))) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (ADVP-TMP (RB previously)) (VP (VBN reported) (SBAR (IN that) (S (NP-SBJ (NN Pten) (JJ heterozygous) (NNS mutants)) (VP (VBP are) (ADJP-PRD (ADJP (NN tumor) (JJ prone)) (CC and) (ADJP (JJ viable))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (JJ complete) (NN Pten) (NN inactivation)) (VP (VBZ results) (PP (IN in) (NP (JJ embryonic) (NN lethality))))))))) (CIT (-LRB- -LRB-) (NNP Di) (NNP Cristofano) (FW et) (FW al.) (CD 1998) (, ,) (CD 2001a) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-3 (PRP We)) (ADVP (RB therefore)) (VP (VBD decided) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (TO to) (VP (VB generate) (CC and) (VB characterize) (NP (NP (DT a) (NN mouse) (NN mutant)) (SBAR (WHPP-2 (IN in) (WHNP (WDT which))) (S (NP-SBJ-1 (NP (DT the) (NN dose)) (PP (IN of) (NP (NN Pten)))) (VP (MD would) (VP (VB be) (VP (VBN reduced) (NP-1 (-NONE- *)) (ADVP (RB further) (PP (IN below) (NP (NP (DT the) (NNS levels)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT a) (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (NN mutant))))))) (PP-2 (-NONE- *T*)))))))))))) (. .)) )
( (S (PP-PRP (IN To) (NP (DT this) (NN end))) (, ,) (NP-SBJ (PRP we)) (PP-TMP (IN at) (ADVP (RB first))) (VP (VBD engineered) (PP-MNR (IN by) (NP (JJ homologous) (NN recombination))) (NP (NP (NP (DT an) (NN allele)) (PP (IN of) (NP (NN Pten)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD would) (VP (VB express) (NP (DT a) (NML (JJ wild) (HYPH -) (NN type)) (NN Pten) (NN gene)) (PP (IN at) (NP (VBN reduced) (NNS levels))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG taking) (NP (NN advantage)) (PP (IN of) (NP (NP (DT the) (ADJP (RB well) (HYPH -) (VBN known)) (NN phenomenon)) (PP (IN of) (NP (JJ transcriptional) (NN interference))))))) (CIT (-LRB- -LRB-) (NNP McDevitt) (FW et) (FW al.) (CD 1997) (: ;) (NNP Morita) (FW et) (FW al.) (CD 2003) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (ADVP (RB therefore)) (VP (VBD targeted) (PP-LOC (IN within) (NP (NN Pten) (NN intron) (CD 3))) (NP (NP (DT the) (NML (NN neomycin) (-LRB- -LRB-) (NN Neo)) (-RRB- -RRB-) (NN cassette)) (PP (IN under) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (DT the) (JJ strong) (NN CMV) (NN promoter))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 1A)) (: ;) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (ADVP (RB also)) (NP (NN Figure) (CD 3A)))) (-RRB- -RRB-)) (PP-LOC (IN in) (NP (NN mouse) (NML (NML (JJ embryonic) (NN stem)) (-LRB- -LRB-) (NML (NN ES))) (-RRB- -RRB-) (NNS cells))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Transcription)) (PP (IN of) (NP (NP (DT the) (NN Neo) (NN cassette)) (PP-LOC (IN in) (NP (DT the) (VBN recombined) (NN allele)))))) (VP (VBD was) (VP (VBN expected) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (DT the) (NN Pten) (NN gene))))) (, ,) (S-ADV (PP (IN in) (NP (NN turn))) (NP-SBJ (-NONE- *PRO*)) (VP (VBG resulting) (PP (IN in) (NP (NP (JJR lower) (NN expression) (NNS levels)) (PP (IN of) (NP (DT a) (NML (JJ wild) (HYPH -) (NN type)) (NN Pten) (NN protein))) (PP (IN by) (NP (DT this) (NN allele)))))))))))) (. .)) )
( (S (NP-SBJ-1 (ADJP (RB Correctly) (VBN recombined)) (NN ES) (NNS clones)) (VP (VBD were) (VP (VP (VBN obtained) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 3B)))) (: ;) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NNS Materials) (CC and) (NNS Methods)))) (-RRB- -RRB-))) (CC and) (VP (VBN injected) (NP-1 (-NONE- *)) (PP (IN into) (NP (NNS blastocysts))) (PP-PRP (IN for) (NP (NN germline) (NN transmission)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Mutants)) (VP (VBG harboring) (NP (DT the) (NN Ptenhy) (NN allele)))) (VP (VP (VBD were) (VP (VBN obtained) (NP-1 (-NONE- *)) (PP (IN from) (NP (VBN recombined) (NN ES) (NNS cells))))) (CC and) (VP (VBD were) (VP (VBN found) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ viable) (, ,) (VBG thriving) (, ,) (CC and) (JJ fertile)))))) (. .)) )
( (S (NP-SBJ-1 (PRP We)) (ADVP-TMP (RB next)) (VP (VBD intercrossed) (NP (NML (NN Ptenhy) (HYPH /) (SYM +)) (NNS mice)) (PP (IN with) (NP (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (NNS mice))) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB generate) (NP (DT a) (JJ hypomorphic) (NN series))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 1B)) (-RRB- -RRB-))) (. .)) )
( (HEADING (NP (NP (JJ Partial) (NN Rescue)) (PP (IN of) (NP (JJ Embryonic) (NN Lethality))) (PP-LOC (IN in) (NP (NN Pten) (JJ Hypomorphic) (NNS Mutants))))) )
( (S (S (NP-SBJ (NP (DT The) (JJ further) (NN reduction)) (PP (IN of) (NP (DT the) (NN Pten) (NN dose)))) (VP (MD could) (ADVP (RB indeed)) (VP (VB result) (PP (IN in) (NP (JJ embryonic) (NN lethality)))))) (: ;) (S (NP-SBJ (PRP we)) (ADVP (RB therefore)) (VP (VBD assessed) (SBAR-NOM (IN whether) (S (NP-SBJ-1 (NN compound) (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mice)) (VP (MD would) (VP (VB be) (VP (VBN born) (NP-1 (-NONE- *)) (ADVP (RB at) (RB all))))))))) (. .)) )
( (S (PP (IN In) (NP (DT the) (VBN analyzed) (NN cohort) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 190)))) (-RRB- -RRB-)))) (, ,) (NP-SBJ-1 (JJ viable) (ADJP (JJ male) (CC and) (JJ female)) (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants)) (VP (VBD were) (PP (IN in) (NP (NN fact))) (VP (VBN obtained) (NP-1 (-NONE- *)))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NP (DT the) (NNS frequencies)) (PP (IN among) (NP (JJ various) (NNS genotypes)))) (VP (VBD did) (RB not) (VP (VB follow) (NP (JJ Mendelian) (NNS ratios)))) (. .)) )
( (S (PP-TPC-2 (IN Out) (PP (IN of) (NP (NP (DT the) (NML (NML (CD 25) (NN %)) (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants)) (VP (VBN expected) (NP (-NONE- *)) (PP (IN in) (NP (DT these) (NNS crosses))))))) (, ,) (NP-SBJ-1 (NP (QP (RB only) (CD 10)) (NN %)) (PP-2 (-NONE- *T*))) (VP (VBD were) (VP (VBN born) (NP-1 (-NONE- *)))) (. .)) )
( (S (PP (IN In) (ADJP (JJ particular))) (, ,) (NP-SBJ-1 (NP (NP (QP (RB approximately) (CD 40)) (NN %)) (PP (IN of) (NP (DT the) (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS males)))) (CC and) (NP (NP (CD 75) (NN %)) (PP (IN of) (NP (DT the) (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS females))))) (VP (VBD were) (VP (VBN lost) (NP-1 (-NONE- *)) (PP-TMP (IN during) (NP (NN gestation))))) (. .)) )
( (S (NP-SBJ (DT This)) (ADVP (RB strongly)) (VP (VBD suggested) (SBAR (SBAR (IN that) (S (NP-SBJ (NP (DT a) (JJ further) (NN reduction)) (PP (IN of) (NP (DT the) (NN Pten) (NN dose)))) (VP (VBD had) (VP (VBN occurred) (PP-LOC (IN in) (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants))))))) (CC and) (SBAR (IN that) (S (NP-SBJ (DT this) (NN reduction)) (ADVP-TMP (RB still)) (VP (VBZ results) (PP (IN in) (NP (JJ embryonic) (NN lethality))) (, ,) (NAC (IN albeit) (PP-TMP (IN at) (NP (JJ incomplete) (NN penetrance)))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NP (DT the) (JJ embryonic) (NN phenotype)) (PP (IN of) (NP (DT the) (NN Ptenhy) (HYPH /) (SYM −)))) (VP (MD will) (VP (VB be) (VP (VBN described) (NP-1 (-NONE- *)) (ADVP (RB elsewhere)))))) (: ;)))))) (CIT (NNP L.) (NNP C.) (NNP Trotman) (CC and) (NNP P.) (NNP P.) (NNP Pandolfi) (, ,) (JJ unpublished) (NNS data) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (JJ Enough) (JJ viable) (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS males)) (VP (VBD were) (VP (VP (VBN obtained) (NP-1 (-NONE- *)) (, ,) (ADVP (RB however))) (, ,) (CC and) (VP (VBN monitored) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NN tumorigenesis))) (PP-LOC (IN in) (NP (DT the) (NN prostate)))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN predicted) (NP-1 (-NONE- *))))) (, ,) (NP-SBJ-2 (NP (NP (DT a) (JJ significant) (NN reduction)) (PP (IN in) (NP (NN Pten) (NNS levels)))) (CC and) (NP (NP (DT the) (JJ consequent) (NN increase)) (PP (IN in) (NP (NN Akt) (NN activation))) (PRN (-LRB- -LRB-) (NP (NML (NN phospho-Akt) (HYPH /) (NN Akt)) (NN ratio)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN observed) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NP (NNS organs)) (CC and) (NP (JJ primary) (NNS cells))) (PP (IN from) (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants))))) (SBAR-ADV (WHADVP-4 (WRB when)) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN compared) (NP-3 (-NONE- *)) (PP (IN to) (NP (NML (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (, ,) (NML (NN Ptenhy) (HYPH /) (SYM +)) (, ,) (CC and) (NML (JJ wild) (HYPH -) (NN type))) (NNS littermates))) (ADVP-TMP-4 (-NONE- *T*))))))) (. .)) )
( (S (PP (IN In) (ADJP (JJ particular))) (, ,) (NP-SBJ (PRP we)) (VP (VBD analyzed) (NP (NP (NP (NN mouse) (JJ embryonic) (NNS fibroblasts)) (-LRB- -LRB-) (NP (NNS MEFs))) (-RRB- -RRB-) (, ,) (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (-LRB- -LRB-) (NP (NNS PBMCs))) (-RRB- -RRB-) (, ,) (CC and) (NP (NP (NNS prostates)) (PP (IN of) (NP (JJ various) (NNS genotypes))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 1C)) (: ;) (NP (NN Figure) (NML (CD 2A) (CC and) (CD 2B))) (: ;) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (JJ Semiquantitative) (NML (NN RT) (HYPH –) (NN PCR)) (NN analysis)) (VP (VBD confirmed) (NP (NP (DT the) (NN reduction)) (PP (IN of) (NP (NML (NN Pten) (NN mRNA)) (NN expression))) (PP-LOC (IN in) (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS MEFs)))) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN to) (NP (NML (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (CC and) (NML (JJ wild) (HYPH -) (NN type))) (NNS cells))) (ADVP-TMP-2 (-NONE- *T*))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 1D)))) (-RRB- -RRB-))) (. .)) )
( (HEADING (NP (NP (NP (JJ Massive) (NN Prostate) (NN Hyperplasia)) (CC and) (NP (JJ Invasive) (NN CaP))) (PP-LOC (IN in) (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS Mutants))))) )
( (S (NP-SBJ-1 (NP (DT The) (NNS levels)) (PP (IN of) (NP (NN Pten)))) (VP (VBD were) (ADVP (RB indeed)) (ADVP (RB further)) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (NNS prostates)) (PP (IN from) (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants))))) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN compared) (NP-2 (-NONE- *)) (PP (IN to) (NP (NML (NML (JJ wild) (HYPH -) (NN type)) (, ,) (NML (NN Ptenhy) (HYPH /) (SYM +)) (, ,) (CC and) (NML (NN Pten) (SYM +) (HYPH /) (SYM −))) (NNS mice))) (ADVP-TMP-3 (-NONE- *T*))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (CD 2A) (CC and) (CD 2B))) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP (RB Conversely)) (, ,) (NP-SBJ-1 (NN Akt) (NN activation)) (VP (VBD was) (VP (VBN increased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2B)) (-RRB- -RRB-)))) (. .)) )
( (S (PP-PRP (IN On) (NP (DT this) (NN premise))) (, ,) (NP-SBJ (PRP we)) (ADVP (RB therefore)) (VP (VBD studied) (NP (NN prostate) (NN tumorigenesis)) (PP-LOC (IN in) (NP (NML (NML (NN Ptenhy) (HYPH /) (SYM +) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 26)))) (-RRB- -RRB-))) (, ,) (NML (NN Pten) (SYM +) (HYPH /) (SYM −) (PRN (-LRB- -LRB-) (S (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 24)) (PP (IN in) (NP (DT this) (NN study))))) (CC plus) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 18)) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN reported) (NP-1 (-NONE- *))))) (: ;) (CIT (NNP Di) (NNP Cristofano) (FW et) (FW al.) (CD 2001a))))) (-RRB- -RRB-))) (, ,) (CC and) (NML (NN Ptenhy) (HYPH /) (SYM −) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 14)))) (-RRB- -RRB-)))) (NNS mutants))) (PP (IN on) (NP (DT a) (JJ comparative) (NN basis)))) (. .)) )
( (S (NP-SBJ-1 (NNS Mice)) (VP (VBD were) (VP (VBN followed) (NP-1 (-NONE- *)) (PP-TMP (IN throughout) (NP (PRP$ their) (NNS lives))) (PP-MNR (VBG according) (PP (IN to) (NP (DT the) (JJ following) (JJ experimental) (NN scheme) (: :))))))) )
( (S (LST (-LRB- -LRB-) (LS i) (-RRB- -RRB-)) (NP-SBJ-2 (DT all) (NNS cohorts)) (VP (VBD were) (VP (VBN subjected) (NP-2 (-NONE- *)) (PP (IN to) (NP (JJ serial) (JJ monthly) (PRN (-LRB- -LRB-) (PP (IN in) (NP (VBN selected) (NNS cases))) (, ,) (ADJP (JJ biweekly)) (-RRB- -RRB-)) (JJ nuclear) (NML (NML (JJ magnetic) (NN resonance) (NN imaging)) (-LRB- -LRB-) (NML (NN MRI))) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NNS Materials) (CC and) (NNS Methods)))) (-RRB- -RRB-)) (PP-PRP (IN for) (NP (NP (NN detection)) (PP (IN of) (NP (NP (JJ morphological) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NML (NN size) (CC and) (NN shape))) (PP (IN of) (NP (DT the) (NN prostate))))))))))) (: ;)) )
( (S (LST (-LRB- -LRB-) (LS ii) (-RRB- -RRB-)) (NP-SBJ-3 (NNS mice)) (VP (VBD were) (VP (VBN sacrificed) (NP-3 (-NONE- *)) (PP-TMP (PP (IN at) (NP-4 (-NONE- *RNR*))) (CC or) (PP (IN prior) (PP (IN to) (NP-4 (-NONE- *RNR*)))) (NP-4 (NN tumor) (NN detection))) (PP-PRP (IN for) (NP (JJ postmortem) (JJ pathological) (NN analysis))) (NAC (CC or) (SBAR-TMP (WHADVP-6 (WRB when)) (S (NP-SBJ-5 (NP (JJ manifest) (NN sign)) (PP (IN of) (NP (NN distress)))) (VP (VBD were) (VP (VBN observed) (NP-5 (-NONE- *)) (ADVP-TMP-6 (-NONE- *T*))))))))) (PRN (-LRB- -LRB-) (S (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG owing) (PP (IN to) (NP (NN tumor) (NN codevelopment))))) (: ;)))) )
( (S (NP-SBJ (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants)) (, ,) (PP (IN as) (NP (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (NNS mice)))) (, ,) (PP (IN in) (NP (NN fact))) (, ,) (VP (VBD developed) (NP (NP (NNS tumors)) (PP (IN of) (NP (JJ multiple) (JJ histologic) (NNS origins))))) (: ;)) )
( (S (NP-SBJ-7 (NNS data)) (RB not) (VP (VBN shown) (NP-7 (-NONE- *))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ-1 (JJ Striking) (NNS differences)) (VP (VBD were) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (NNS prostates)) (PP (IN of) (NP (DT these) (CD three) (NNS cohorts))))) (PP-TMP (IN over) (NP (NN time))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NNS prostates)) (PP (IN of) (NP (NML (NML (NN Pten) (SYM +) (HYPH /) (SYM +)) (CC and) (NML (NN Pten) (SYM +) (HYPH /) (SYM −))) (NNS mice)))) (VP (VBD were) (ADVP (RB never)) (VP (VBN found) (S (NP-SBJ-1 (-NONE- *)) (VP (VBN enlarged) (PP-MNR (IN by) (NP (NN MRI) (NN analysis))))) (PP-TMP (IN at) (NP (DT any) (NN age))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2C)) (: ;) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 5D)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (NNS mutants)) (VP (VBD developed) (NP (NP (NP (NML (ADJP (JJ moderate) (HYPH /) (JJ low)) (HYPH -) (NN grade)) (NNS PINs)) (PP (IN at) (NP (JJ incomplete) (NN penetrance) (PRN (-LRB- -LRB-) (NP (NP (CD 35) (NN %)) (PP (SYM –) (NP (CD 40) (NN %))) (ADVP (RB approximately)) (, ,) (PP (IN after) (NP (NP (DT a) (JJ long) (NN latency)) (PP (IN of) (NP (QP (SYM >) (CD 12)) (NN mo)))))) (-RRB- -RRB-))))) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD were) (ADVP (RB only)) (VP (VBN detected) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (JJ serial) (NN postmortem) (NN analysis)))))))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN reported) (NP-3 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2F)) (: ;))))) (CIT (NNP Di) (NNP Cristofano) (FW et) (FW al.) (CD 2001a) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB Strikingly)) (, ,) (ADVP (RB however)) (, ,) (NP-SBJ (NN MRI) (NN analysis)) (ADVP-TMP (RB immediately)) (VP (VBD revealed) (NP (DT a) (JJ profound) (NN difference)) (PP-LOC (IN in) (NP (DT the) (NML (NN Ptenhy) (HYPH /) (SYM −)) (NN cohort)))) (. .)) )
( (S (S (NP-SBJ-1 (NP (DT The) (NNS prostates)) (PP (IN of) (NP (DT these) (NNS mice)))) (VP (VBD were) (VP (VBN found) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (RB markedly) (JJ enlarged)))))) (, ,) (CC and) (S (NP-SBJ-2 (NN prostate) (NNS growths)) (VP (VBD were) (VP (VBN detected) (NP-2 (-NONE- *)) (S-TMP (NP-SBJ (-NONE- *PRO*)) (VP (VBG starting) (PP-TMP (IN at) (NP (CD 3) (NN mo))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 5D)))) (-RRB- -RRB-))))) (. .)) )
( (S (PP-TMP (IN By) (NP (QP (CD 6) (SYM –) (CD 8)) (NN mo))) (, ,) (NP-SBJ (DT these) (NNS growths)) (ADVP (RB typically)) (VP (VBD surpassed) (NP (NP (DT the) (NN size)) (PP (IN of) (NP (JJ seminal) (NNS vesicles)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (CD 2C) (CC and) (CD 2D))) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (NP-SBJ-1 (NN prostate) (NNS enlargements)) (VP (VBD were) (RB not) (VP (VBN accompanied) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT an) (JJ overall) (NN increase)) (PP (IN in) (NP (NP (JJ total) (NN body) (NN weight)) (CC or) (NP (NN size)))))) (PP-LOC (IN in) (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (JJ Postmortem) (JJ pathological) (NN analysis)) (PP (IN of) (NP (JJ such) (NNS mutants)))) (VP (VBD confirmed) (NP (NP (DT the) (JJ marked) (JJ epithelial) (NN hyperplasia)) (PP (IN of) (NP (DT the) (NN prostate)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2F)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (DT All) (NNS lobes)) (VP (VBD were) (VP (VBN found) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ hypercellular)) (, ,) (PP (IN with) (NP (NP (JJ prominent) (JJ macroscopic) (NNS enlargements)) (PP (IN of) (NP (ADJP (JJ anterior) (CC and) (JJ dorsolateral)) (NNS lobes)))))))))) (. .)) )
( (S (ADVP (RB Microscopically)) (, ,) (NP-SBJ-1 (NP (DT the) (ADJP (JJ regular) (CC and) (JJ round)) (JJ prostatic) (NNS glands)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))))) (VP (VBD were) (VP (VBN replaced) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (ADJP (JJ large) (, ,) (JJ irregular) (, ,) (CC and) (JJ complex)) (NNS glands)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD contained) (NP (JJ multiple) (JJ intraluminal) (JJ papillary) (NNS projections)) (ADVP-TMP (RB already)) (PP-TMP (IN at) (NP (NN age) (QP (CD 2) (SYM –) (CD 3)) (NN mo)))))))))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (JJ many) (NNS cells)) (VP (VBD had) (NP (NP (JJ sizeable) (NNS nuclei)) (, ,) (NP (JJ clumped) (NN chromatin)) (, ,) (CC and) (NP (JJ prominent) (NNS nucleoli))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG forming) (NP (NP (NNS foci)) (PP (IN of) (NP (JJ epithelial) (NN dysplasia))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN phenotype)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NML (DT the) (NN Ptenhy) (HYPH /) (SYM −)) (NNS mice))))) (VP (VBD was) (VP (VBN characterized) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (DT a) (JJ wide) (NN spectrum)) (PP (IN of) (NP (NP (NNS levels)) (PP (IN of) (NP (JJ cellular) (NN differentiation)))))) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD was) (RB not) (ADVP (RB typically)) (VP (VBN observed) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (NNS mice))))))))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ (PRP we)) (ADVP-TMP (RB previously)) (VP (VBD reported) (PP-LOC (IN in) (NP (NML (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (CC and) (NML (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (HYPH /) (NML (NN p27Kip1) (SYM −) (HYPH /) (SYM −)))) (NNS mutants) (CIT (-LRB- -LRB-) (NNP Di) (NNP Cristofano) (FW et) (FW al.) (CD 2001a) (-RRB- -RRB-))))))) (, ,) (S (S (NP-SBJ-1 (NML (NN Pten) (NN protein)) (NN expression)) (VP (VBD was) (ADVP (RB also)) (ADVP-TMP (RB still)) (VP (VBN retained) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (JJ hyperplastic) (NNS prostates)) (PP (IN from) (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants)))))))) (, ,) (CC and) (S (NP-SBJ (NML (NNP Southern) (NN blot)) (NN analysis)) (VP (VBD confirmed) (NP (NP (NN retention)) (PP (IN of) (NP (DT the) (JJ hypomorphic) (NN Pten) (NN allele)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2E)) (: ;) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-))))) (. .)) )
( (S (ADVP (RB Importantly)) (, ,) (NP-SBJ (NP (QP (RB approximately) (CD 25)) (NN %)) (PP (IN of) (NP (NP (DT the) (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mice)) (VP (VBN analyzed) (NP (-NONE- *)) (PP-TMP (IN at) (NP (NP (QP (JJR more) (IN than) (CD 6)) (NN mo)) (PP (IN of) (NP (NN age))))))))) (VP (VBD showed) (NP (NP (JJ histological) (NNS signs)) (PP (IN of) (NP (JJ local) (NN invasion)))) (, ,) (PP (IN with) (S-NOM (NP-SBJ (NN tumor) (NNS cells)) (VP (VP (VBG disrupting) (NP (NP (DT the) (NN basement) (NN membrane)) (PP (IN of) (NP (DT the) (NN gland))))) (CC and) (VP (VBG growing) (PP-DIR (IN into) (NP (DT the) (VBG surrounding) (NN stroma))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2F)) (: ;) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 5E)))) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (ADVP (RB strikingly)) (, ,) (NP-SBJ (NP (DT a) (JJ further) (NN reduction)) (PP (IN in) (NP (DT the) (NN Pten) (NN dose)))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants))) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN compared) (NP-2 (-NONE- *)) (PP (IN with) (NP (NML (NN Pten) (SYM +) (HYPH /) (NN −)) (NNS mutants))) (ADVP-TMP-3 (-NONE- *T*)))))))) (VP (VP (VBZ does) (VP (VB lead) (PP (IN to) (NP (JJ massive) (NN prostate) (NN hyperplasia))) (PP-TMP (IN at) (NP (JJ complete) (NN penetrance))))) (CC and) (VP (VBZ accelerates) (NP (NN tumor) (NN progression)) (PP (PP (IN from) (NP (NML (JJ high) (HYPH -) (NN grade)) (NN PIN) (PRN (-LRB- -LRB-) (NP (NP (NML (NML (NN grade) (CD 3)) (PP (SYM –) (NP (CD 4)))) (NN tumor)) (PP (IN as) (PP (IN per) (NP (NP (DT the) (NN CaP) (NN grading) (NN system)) (PP (IN for) (NP (ADJP (RB genetically) (VBN engineered)) (NNS mice))) (CIT (: ;) (NNP Park) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-))))))))) (PP (IN to) (NP (ADJP (RB locally) (JJ invasive)) (NN CaP)))) (PP-LOC (IN in) (NP (DT this) (NN mouse) (NN model))))) (. .)) )
( (HEADING (NP (NP (NN Generation)) (PP (IN of) (NP (JJ Conditional) (ADJP (NN Prostate) (HYPH -) (JJ Specific)) (NN Pten) (NNS Mutants))))) )
( (S (NP-SBJ (PRP We)) (ADVP-TMP (RB next)) (VP (VBD determined) (SBAR (IN whether) (S (NP-SBJ (NP (JJ complete) (NN Pten) (NN inactivation)) (PP-LOC (IN in) (NP (DT the) (NN prostate)))) (VP (MD would) (ADVP (RB further)) (VP (VB affect) (NP (NML (NN CaP) (NN tumor)) (NN progression))))))) (. .)) )
( (S (PP-PRP (IN To) (NP (DT this) (NN end))) (, ,) (NP-SBJ (PRP we)) (VP (VBD generated) (NP (NP (NN mouse) (NNS mutants)) (SBAR (WHPP-2 (IN in) (WHNP (WDT which))) (S (NP-SBJ-1 (NN Pten) (NNS exons) (NML (CD 4) (CC and) (CD 5))) (VP (VBP are) (VP (VBN flanked) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN loxP) (NNS sites))) (PP-2 (-NONE- *T*))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 3A)) (: ;) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NNS Materials) (CC and) (NNS Methods)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN Neo) (NN cassette)) (VP (VBD was) (VP (VBN excised) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT the) (NN locus))) (ADVP-LOC (FW in) (FW vivo)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG intercrossing) (NP (NML (NN Ptenhy) (HYPH /) (SYM +)) (NML-2 (-NONE- *RNR*))) (PP (IN with) (NP (NML (NN EIIA) (HYPH -) (NN Cre)) (NML-2 (-NONE- *RNR*)))) (NML-2 (JJ transgenic) (NNS mice))))) (CIT (-LRB- -LRB-) (NNP Lakso) (FW et) (FW al.) (CD 1996) (-RRB- -RRB-)))) (. .)) )
( (S (PP-LOC (IN In) (NP (DT these) (NNS mice))) (, ,) (NP-SBJ-1 (DT the) (NN Cre) (NN recombinase)) (VP (VBZ is) (VP (VBN expressed) (NP-1 (-NONE- *)) (ADVP (RB transiently)) (, ,) (ADVP-TMP (RB early) (PP (IN in) (NP (NN embryogenesis)))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG allowing) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (DT a) (JJ mosaic) (NN progeny)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ harbors) (PP-LOC (IN in) (NP (DT the) (NN germline) (NN Pten))) (NP (NP (NNS alleles)) (PP (IN in) (NP (NP (CD three) (JJ different) (NNS configurations)) (: :) (NP (NP (VBN targeted) (JJ unmodified) (PRN (-LRB- -LRB-) (S (NP-SBJ (-NONE- *PRO*)) (ADVP-TMP (RB still)) (VP (VBG retaining) (NP (DT the) (NN Neo) (NN cassette)))) (-RRB- -RRB-))) (, ,) (NP (NP (NN Pten)) (VP (VBN floxed) (NP (-NONE- *)))) (, ,) (CC or) (NP (NP (NN Pten)) (VP (VBN deleted) (NP (-NONE- *)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 3A)) (-RRB- -RRB-)))))))))))))))) (. .)) )
( (S (NP-SBJ (NP (NN Breeding)) (PP (IN of) (NP (DT these) (JJ mosaic) (NNS mutants)))) (VP (VBD allowed) (S (NP-SBJ-1 (PRP us)) (VP (TO to) (VP (VB generate) (NP (NP (NNS mice)) (ADJP (JJ heterozygous) (PP (IN for) (NP (DT the) (ADJP (NN Pten) (VBN floxed)) (NN allele) (PRN (-LRB- -LRB-) (NP (NN PtenloxP) (NNS mutants)) (: ;) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 3B)))) (-RRB- -RRB-)))))))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN expected) (NP-1 (-NONE- *))))) (, ,) (NP-SBJ-2 (NN PtenloxP) (NNS mice)) (VP (VP (VBD were) (VP (VBN born) (NP-2 (-NONE- *)) (PP (VBG following) (NP (JJ Mendelian) (NNS frequencies))) (, ,) (S-CLR (NP-SBJ-2 (-NONE- *PRO*)) (ADJP-PRD (JJ viable) (CC and) (JJ fertile))))) (, ,) (CC and) (VP (VBD were) (VP (VBN utilized) (NP-2 (-NONE- *)) (PP-PRP (IN for) (NP (NP (DT the) (JJ conditional) (NN inactivation)) (PP (IN of) (NP (DT the) (NN Pten) (NN gene))) (PP-LOC (IN in) (NP (DT the) (NN prostate)))))))) (. .)) )
( (S (PP-PRP (IN To) (NP (DT this) (NN end))) (, ,) (NP-SBJ (PRP we)) (VP (VBD made) (NP (NN use)) (PP (IN of) (NP (NP (NP (CD two) (JJ different) (NN Cre) (JJ transgenic) (NNS lines)) (, ,) (NP (NP (NN PB) (HYPH -) (NN Cre)) (CC and) (NP (NN PB) (HYPH -) (NN Cre4)))) (, ,) (SBAR (WHPP-1 (IN in) (WHNP (WDT which))) (S (NP-SBJ (DT the) (NN Cre) (NN gene)) (VP (VBZ is) (PP-PRD (IN under) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NP (CD two) (JJ distinct) (NNS versions)) (PP (IN of) (NP (DT the) (NN rat) (NML (NML (NN Probasin)) (-LRB- -LRB-) (NML (NN PB))) (-RRB- -RRB-) (NN gene) (NN promoter))))))) (PP-1 (-NONE- *T*))))))) (CIT (-LRB- -LRB-) (NNP Maddison) (FW et) (FW al.) (CD 2000) (: ;) (NNP Wu) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN PB) (NN gene)) (VP (VBZ is) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (JJ prostatic) (NN epithelium))) (ADVP-TMP (RB postpuberty)) (SBAR-PRP (IN since) (S (NP-SBJ (DT the) (NN gene)) (VP (VBZ is) (ADJP-PRD (NN androgen) (JJ responsive))))) (CIT (-LRB- -LRB-) (NNP Matusik) (FW et) (FW al.) (CD 1986) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP (RB Hence)) (, ,) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT both) (NML (NN PB) (HYPH -) (NN Cre)) (JJ transgenic) (NNS lines)))) (, ,) (NP-SBJ (NP (NN excision)) (PP (IN of) (NP (DT the) (NN Pten) (NN gene)))) (VP (MD would) (VP (VB occur) (PP-LOC (IN in) (NP (DT the) (JJ prostatic) (NN epithelium))) (ADVP-TMP (RB postpuberty)))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBZ is) (PP-PRD (IN of) (NP (NN relevance))) (SBAR-PRP (IN because) (S (NP-SBJ (PRP it)) (VP (VBZ avoids) (NP (DT any) (JJ possible) (JJ developmental) (NN effect)) (PP-PRP (IN due) (IN to) (NP (NP (JJ complete) (NN inactivation)) (PP (IN of) (NP (NN Pten))) (PP-TMP (IN during) (NP (NN prostate) (NN organogenesis))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ main) (NN difference)) (PP (IN in) (NP (DT the) (CD two) (NNS lines)))) (ADVP (RB essentially)) (VP (VBZ resides) (PP (IN in) (NP (NP (DT the) (NN strength)) (PP (IN of) (NP (DT the) (NN promoter)))))) (. .)) )
( (S (PP-LOC (IN In) (NP (DT the) (NML (NN PB) (HYPH -) (NN Cre4)) (NN line) (CIT (-LRB- -LRB-) (NNP Wu) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-)))) (, ,) (NP-SBJ-1 (DT the) (NN Cre) (NN gene)) (VP (VBZ is) (VP (VBN driven) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (DT a) (JJ composite) (NN promoter)) (, ,) (NP (NN ARR2) (NN PB))) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ is) (NP-PRD (NP (DT a) (NN derivative)) (PP (IN of) (NP (NP (DT the) (NN rat) (NN PB) (NN promoter)) (SBAR (WHPP-3 (IN from) (WHNP (WDT which))) (S (NP-SBJ-4 (DT the) (NML (NN PB) (HYPH -) (NN Cre)) (NN line) (CIT (-LRB- -LRB-) (NNP Maddison) (FW et) (FW al.) (CD 2000) (-RRB- -RRB-))) (VP (VBD was) (ADVP-TMP (RB originally)) (VP (VBN generated) (NP-4 (-NONE- *)) (PP-3 (-NONE- *T*)))))))))))))))) (. .)) )
( (S (NP-SBJ (NML (NN PB) (HYPH -) (NN Cre4)) (NNS mice)) (VP (VBP express) (NP (NN Cre)) (PP (PP (IN at) (NP (JJ high) (NNS levels))) (CC and) (PP (IN at) (NP (JJ high) (NN penetrance)))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NML (NN PB) (HYPH -) (NN Cre)) (NNS mice)) (VP (VBP express) (NP (NN Cre)) (PP (PP (IN at) (NP (JJR lower) (NNS levels))) (CC and) (PP-LOC (IN in) (NP (JJR fewer) (NNS cells)))))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (MD could) (PP (IN in) (NP (NN turn))) (VP (VB result) (PP (IN in) (NP (DT a) (ADJP (ADJP (RBR more) (JJ focal)) (CC or) (ADJP (RBR more) (JJ diffuse))) (NN inactivation))) (PP-LOC (IN on) (NP (NN Pten))) (PP-LOC (IN in) (NP (DT the) (JJ prostatic) (NN epithelium))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ (PRP we)) (VP (MD could) (ADVP (RB indeed)) (VP (VB document))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 4A)) (-RRB- -RRB-)))) (. .)) )
( (S (PP (ADVP (RB Also)) (IN of) (NP (NN note))) (, ,) (NP-SBJ-1 (NML (NML (NN PB) (HYPH -) (NN Cre)) (CC and) (NML (NN PB) (HYPH -) (NN Cre4))) (NNS mice)) (VP (VBD were) (VP (VBN crossed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN PtenloxP) (NNS mutants))) (PP-PRP (IN in) (NP (NN order) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB generate) (NP (NML (NN PB) (HYPH -) (NN Cre)) (HYPH /) (NN PtenloxP) (HYPH /) (NN loxP) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (-NONE- *PRO*)) (ADVP-TMP (RB hereafter)) (VP (VBN referred) (PP (IN to) (NP-2 (-NONE- *))) (PP-MNR (IN as) (NP (NN Ptenpc1) (NNS mutants))))) (-RRB- -RRB-))) (CC or) (NP (NML (NN PB) (HYPH -) (NN Cre4)) (HYPH /) (NN PtenloxP) (HYPH /) (NN loxP) (PRN (-LRB- -LRB-) (S (NP-SBJ-3 (-NONE- *PRO*)) (ADVP (RB hereafter)) (VP (VBN referred) (PP (IN to) (NP-3 (-NONE- *))) (PP-MNR (IN as) (NP (NN Ptenpc2) (NNS mutants))))) (-RRB- -RRB-)))))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 3C)))) (-RRB- -RRB-)))) (. .)) )
( (HEADING (S (NP-SBJ (NP (DT The) (NN Dose)) (PP (IN of) (NP (NN Pten)))) (VP (VBZ Dictates) (NP (NN Tumor) (NN Progression)) (PP-LOC (IN in) (NP (DT the) (NN Prostate)))))) )
( (S (NP-SBJ (PRP We)) (ADVP-TMP (RB next)) (VP (VBD studied) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (JJ complete) (NN Pten) (NN inactivation))) (PP (IN on) (NP (NN prostate) (NN tumorigenesis)))) (PP-LOC (IN in) (NP (NML (NN Ptenpc1) (CC and) (NN Ptenpc2)) (NNS mutants)))) (. .)) )
( (S (NP-SBJ-1 (NNS Mice)) (VP (VBD were) (VP (VBN followed) (NP-1 (-NONE- *)) (PP-TMP (IN over) (NP (NN time))) (SBAR-ADV (ADVP (RB exactly)) (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (PP (IN for) (NP (DT the) (NN Pten) (JJ hypomorphic) (NN series)))))) (PP-MNR (IN by) (NP (UCP (NML (JJ serial) (NN MRI)) (CC and) (ADJP (JJ pathological))) (NN analysis))) (PP-TMP (IN over) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (QP (RB approximately) (CD 18)) (NN mo))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (CD 5D) (CC and) (CD 5E))) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP (RB Strikingly)) (, ,) (NP-SBJ (PRP we)) (VP (VBD observed) (NP (DT a) (JJ dramatic) (NN difference)) (PP-LOC (IN in) (NP (NML (NN Ptenpc1) (HYPH /) (CD 2)) (NNS mutants))) (SBAR-TMP (SBAR (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN to) (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants))) (ADVP-TMP-2 (-NONE- *T*))))) (, ,) (CC but) (SBAR-TMP (ADVP (RB also)) (, ,) (ADVP (RB importantly)) (, ,) (WHADVP-3 (WRB when)) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBG comparing) (NP (NN Ptenpc1)) (PP (IN with) (NP (NN Ptenpc2) (NNS mutants))) (ADVP-TMP-3 (-NONE- *T*))))))) (. .)) )
( (S (NP-SBJ (NP (UCP (NN MRI) (CC and) (JJ macroscopic)) (JJ postmortem) (NN analysis)) (PP (IN of) (NP (DT the) (NN prostate)))) (VP (VBD revealed) (NP (NP (DT a) (JJ rapid) (JJ massive) (NN enlargement)) (PP (IN of) (NP (NP (PDT all) (DT the) (JJ prostatic) (NNS lobes)) (VP (ADVP-TMP (RB already)) (VBN manifested) (NP (-NONE- *)) (PP (IN from) (NP (NP (QP (CD 2) (SYM –) (CD 3)) (NN mo)) (PP (IN of) (NP (NN age))))) (PP-LOC (IN in) (NP (NN Ptenpc2) (NNS mutants))) (PP-TMP (IN at) (NP (JJ complete) (NN penetrance))))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NP (NN Figure) (CD 4B)) (: ;) (NP (NN Figure) (CD 5D))))) (-RRB- -RRB-))) (. .)) )
( (S (PP-LOC (IN In) (NP (NN Ptenpc1) (NNS mutants))) (, ,) (NP-SBJ (DT the) (NN enlargement)) (VP (VBD was) (ADJP-PRD (ADJP (ADJP (RBR less) (JJ pronounced) (PP-TMP (IN at) (NP (JJ early) (NNS stages)))) (CC and) (ADJP (JJ undetectable) (PP-MNR (IN by) (NP (NN MRI))))) (, ,) (CC but) (ADJP (ADVP-TMP (RB still)) (JJ apparent))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NP (NN Figure) (CD 4B)) (: ;) (NP (NN Figure) (CD 5D))))) (-RRB- -RRB-))) (. .)) )
( (S (SBAR-ADV (IN As) (FRAG (ADJP (JJ aforementioned)))) (, ,) (NP-SBJ (NP (DT the) (NN pattern)) (PP (IN of) (NP (NN Pten) (NN inactivation))) (PP-LOC (IN in) (NP (DT the) (JJ prostatic) (NN epithelium)))) (VP (VBD was) (ADJP-PRD (JJ different)) (PP-LOC (IN in) (NP (NML (NN Ptenpc1) (CC versus) (NN Ptenpc2)) (NNS mutants))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NP (NN Figure) (CD 4A)) (: ;) (NP (NP (NP (NN Ptenpc1)) (ADJP (JJ focal))) (CC versus) (NP (NP (NN Ptenpc2)) (ADJP (JJ widespread))))))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT This) (NN difference)) (ADVP (RB also)) (VP (VBD correlated) (PP (IN with) (NP (NP (DT a) (JJ clear) (NN difference)) (PP (IN in) (NP (NP (CC both) (DT the) (NML (NML (NN morphology)) (CC and) (NML (JJ proliferative) (NNS rates)))) (PP (IN of) (NP (DT the) (JJ prostatic) (NN epithelium))))))) (PP-LOC (IN in) (NP (DT these) (CD two) (NNS models))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 4A)))) (: ;) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (ADVP (RB also)) (NP (DT the) (JJ following) (NN paragraph)))) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (NN Ptenpc2) (NNS mutants)) (VP (VBD displayed) (NP (NP (DT a) (ADJP (ADVP (RB much) (RBR more)) (JJ severe)) (NN prostate) (NN enlargement)) (SBAR (IN than) (SINV (VBD did) (NP-SBJ (NN Ptenpc1) (NNS mutants)) (VP (-NONE- *?*))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 4B)) (: ;) (NP (NN Figure) (CD 5D)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NN Ptenpc1) (NNS mice)) (VP (VBD displayed) (NP (NP (JJ focal) (NNS areas)) (PP (IN of) (NP (JJ epithelial) (NN hyperplasia))) (, ,) (PP (IN with) (NP (NP (VBN enlarged) (NNS glands)) (VP (VBN formed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (RB relatively) (JJ regular) (NNS cells))))))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NN Ptenpc2) (NNS mice)) (VP (VBD presented) (NP (JJ disorganized) (JJ hyperplastic) (NNS glands)) (PP-LOC (IN in) (NP (DT all) (NNS lobes))) (PP (IN with) (NP (NP (NNS signs)) (PP (IN of) (NP (JJ cellular) (NN dysplasia))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG containing) (NP (NP (JJ large) (, ,) (JJ irregular) (NNS cells)) (, ,) (VP (VBG forming) (PP-TMP (IN at) (NP (NNS times))) (NP (JJ cryptic) (JJ glandular) (NNS formations))))))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 4A)))) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (ADVP (RB Even) (RBR more)) (RB strikingly)) (, ,) (ADVP (RB however)) (, ,) (NP-SBJ (NP (JJ pathological) (NN analysis)) (PP (IN of) (NP (NP (NNS prostates)) (PP (IN from) (NP (NML (NN Ptenpc1) (CC and) (NN Ptenpc2)) (NNS mice)))))) (VP (VBD revealed) (PP-LOC (IN in) (NP (DT both) (NNS mutants))) (, ,) (PP-TMP (IN at) (NP (JJ complete) (NN penetrance))) (, ,) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (ADJP (JJ invasive) (CC and) (JJ diffuse)) (NN CaP))) (PP (IN after) (NP (DT a) (JJ variable) (NN latency)))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NP (NN Figure) (CD 4B)) (: ;) (NP (NN Figure) (CD 5E))))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (NNS Tumors)) (VP (VBD were) (PP (IN in) (NP (DT both) (NNS cases))) (VP (VBN made) (NP-1 (-NONE- *)) (PP (IN of) (NP (ADJP (NN Pten) (JJ null)) (NNS cells))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Continuity)) (PP (IN of) (NP (JJ local) (JJ invasive) (NN disease))) (PP (IN with) (NP (NP (DT that)) (PP (IN of) (NP (JJ intraepithelial) (NNS lumens)))))) (VP (VBD was) (ADVP-TMP (RB often)) (VP (VBN observed) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS tumors)) (VP (VBD were) (VP (VBN composed) (NP-1 (-NONE- *)) (PP (IN of) (NP (ADJP (RB rather) (JJ large)) (, ,) (JJ mature) (JJ epithelial) (NNS cells))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Neuroendocrine) (NNS features)) (, ,) (PP (JJ such) (IN as) (NP (NP (JJ cytoplasmic) (NN granularity)) (CC and) (NP (JJ small) (JJ round) (NNS cells))))) (, ,) (VP (VBD were) (RB not) (VP (VBN seen) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (NNS tumors)) (VP (VBN analyzed) (NP (-NONE- *))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 4B)))) (-RRB- -RRB-)))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ (DT the) (NNS tumors)) (VP (VBD were) (ADJP-PRD (RB clearly) (JJ invasive)) (PP-LOC (IN in) (NP (NP (NML (CC both) (NN Ptenpc1) (CC and) (NN Ptenpc2)) (NNS mutants)) (PP (IN with) (NP (NP (NP (NN disruption)) (PP (IN of) (NP (DT the) (NN basement) (NN membrane)))) (CC and) (NP (NP (JJ clear) (NNS signs)) (PP (IN of) (NP (NN organ) (NN infiltration))))))))))) (, ,) (ADVP-TMP (RB once) (RB again)) (NP-SBJ (PRP we)) (VP (VBD observed) (NP (NNS differences)) (PP-LOC (IN in) (NP (NP (DT the) (NNS CaPs)) (PP (IN from) (NP (DT these) (CD two) (NNS models)))))) (. .)) )
( (S (PP (IN In) (NP (JJ many) (NNS instances))) (, ,) (PP-LOC (IN in) (NP (NN Ptenpc2) (NNS mutants))) (NP-SBJ-1 (QP (JJR more) (IN than) (CD one)) (NN prostate) (NN lobe)) (VP (VBD was) (ADVP (RB completely)) (VP (VBN effaced) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (VBG infiltrating) (JJ neoplastic) (NNS cells))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (NP (DT a) (JJ multifocal) (NN tumor) (NN origin)))) (, ,) (SBAR-ADV (IN while) (S (S (NP-SBJ (NP (JJ invasive) (NNS tumors)) (PP-LOC (IN in) (NP (NN Ptenpc1) (NNS mutants)))) (VP (VBD were) (ADVP-TMP (RB often)) (VP (VBG affecting) (NP (NP (RB only) (CD one) (NN lobe)) (PP-TMP (IN at) (NP (DT a) (NN time))))))) (CC and) (S (NP-SBJ (NP (DT the) (NN extent)) (PP (IN of) (NP (DT the) (NN infiltration)))) (VP (VBD was) (ADJP-PRD (RBR less) (JJ diffuse)))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 4B)))) (-RRB- -RRB-)))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NP (NNS tumors)) (PP-LOC (IN in) (NP (DT the) (NN Ptenpc1) (NNS animals)))) (VP (VBD were) (ADJP-PRD (ADVP (RB well) (HYPH -) (PP (IN to) (HYPH -) (ADVP (RB moderately)))) (VBN differentiated)) (SBAR-ADV (IN while) (S (NP-SBJ (NP (NNS tumors)) (PP-LOC (IN in) (NP (DT the) (NN Ptenpc2) (NNS mice)))) (VP (VBD were) (PP (IN in) (ADJP (JJ general))) (NP-PRD (UCP (NML (JJ high) (HYPH -) (NN grade)) (, ,) (ADJP (JJ undifferentiated))) (NNS lesions)))))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants)) (VP (VBD displayed) (NP (NP (NP (DT a) (NN spectrum)) (PP (IN of) (NP (NNS phenotypes)))) (, ,) (NP (NML (PP (PP (IN from) (ADVP (RB well))) (PP (PP (IN to) (ADJP (JJ undifferentiated))) (CC and) (PP (ADVP-TMP (RB occasionally)) (IN to) (NP (ADJP (RB locally) (JJ invasive))))))) (NNS phenotypes))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN shown) (NP-1 (-NONE- *)))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (NP (NN Pten) (JJ conditional) (NN inactivation)) (PP-LOC (IN in) (NP (DT the) (NN prostate)))) (VP (VBZ leads) (PP (IN to) (NP (ADJP (JJ invasive) (CC and) (JJ diffuse)) (NN CaP))) (PP-TMP (IN at) (NP (JJ complete) (NN penetrance)))) (. .)) )
( (HEADING (NP (NP (NNS Effects)) (PP (IN of) (NP (DT the) (NN Pten) (NN Dose))) (PP (IN on) (NP (NP (DT the) (NN Biology)) (PP (IN of) (NP (DT the) (JJ Prostatic) (NN Epithelium))))))) )
( (S (NP-SBJ (PRP We)) (VP (VBD studied) (NP (NP (DT the) (ADJP (JJ molecular) (CC and) (JJ biological)) (NNS consequences)) (PP (IN of) (NP (NN Pten) (NN dose) (NNS variations)))) (PP-LOC (IN in) (NP (NP (DT the) (JJ prostatic) (NN epithelium)) (PP (IN of) (NP (PRP$ our) (JJ various) (NNS mutants)))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD included) (PP (IN in) (NP (DT the) (NN analysis))) (NP (ADJP (NN age) (HYPH -) (VBN matched) (PRN (-LRB- -LRB-) (ADJP (NP (CD 8) (HYPH -) (NN wk)) (HYPH -) (JJ old)) (-RRB- -RRB-))) (NML (NML (NN Pten) (SYM +) (HYPH /) (SYM +)) (, ,) (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (, ,) (NML (NN Ptenhy) (HYPH /) (SYM −)) (, ,) (CC and) (NML (NN Ptenpc2))) (NNS males))) (. .)) )
( (S (NP-SBJ-1 (DT The) (JJ latter) (NNS mutants)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP (RB instead) (IN of) (NP (NN Ptenpc1) (NNS mice))) (PP-PRP (IN in) (NP (NP (NN view)) (PP (IN of) (NP (NP (DT the) (ADJP (RBR more) (JJ widespread)) (NN pattern)) (PP (IN of) (NP (NP (NN Pten) (NN inactivation)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (PRP$ their) (NNS prostates)))))))))))) (. .)) )
( (S (ADVP-TMP (RB First)) (, ,) (NP-SBJ (PRP we)) (VP (VBD determined) (SBAR (IN whether) (S (NP-SBJ (NP (NN reduction)) (PP (IN in) (NP (DT the) (NN Pten) (NN dose)))) (VP (MD would) (VP (VB affect) (NP (NP (NN proliferation)) (PP (IN of) (NP (JJ epithelial) (NNS cells))))))))) (. .)) )
( (S (PP-TMP (IN Upon) (NP (NML (NN Ki) (HYPH -) (CD 67)) (VBG staining))) (, ,) (NP-SBJ (PRP we)) (VP (VBD observed) (NP (NP (NP (DT a) (JJ progressive) (NN increase)) (PP (IN in) (NP (NP (DT the) (JJ proliferative) (NNS rates)) (PP (IN of) (NP (NN prostate) (JJ epithelial) (NNS cells)))))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN reduction)) (PP (IN in) (NP (NN Pten) (NN expression) (NNS levels)))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 5A)) (-RRB- -RRB-)))) (. .)) )
( (S (PP (IN For) (NP (NN instance))) (, ,) (NP-SBJ-1 (ADJP (QP (RB approximately) (JJ 10-fold)) (JJR more)) (NNS cells)) (VP (VBD were) (VP (VBN found) (NP-1 (-NONE- *)) (PP (IN in) (NP (JJ active) (NN proliferation))) (PP-LOC (IN in) (NP (NP (DT the) (NNS prostates)) (PP (IN from) (NP (NN Ptenpc2) (NNS mutants))))) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN compared) (NP-2 (-NONE- *)) (PP (IN with) (NP (NML (NN Pten) (SYM +) (HYPH /) (SYM +)) (NNS mice))) (ADVP-TMP-3 (-NONE- *T*))))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (NN Pten) (NN inactivation)) (, ,) (PP-MNR (IN in) (NP (DT a) (ADJP (NN dose) (HYPH -) (JJ dependent)) (NN manner))) (, ,) (VP (VBZ lends) (PP (IN to) (NP (JJ epithelial) (NNS cells))) (NP (DT a) (JJ dramatic) (NN growth) (NN advantage)) (PP-LOC (IN in) (NP (DT the) (NN prostate)))) (. .)) )
( (S (PP (IN By) (NP (NN contrast))) (, ,) (NP-SBJ-2 (NP (NNS MEFs)) (PP (IN of) (NP (NP (DT all) (NNS genotypes)) (PP (IN from) (NP (DT the) (JJ hypomorphic) (NN series)))))) (VP (VBD did) (RB not) (VP (VB show) (NP (NP (JJ noticeable) (NNS differences)) (PP (IN in) (NP (PRP$ their) (NN growth) (NNS rates)))) (PP (IN under) (NP (JJ standard) (NN culture) (NNS conditions))) (, ,) (SBAR-TMP (IN while) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBG showing) (NP (NP (JJ progressive) (NN activation)) (PP (IN of) (NP (DT the) (NN Akt) (NN signaling) (NN pathway))))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (: ;) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 1C)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (MD may) (VP (VB reflect) (NP (NP (DT an) (JJ intrinsic) (JJ differential) (NML (NN cell) (HYPH -) (NN type)) (NN sensitivity)) (PP (IN to) (NP (NN Pten) (NN inactivation)))) (, ,) (PP (ADVP (RB also)) (IN in) (NP (NP (NN agreement)) (PP (IN with) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP-SBJ (NN Pten) (NN hypomorphism)) (VP (VBZ does) (RB not) (VP (VB result) (PP (IN in) (NP (JJ overall) (JJ increased) (NN body) (NML (NN size) (CC and) (NN weight)))))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (ADVP-TMP (RB next)) (VP (VBD assessed) (SBAR (IN whether) (CC and) (WHADVP-2 (WRB how)) (S (NP-SBJ-1 (NP (DT the) (JJ progressive) (NN reduction)) (PP (IN of) (NP (DT the) (NN Pten) (NN dose)))) (VP (MD would) (VP (VB affect) (NP (NP (DT the) (NNS functions)) (PP (IN of) (NP (NP (JJ key) (JJ downstream) (NNS targets)) (PP (JJ such) (IN as) (NP (NN Akt) (, ,) (NN p27Kip1) (, ,) (NN mTOR) (, ,) (CC and) (NN FOXO3)))))) (ADVP-MNR-2 (-NONE- *T*)))))) (PP-MNR (IN by) (NP (NML (NML (NML (NN immunohistochemistry)) (-LRB- -LRB-) (NML (NN IHC)) (-RRB- -RRB-)) (CC and) (NML (NML (NNP Western) (NN blot)) (-LRB- -LRB-) (NML (NN WB)) (-RRB- -RRB-))) (NN analysis))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NNS Materials) (CC and) (NNS Methods)))) (-RRB- -RRB-))) (. .)) )
( (S (SBAR-ADV (IN As) (FRAG (ADJP (JJ aforementioned)))) (, ,) (NP-SBJ (PRP we)) (VP (VBD studied) (NP (NP (DT the) (NN status)) (PP (IN of) (NP (NP (NN Akt) (NN phosphorylation)) (, ,) (NP (NP (DT the) (JJ major) (JJ known) (JJ biochemical) (NN effect)) (PP (IN of) (NP (NN Pten) (NN loss))) (CIT (-LRB- -LRB-) (NNP Vivanco) (CC and) (NNP Sawyers) (CD 2002) (-RRB- -RRB-)))))) (, ,) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT an) (ADJP (NP (JJ anti-phospho) (HYPH -) (NN Akt)) (HYPH -) (JJ specific)) (NN antibody)) (PP (IN on) (NP (NP (NNS cells) (CC and) (NNS extracts)) (PP (IN from) (NP (DT the) (JJ various) (NN Pten) (NNS mutants)))))))) (. .)) )
( (S (NP-SBJ (NP (NN Staining)) (PP (IN of) (NP (NP (NNS prostates)) (PP (IN from) (NP (JJ various) (NNS genotypes))))) (PP (IN with) (NP (DT this) (NN antibody)))) (VP (VBD increased) (ADVP (RB proportionally) (PP (IN to) (NP (NP (DT the) (NN decrease)) (PP (IN in) (NP (NN Pten) (NNS levels)))))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN confirmed) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN WB) (NN analysis)))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NNS Figures) (NML (CD 2B) (, ,) (CD 5B) (, ,) (CC and) (CD 5C))))) (: ;) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NN IHC) (NN analysis)) (VP (VBD revealed) (NP (NP (DT a) (ADJP (RB drastically) (JJ different)) (NN staining) (NN pattern)) (PP-1 (-NONE- *ICH*))) (PP-LOC (IN in) (NP (NN prostate) (NNS cells))) (PP-1 (IN from) (NP (NN Ptenpc2) (NNS mutants))) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN compared) (NP-2 (-NONE- *)) (PP (IN with) (NP (NP (NNS cells)) (PP (IN from) (NP (JJ other) (NNS genotypes))))) (ADVP-TMP-2 (-NONE- *T*))))) (SBAR-ADV (IN in) (DT that) (S (NP-SBJ-4 (NN phospho) (HYPH -) (NN Akt)) (VP (VBD was) (VP (VBN found) (S (NP-SBJ-4 (-NONE- *)) (VP (TO to) (ADVP (RB overtly)) (VP (VB accumulate) (PP-LOC (IN at) (NP (DT the) (NN plasma) (NN membrane)))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 5C)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (DT A) (JJ similar) (NN staining) (NN pattern)) (VP (VBD was) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (CC both) (PP (IN in) (NP (NP (ADJP (NN Pten) (JJ null)) (NN epithelium)) (PP-TMP (JJ prior) (PP (IN to) (NP (NN tumor) (NN occurrence)))))) (CC and) (PP (IN in) (NP (NP (NNS cells)) (PP (IN from) (NP (NP (JJ overt) (NNS tumors)) (PP (IN from) (NP (NML (CC both) (NN Ptenpc1) (CC and) (NN Ptenpc2)) (NNS mutants)))))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ-1 (NN Akt)) (VP (VBZ is) (ADVP (RB progressively)) (VP (VBN activated) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (DT the) (NN Pten) (NN dose)))) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (PP (IN in) (NP (NN turn))) (VP (VBZ results) (PP (IN in) (NP (NP (PRP$ its) (NN recruitment)) (PP (IN to) (NP (DT the) (NN plasma) (NN membrane)))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (ADVP-TMP (RB next)) (VP (VBD studied) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN Pten) (NN inactivation))) (PP (IN on) (NP (NP (NN p27Kip1) (, ,) (NN FOXO3) (, ,) (CC and) (NN mTOR)) (, ,) (NP (NP (JJ known) (NNS targets)) (PP (IN of) (NP (NML (NN Akt) (NN kinase)) (NN activity)))))))) (. .)) )
( (S (NP-SBJ (NP (NN Phosphorylation)) (PP (IN of) (NP (NN p27Kip1) (CC and) (NN FOXO3))) (PP (IN by) (NP (NN Akt)))) (VP (VBZ results) (PP (IN in) (NP (NP (PRP$ their) (JJ functional) (NN inactivation)) (PP (IN through) (NP (NP (NP (JJ multiple) (NNS mechanisms)) (PP (JJ such) (IN as) (NP (NP (JJ nuclear) (NN export)) (, ,) (PP (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN FOXO))) (CIT (-LRB- -LRB-) (NNP Brunet) (FW et) (FW al.) (CD 1999) (-RRB- -RRB-) (, ,))))))) (CC or) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ nuclear) (NML (NN import) (CC and) (NN downregulation)))) (, ,) (PP (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN p27Kip1))))) (CIT (-LRB- -LRB-) (NNP Mamillapalli) (FW et) (FW al.) (CD 2001) (: ;) (NNP Liang) (FW et) (FW al.) (CD 2002) (: ;) (NNP Shin) (FW et) (FW al.) (CD 2002) (: ;) (NNP Viglietto) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-)))))))) (. .)) )
( (S (PP (IN By) (NP (NN contrast))) (, ,) (NP-SBJ (NN Akt) (NN activation)) (VP (VBZ results) (PP (IN in) (NP (NP (NN mTOR) (NN phosphorylation)) (CC and) (NP (VBN increased) (NML (NML (NN protein) (NN translation)) (CC and) (NML (NN translation) (NN initiation)))))) (CIT (-LRB- -LRB-) (NNP Gingras) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (PRP We)) (ADVP-TMP (RB previously)) (VP (VBD reported) (SBAR (IN that) (S (NP-SBJ-1 (NP (NP (DT the) (NN localization)) (CC or) (NP (DT the) (NN expression) (NNS levels))) (PP (IN of) (NP (NN p27Kip1)))) (VP (VBD were) (RB not) (VP (VBN affected) (NP-1 (-NONE- *)) (PP (IN in) (NP (NML (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (CC and) (NML (NML (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (HYPH /) (NML (NN p27Kip1) (SYM −) (HYPH /) (SYM −))) (NN compound))) (NNS mutants))))))) (CIT (-LRB- -LRB-) (NNP Di) (NNP Cristofano) (FW et) (FW al.) (CD 2001a) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN By) (NP (NN contrast))) (, ,) (NP-SBJ-1 (NP (DT a) (JJ progressive) (NN downregulation)) (PP (IN in) (NP (NN p27Kip1) (NN staining)))) (VP (VBD was) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN in) (NP (NML (NML (NN Ptenhy) (HYPH /) (SYM −)) (CC and) (NML (NN Ptenpc2))) (NNS mutants))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 5C)) (: ;) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)))) (. .)) )
( (S (S (NP-SBJ-1 (NN p27Kip1)) (VP (VBD was) (ADVP (RB apparently)) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP (IN at) (NP (JJR lower) (NNS levels)))))) (, ,) (CC and) (S (NP-SBJ-2 (JJR fewer) (NNS cells)) (VP (VBD were) (VP (VBN found) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB express) (NP (DT the) (NN protein))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 5C)) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ (PRP We)) (ADVP (RB also)) (VP (VBD studied) (NP (NP (DT the) (NN status)) (PP (IN of) (NP (NN FOXO3)))) (PP-LOC (IN in) (NP (DT the) (JJ various) (NN Pten) (NNS mutants))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG analyzing) (NP (CC both) (NP (PRP$ its) (NN localization)) (CC and) (NP (NN threonine) (NN phosphorylation))) (PP-MNR (IN with) (NP (DT a) (JJ specific) (NML (JJ anti-phospho) (HYPH -) (NN FOXO3)) (NN antibody))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NNS Materials) (CC and) (NNS Methods)))) (-RRB- -RRB-))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ-1 (DT no) (JJ noticeable) (NNS differences)) (VP (VBD were) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN in) (NP (NML (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (CC and) (NML (NN Ptenhy) (HYPH /) (SYM −))) (NNS mutants))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)))))) (, ,) (NP-SBJ-3 (NP (NN increase)) (PP (IN in) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NML (JJ anti-phospho) (HYPH -) (NN FOXO3)) (JJ cytoplasmic) (NN staining)))))) (VP (VBD were) (VP (VBN observed) (NP-3 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NN prostate) (JJ epithelial) (NNS cells)) (PP (IN from) (NP (NN Ptenpc2) (NNS mutants))))) (SBAR-TMP (WHADVP-5 (WRB when)) (S (NP-SBJ-4 (-NONE- *PRO*)) (VP (VBN compared) (NP-4 (-NONE- *)) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))) (ADVP-TMP-5 (-NONE- *T*))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 5C)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (JJ Complete) (NN Pten) (NN inactivation)) (ADVP (RB also)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN mTOR) (NN phosphorylation))))) (PP-LOC (IN in) (NP (NP (DT the) (JJ prostatic) (NN epithelium)) (PP (IN of) (NP (NN Ptenpc2) (NNS mutants))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 5C)) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (NP (NP (DT the) (JJ progressive) (NN reduction)) (PP (IN of) (NP (DT the) (NN Pten) (NN dose)))) (-LRB- -LRB-) (CC and) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NP (NN Pten) (NN inactivation)) (PP-LOC (IN in) (NP (NML (NN Ptenpc1) (HYPH /) (CD 2)) (NNS mutants))))))) (-RRB- -RRB-) (VP (VP (VBZ affects) (NP (NP (DT the) (JJ proliferative) (NN rate)) (PP (IN of) (NP (DT the) (JJ prostatic) (NN epithelium))))) (CC and) (VP (VBZ results) (PP (IN in) (NP (NP (JJ molecular) (NNS changes)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (PP (IN in) (NP (NN turn))) (VP (VBZ dictates) (NP (NP (DT the) (JJ natural) (NN history)) (PP (IN of) (NP (NP (DT these) (NNS lesions)) (CC and) (NP (NN tumor) (NN progression))))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (CD 5D) (CC and) (CD 5E))) (-RRB- -RRB-))) (. .)) )
( (HEADING (NP (NN Discussion))) )
( (S (NP-SBJ (PRP$ Our) (NN analysis)) (VP (VBZ allows) (NP (NP (DT a) (JJ detailed) (NN deconstruction)) (FRAG (NP (NP (NP (DT the) (JJ molecular) (NN genetics)) (VP (VBG underlying) (NP (NP (NN cancer) (NN progression)) (PP-LOC (IN in) (NP (DT the) (NN prostate)))))) (CC and) (NP (NP (DT the) (NN assessment)) (PP (IN of) (NP (NP (DT the) (JJ key) (NN relevance)) (PP (IN of) (NP (NP (UCP (NN Pten) (CC and) (JJ subtle)) (NNS variations)) (PP (IN in) (NP (PRP$ its) (NN dose))) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG controlling) (NP (DT this) (NN process)))))))))))))) (. .)) )
( (S (PP (VBN Based) (PP (IN on) (NP (PRP$ our) (NNS findings)))) (, ,) (NP-SBJ (PRP we)) (VP (MD can) (ADVP-TMP (RB now)) (VP (VB attribute) (NP (JJ distinct) (ADJP (JJ preneoplastic) (CC or) (JJ malignant)) (JJ pathological) (NNS entities)) (PP (IN to) (NP (JJ distinct) (JJ molecular) (NNS states))))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (DT this) (JJ new) (NN knowledge)) (VP (VBZ allows) (NP (NP (DT the) (NN reclassification)) (PP-1 (-NONE- *ICH*))) (, ,) (PP-PRP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (PRP$ their) (JJ true) (JJ molecular) (NN nature))))) (, ,) (PP-1 (IN of) (NP (NP (JJ pathological) (NNS lesions)) (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (PP (IN at) (NP (DT a) (JJ superficial) (NN analysis))) (VP (VBD appeared) (S (NP-SBJ-3 (-NONE- *)) (ADJP-PRD (RB very) (JJ similar)))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 6)) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NP (DT this) (ADJP (RB supposedly) (JJ linear) (CC and) (JJ multistep)) (NN process)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ separates) (NP (NP (CD two) (ADJP (RB extremely) (JJ different)) (ADJP (JJ anatomical) (CC and) (JJ pathological)) (NNS entities)) (, ,) (NP (NP (DT a) (JJ normal) (JJ prostatic) (NN epithelium)) (PP (IN from) (NP (DT an) (JJ invasive) (NN CaP)))))))))) (, ,) (NP-SBJ (EX there)) (VP (VBP are) (, ,) (ADVP (RB in) (RB between)) (, ,) (NP-PRD (NP (DT a) (JJ discrete) (NN number)) (PP (IN of) (NP (NP (ADJP (RB anatomically) (JJ distinct)) (JJ intermediary) (NNS steps)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN prostate) (NN hyperplasia)) (ADJP (SYM >) (NP (NP (NP (NN displasia)) (HYPH /) (NP (NML (JJ low) (HYPH -) (NN grade)) (NN PIN))) (ADJP (SYM >) (NP (NP (NML (JJ high) (HYPH -) (NN grade)) (NN PIN)) (ADJP (SYM >) (NP (NP (ADJP (RB locally) (JJ invasive)) (NN CaP)) (ADJP (SYM >) (NP (JJ diffused) (NN CaP))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT These) (NNS entities)) (VP (VBP have) (VP (VBN been) (VP (VBN recognized) (NP-1 (-NONE- *)) (ADVP-TMP (RB before)) (PP-MNR (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (PRP$ their) (JJ pathological) (NNS features)))))))) (. .)) )
( (S (NP-SBJ (DT The) (NN fact) (SBAR (IN that) (S (NP-SBJ-1 (PRP we)) (VP (VBP are) (ADVP-TMP (RB now)) (ADJP-PRD (JJ able) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB correlate) (NP (DT these) (JJ anatomical) (NNS stages)) (PP (IN with) (NP (NP (JJ specific) (JJ molecular) (NNS events)) (, ,) (PP (JJ such) (IN as) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NN expression)) (PP (IN of) (NP (DT a) (JJ single) (NML (NN tumor) (NN suppressor)) (NN gene))))))))))))))))) (, ,) (VP (CONJP (RB not) (RB only)) (VP (VBZ represents) (NP (NP (DT an) (NN integration)) (PP (IN of) (NP (JJ anatomical) (, ,) (JJ descriptive) (NNS findings))) (PP (IN with) (NP (JJ biological) (NNS data))))) (, ,) (CONJP (CC but) (RB also)) (VP (VBZ offers) (NP (NP (DT the) (NN opportunity)) (PP (IN of) (NP (JJ therapeutic) (NNS interventions)))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP show) (PP (IN in) (NP (DT this) (NN study))) (SBAR (IN that) (S (NP-SBJ (NP (NN inactivation)) (PP (IN of) (NP (CD one) (NN Pten) (NN allele))) (PP-LOC (IN in) (NP (DT the) (NN mouse)))) (VP (MD may) (VP (VB lead) (PP (IN to) (NP (NN prostate) (JJ epithelial) (NN hyperplasia))) (, ,) (SBAR-PRP (IN as) (S (NP-SBJ (NP (JJ complete) (NN inactivation)) (PP (IN of) (NP (NN p27Kip1))) (PP-LOC (IN in) (NP (DT the) (NN mouse)))) (VP (VBZ leads) (PP (IN to) (SBAR-NOM (WHNP-1 (WP what)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ resembles) (NP (JJ human) (NML (NML (JJ benign) (NN prostate) (NN hyperplasia)) (-LRB- -LRB-) (NML (NN BPH)))))))))))))))) (-RRB- -RRB-) (. .)) )
( (S (S (ADVP (RB However)) (, ,) (NP-SBJ (DT these) (CD two) (NNS lesions)) (VP (VBP are) (ADJP-PRD (RB very) (JJ different)) (PP (IN in) (NP (NN nature) (CC and) (NN outcome))))) (: :) (S (NP-SBJ (DT the) (JJ first)) (, ,) (PP (IN in) (NP (NN fact))) (, ,) (VP (VP (VP (VBZ impacts) (PP (ADVP (RB only)) (IN on) (NP (JJ epithelial) (NNS elements)))) (CC and) (VP (PP-TMP (IN over) (NP (NN time))) (VBZ evolves) (PP (IN to) (NP (NML (JJ low) (HYPH -) (NN grade)) (NN PIN))))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (DT the) (JJ second)) (VP (VP (VBZ impacts) (PP (IN on) (NP (UCP (CC both) (JJ epithelial) (CC and) (NN stroma)) (NNS elements))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG representing) (NP (NP (NN hyperplasia)) (PP (IN of) (NP (DT the) (JJ whole) (NN organ))))))) (, ,) (CC but) (VP (VBZ does) (RB not) (VP (VB evolve) (PP (IN toward) (NP (NN malignancy))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 6)) (: ;))))) (CIT (NNP Cordon) (HYPH -) (NNP Cardo) (FW et) (FW al.) (CD 1998) (: ;) (NNP Di) (NNP Cristofano) (FW et) (FW al.) (CD 2001a) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT This)) (ADVP (RB obviously)) (VP (VBZ does) (RB not) (VP (VB exclude) (SBAR (IN that) (S (NP-SBJ (NP (NN loss)) (PP (IN of) (NP (NN p27Kip1) (NN expression)))) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN accompanied) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (JJ additional) (JJ genetic) (NNS events)) (-LRB- -LRB-) (NP (ADVP (FW e.g.)) (NP (, ,) (NN loss)) (PP (IN of) (NP (NN PTEN)))) (-RRB- -RRB-))) (ADVP-TMP-2 (-NONE- *T*))))) (VP (MD may) (VP (VB lead) (PP (IN to) (NP (DT a) (ADJP (RB completely) (JJ different)) (NN outcome))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN supported) (NP-3 (-NONE- *)) (PP (IN by) (NP-LGS (NP (PRP$ our) (JJ previous) (ADJP (FW in) (FW vivo)) (NN analysis)) (PP-LOC (IN in) (NP (DT the) (NN mouse))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 6)) (: ;)) (CIT (NNP Di) (NNP Cristofano) (FW et) (FW al.) (CD 2001a) (-RRB- -RRB-)))))))))))) (. .)) )
( (S (ADVP (RB Moreover)) (, ,) (NP-SBJ (PRP$ our) (NNS data)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (NP (DT a) (JJ further) (NN reduction)) (PP (IN in) (NP (DT the) (NN Pten) (NN dose)))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants)))))) (, ,) (VP (VBZ accelerates) (NP (NN tumor) (NN progression)) (ADVP (RB dramatically)) (, ,) (S-ADV (ADVP-TMP (RB eventually)) (NP-SBJ (-NONE- *PRO*)) (VP (VBG resulting) (PP (IN in) (NP (NP (NML (JJ high) (HYPH -) (NN grade)) (NN PIN)) (CC and) (NP (ADJP (RB locally) (JJ invasive)) (NN carcinoma)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 6)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (DT This) (NN fact)) (VP (VBZ has) (NP (ADJP (RB very) (JJ important)) (JJ therapeutic) (NNS implications))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ (NP (DT a) (JJ large) (NN number)) (PP (IN of) (NP (NN CaP) (NNS patients))) (PRN (-LRB- -LRB-) (NP (QP (JJR more) (IN than) (CD 80)) (NN %)) (-RRB- -RRB-))) (VP (VP (VBP display) (PP-TMP (IN at) (NP (NN presentation))) (NP (NP (NN loss)) (PP (IN of) (NP (CD one) (NN PTEN) (NN allele))))) (, ,) (CC but) (VP (VBP do) (VP (VB retain) (NP (DT the) (JJ other) (JJ normal) (NN PTEN) (NN allele))))))) (, ,) (NP-SBJ-3 (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (MD could) (VP (VB be) (VP (VBN proposed) (NP-3 (-NONE- *)) (SBAR-1 (IN that) (S (NP-SBJ-2 (NP (NML (JJ high) (HYPH -) (NN grade)) (NN PIN)) (CC or) (NP (ADJP (RB locally) (JJ invasive)) (NN prostate) (NNS carcinomas))) (VP (MD could) (VP (VB be) (VP (VBN prevented) (CC or) (VBN treated) (NP-2 (-NONE- *)) (PP-MNR (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (ADVP (RB pharmacologically)) (VP (VBG modulating) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (VBG remaining) (NN PTEN) (NN allele))))))) (CC or) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG antagonizing) (NP (NP (NP (DT the) (JJ downstream) (NNS consequences)) (PP (IN of) (NP (NN PTEN) (NN downregulation)))) (CC or) (NP (JJ partial) (NN inactivation) (PRN (-LRB- -LRB-) (NP (ADVP (FW e.g.)) (, ,) (NML (NN PI3K) (HYPH /) (NN mTOR)) (NN activation)) (: ;) (NP (NN Figure) (CD 6)) (-RRB- -RRB-)))))))))))))))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ-2 (NP (DT the) (JJ massive) (NN prostate) (NML (NN hyperplasia) (HYPH /) (NN dysplasia))) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants))))) (VP (VBZ is) (RB not) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN expected) (NP-1 (-NONE- *))))) (, ,) (VP (VBN accompanied) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (NP (JJ complete) (NN loss)) (PP (IN of) (NP (NN Pten) (NN expression))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 2E)))) (-RRB- -RRB-)))))))) (, ,) (NP-SBJ (NP (DT the) (JJ low) (NN penetrance)) (PP (IN of) (NP (DT the) (JJ invasive) (NN CaP))) (PP-LOC (IN in) (NP (DT these) (NNS mutants)))) (ADVP (RB strongly)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ-3 (JJ additional) (NNS events)) (VP (VBP have) (S (NP-SBJ-3 (-NONE- *)) (VP (TO to) (VP (VB occur) (SBAR-PRP (IN for) (S (NP-SBJ (DT this) (JJ pathological) (NN transition)) (VP (TO to) (VP (VB occur)))))))))))) (. .)) )
( (S (ADVP (RB Nevertheless)) (, ,) (NP-SBJ (NP (PRP it)) (S-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ important)) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB underscore) (SBAR (IN that) (S (NP-SBJ (NP (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (, ,) (PP (IN unlike) (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants)))) (, ,) (VP (VBP do) (RB not) (VP (VB develop) (NP (NP (JJ invasive) (NN CaP)) (, ,) (CC but) (NP (RB only) (NML (JJ low) (HYPH -) (NN grade)) (NN PIN) (NNS lesions)))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 6)) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ-1 (NP (DT a) (JJ further) (NN reduction)) (PP (IN of) (NP (DT the) (NN Pten) (NN dose)))) (VP (VBZ seems) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ essential)) (PP (IN for) (NP (DT this) (NN process))))))) (. .)) )
( (S (NP-SBJ-2 (NP (JJ Several) (NNS possibilities)) (, ,) (RRC (RB not) (ADJP-PRD (RB mutually) (JJ exclusive)))) (, ,) (VP (MD could) (VP (VB be) (VP (VBN entertained) (NP-2 (-NONE- *))))) (: :)) ) 
( (S (LST (-LRB- -LRB-) (LS i) (-RRB- -RRB-)) (NP-SBJ (NP (DT a) (ADJP (RBR more) (JJ severe)) (NN reduction)) (PP (IN in) (NP (DT the) (NN Pten) (NN dose)))) (VP (MD could) (VP (VB facilitate) (NP (JJ cooperative) (NN tumorigenesis)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG rendering) (NP-3 (DT the) (NNS cells)) (S-CLR (NP-SBJ-3 (-NONE- *PRO*)) (ADJP-PRD (ADJP (JJ permissive)) (CC and) (ADJP (JJ sensitive) (PP (IN to) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (JJ additional) (JJ oncogenic) (NNS pathways))))))))))))) (: ;)) )
( (S (LST (-LRB- -LRB-) (LS ii) (-RRB- -RRB-)) (NP-SBJ (DT the) (JJ massive) (NN prostate) (NN hyperplasia)) (VP (MD could) (VP (VB facilitate) (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NP (JJ additional) (JJ genetic) (NNS hits)) (-LRB- -LRB-) (PP (VBG including) (NP (JJ complete) (NN Pten) (NN loss))) (-RRB- -RRB-)))) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (ADVP (RB simply)) (VP (VBG expanding) (NP (NP (DT the) (NN pool)) (PP (IN of) (NP (ADJP (RB actively) (VBG dividing)) (NNS cells))))))))) (: ;)) )
( (S (LST (-LRB- -LRB-) (LS iii) (-RRB- -RRB-)) (NP-SBJ (NP (DT a) (ADJP (RBR more) (JJ severe)) (NN reduction)) (PP (IN in) (NP (DT the) (NN Pten) (NN dose)))) (VP (MD could) (VP (VB protect) (NP (NNS cells)) (PP (IN from) (NP (NP (JJ apoptotic) (NNS programs)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP are) (ADVP (RB normally)) (VP (VBN triggered) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NN occurrence)) (PP (IN of) (NP (VBG damaging) (NN genetics) (NNS events))))))))))))) (. .)) )
( (S (NP-SBJ (DT The) (NN fact) (SBAR (IN that) (S (NP-SBJ (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants)) (VP (VBP develop) (NP (NP (JJ massive) (NN prostate) (NN hyperplasia)) (VP (RB not) (VBN accompanied) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT an) (JJ overall) (NN increase)) (PP (IN in) (NP (NN body) (NML (NN weight) (CC and) (NN size)))))))))))) (VP (VBZ underscores) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP-SBJ (JJ different) (NML (NNS tissues) (CC and) (NNS organs))) (VP (VBP are) (ADJP-PRD (RB differentially) (JJ sensitive) (PP (IN to) (NP (NN Pten) (NN dose) (NNS variations)))) (, ,) (S-ADV (NP-SBJ (DT the) (JJ prostatic) (NN epithelium)) (VP (VBG being) (NP-PRD (NP (CD one)) (PP (IN of) (NP (DT the) (RBS most) (JJ sensitive))))))))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN agreement)) (PP (IN with) (NP (DT this) (NN notion))))) (, ,) (NP-SBJ (NP (NNS MEFs)) (PP (IN from) (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants)))) (VP (VBP do) (RB not) (VP (VB display) (NP (NP (JJ proliferative) (NN advantage)) (PP-1 (-NONE- *ICH*))) (PP-LOC (IN in) (NP (JJ standard) (NN culture) (NN condition))) (PP-1 (IN over) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS MEFs))))) (. .)) )
( (S (PP (IN In) (NP (DT this) (NN respect))) (, ,) (NP-SBJ (NP (PRP it)) (S-1 (-NONE- *EXP*))) (VP (VBZ is) (ADVP (RB also)) (ADJP-PRD (JJ important)) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB remember) (SBAR (IN that) (, ,) (S-CLF (PP (IN unlike) (NP (NP (NML (NN p27Kip1) (SYM −) (HYPH /) (SYM −)) (NNS mice)) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP display) (NP (NP (NP (NN hyperplasia)) (PP (IN of) (NP (ADJP (CC both) (JJ stromal) (CC and) (JJ parenchymal)) (NNS components))) (PP-LOC (IN in) (NP (DT the) (NN prostate)))) (-LRB- -LRB-) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN body) (NN mass))))) (CIT (: ;) (NNP Fero) (FW et) (FW al.) (CD 1996) (: ;) (NNP Kiyokawa) (FW et) (FW al.) (CD 1996) (: ;) (NNP Nakayama) (FW et) (FW al.) (CD 1996) (-RRB- -RRB-))))))) (, ,) (PP-LOC (IN in) (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mutants))) (NP-SBJ (PRP it)) (VP (VBZ is) (ADVP (RB specifically)) (NP-PRD (DT the) (JJ prostatic) (NN epithelium)) (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (ADVP (RB actively)) (VP (VBZ proliferates) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG leading) (PP (IN to) (NP (NN prostate) (NN hyperplasia)))))))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 6)) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (NP-SBJ (DT this)) (VP (VBZ does) (RB not) (VP (VB parallel) (SBAR-NOM (WHNP-1 (WP what)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (NP (JJ other) (NN model) (NNS systems)) (, ,) (PP (JJ such) (IN as) (NP (NNP Drosophila)))) (, ,) (SBAR (WHADVP-2 (WRB where)) (S (NP-SBJ (NP (NN dose) (NNS variations)) (PP (IN in) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NN Pten)) (CC or) (NP (NP (JJ downstream) (NN signaling) (NNS components)) (-LRB- -LRB-) (NP (ADVP (FW e.g.)) (, ,) (NN TOR))) (-RRB- -RRB-)))))) (VP (VBP do) (VP (VB result) (PP (IN in) (NP (NP (NNS variations)) (PP (IN in) (NP (NN body) (NML (NN size) (CC and) (NN mass)))))) (ADVP-LOC-2 (-NONE- *T*)))))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN reviewed) (NP-3 (-NONE- *)) (PP (IN in) (NP (NP (NNP Oldham) (CC and) (NNP Hafen)) (NP-TMP (CD 2003)))))) (-RRB- -RRB-)))))))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ (PRP we) (CC and) (NNS others)) (VP (VBD had) (ADVP-TMP (RB previously)) (VP (VBN implicated) (NP (NN Pten) (JJ heterozygous) (NN loss)) (PP (IN in) (NP (NN prostate) (NN tumorigenesis))) (SBAR-TMP (WHADVP (WRB when)) (FRAG (PP (IN in) (NP (NP (NN cooperation)) (PP (IN with) (NP (NP (JJ additional) (JJ oncogenic) (NNS events)) (-LRB- -LRB-) (PP (JJ such) (IN as) (NP (NP (NP (NN loss)) (PP (IN of) (NP (NN p27Kip1) (CC or) (NN Nkx3.1)))) (CC or) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (JJ large) (NN T) (NN oncogene)))))) (CIT (: ;) (NNP Di) (NNP Cristofano) (FW et) (FW al.) (CD 2001a) (: ;) (NNP Kwabi) (HYPH -) (NNP Addo) (FW et) (FW al.) (CD 2001) (: ;) (NNP Kim) (FW et) (FW al.) (CD 2002) (: ;) (NNP Abate) (HYPH -) (NNP Shen) (FW et) (FW al.) (CD 2003) (-RRB- -RRB-)))))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBP demonstrate) (PP (IN in) (NP (DT this) (NN article))) (SBAR (IN that) (S (NP-SBJ (NP (JJ complete) (NN inactivation)) (PP (IN of) (NP (NP (NN Pten)) (ADVP (RB alone)))) (PP-LOC (IN in) (NP (DT the) (NN prostate)))) (VP (VBZ has) (ADVP-TMP (RB already)) (NP (NP (JJ catastrophic) (NNS consequences)) (VP (VBG leading) (PP (IN to) (NP (ADJP (ADJP (JJ invasive)) (, ,) (ADJP (JJ diffuse)) (, ,) (CC and) (ADJP (RB highly) (JJ aggressive))) (NNS malignancies)))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 6)) (-RRB- -RRB-))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ-1 (NP (PRP it)) (SBAR-2 (-NONE- *EXP*))) (VP (MD can) (RB not) (VP (VB be) (ADVP (RB formally)) (VP (VBN excluded) (NP-1 (-NONE- *)) (SBAR-2 (IN that) (S (NP-SBJ (JJ complete) (NN Pten) (NN loss)) (VP (MD would) (ADVP-TMP (RB still)) (VP (VB cooperate) (PP (IN with) (NP (JJ additional) (JJ oncogenic) (NNS events))) (PP (IN toward) (NP (ADJP (JJ full) (HYPH -) (JJ blown)) (NN transformation)))))))))))) (, ,) (NP-SBJ (DT this) (NN finding)) (VP (VBZ underscores) (ADVP-TMP (RB once) (RBR more)) (NP (NP (DT the) (JJ exquisite) (NN sensitivity)) (PP (IN of) (NP (DT the) (JJ prostatic) (NN epithelium))) (PP (IN to) (NP (NP (NN loss)) (PP (IN of) (NP (NN Pten))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN information)) (VP (MD should) (VP (VB be) (VP (VBN factored) (NP-1 (-NONE- *)) (PRT (RP in)) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBG tailoring) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NP (NN CaP)) (CC or) (NP (NML (JJ high) (HYPH -) (NN grade)) (NN PIN) (NNS lesions))) (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBP have) (ADVP (RB completely)) (VP (VBN lost) (NP (NN PTEN) (NN function))))))))) (ADVP-TMP-2 (-NONE- *T*)))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS lesions)) (VP (MD may) (VP (VB be) (ADJP-PRD (RB extremely) (JJ sensitive) (PP (IN to) (NP (NML (NN PI3K) (CC or) (NN mTOR)) (NNS inhibitors)))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NP (NN modulation)) (PP (IN of) (NP (NN PTEN) (NN expression)))) (VP (MD would) (RB not) (VP (VB be) (NP-PRD (DT a) (JJ therapeutic) (NN option)) (PP (IN in) (NP (DT these) (NNS cases))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 6)) (-RRB- -RRB-)))))))) (. .)) )
( (S (PP-PRP (IN On) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (DT these) (NNS findings))))) (, ,) (NP-SBJ-2 (NP (PRP it)) (S-1 (-NONE- *EXP*))) (VP (MD would) (VP (VB seem) (ADVP (RB therefore)) (S (NP-SBJ-2 (-NONE- *)) (PP-PRD (IN of) (NP (JJ paramount) (NN importance)))) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (ADVP (RB routinely)) (VP (VB assess) (NP (NP (NP (DT the) (NN status)) (PP (IN of) (NP (DT the) (NN PTEN) (NN gene)))) (CC and) (NP (PRP$ its) (NN expression))) (PP-LOC (IN in) (NP (NP (JJ human) (NNS CaPs)) (CC and) (NP (JJ precancerous) (NNS lesions)))) (PP (IN as) (NP (DT a) (JJ key) (NN biomarker))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB opt) (PP (IN for) (NP (DT the) (ADJP (RBS most) (JJ appropriate)) (ADJP (JJ therapeutic) (CC or) (JJ chemopreventive)) (NN intervention) (NNS modalities))))))))))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (SBAR-2 (-NONE- *EXP*))) (VP (VBZ remains) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN seen) (NP-1 (-NONE- *)))))) (SBAR-2 (IN whether) (S (NP-SBJ (NP (JJ complete) (NN Pten) (NN inactivation)) (PP-LOC (IN in) (NP (DT the) (NN mouse) (NN prostate)))) (ADVP (RB also)) (VP (VBZ influences) (NP (NP (DT the) (JJ metastatic) (NN potential)) (PP (IN of) (NP (NP (DT these) (JJ invasive) (NNS CaPs)) (UCP (ADVP (RB alone)) (CC or) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ additional) (JJ oncogenic) (NNS events))))))))))))) (. .)) )
( (S (PP (IN In) (NP (DT this) (NN respect))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NML (NN MRI) (CC and) (JJ postmortem)) (NNS analyses)) (VP (VBP have) (ADVP (RB indeed)) (VP (VBN revealed) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN lung) (JJ neoplastic) (NNS lesions)))) (PP-LOC (IN in) (NP (PRP$ our) (JJ conditional) (NN Pten) (NNS mutants))))))) (, ,) (NP-SBJ (ADJP (JJ morphological) (CC and) (JJ molecular)) (NNS analyses)) (VP (VBP have) (ADVP-TMP (RB so) (RB far)) (VP (VBN excluded) (NP (NP (DT the) (JJ metastatic) (NN nature)) (PP (IN of) (NP (DT these) (NNS tumors)))) (CIT (-LRB- -LRB-) (NNP M.) (NNP Niki) (FW et) (FW al.) (, ,) (JJ unpublished) (NNS data) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ stepwise) (NN reduction)) (PP (IN in) (NP (DT the) (NN Pten) (NN dose)))) (VP (VBZ results) (PP (IN in) (NP (JJ clear) (ADJP (RB progressively) (JJ quantitative)) (NNS changes))) (PP-LOC (IN in) (NP (DT the) (NN prostate) (JJ epithelial) (NNS cells))) (PP-TMP (RB prior) (PP (IN to) (NP (NN tumor) (NN development))))) (. .)) )
( (S (NP-SBJ (VBN Increased) (JJ cellular) (NN proliferation)) (VP (VBZ correlates) (PP (IN with) (NP (NP (JJ increased) (NN phosphorylation)) (PP (IN of) (NP (NN Akt)))))) (. .)) )
( (S (PP-LOC (IN In) (NP (ADJP (NN Pten) (JJ null)) (JJ epithelial) (NNS cells))) (, ,) (PP-TMP (CC both) (PP (IN in) (NP (DT the) (JJ preneoplastic) (NN stage))) (CC or) (PP (IN in) (NP (JJ overt) (NNS CaPs)))) (, ,) (NP-SBJ-1 (NN phospho) (HYPH -) (NN Akt)) (VP (VBZ is) (VP (VBN found) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB accumulate) (ADVP (RB almost) (RB exclusively)) (PP-LOC (IN at) (NP (DT the) (NN plasma) (NN membrane)))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 5C)))) (-RRB- -RRB-)))) (. .)) )
( (S (SBAR-NOM-SBJ-1 (IN Whether) (S (NP-SBJ (DT this)) (VP (VP (VBZ represents) (NP (NP (DT the) (JJ extreme) (NN consequence)) (PP (IN of) (NP (NN Akt) (NN superactivation))))) (CONJP (CC or) (RB rather)) (VP (VBZ reflects) (NP (NP (DT a) (JJ genuine) (JJ qualitative) (NN change)) (PP (IN in) (NP (NN Akt) (NML (NN biology) (CC and) (NN function)))) (PP-LOC (IN in) (NP (ADJP (NN Pten) (JJ null)) (NN prostate) (JJ epithelial) (NNS cells)))))))) (VP (VBZ remains) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN determined) (NP-1 (-NONE- *))))))) (. .)) )
( (S (NP-SBJ-1 (NP (PRP It)) (SBAR-2 (-NONE- *EXP*))) (ADVP (RB also)) (VP (VBZ remains) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN resolved) (NP-1 (-NONE- *)))))) (SBAR-2 (IN whether) (S (NP-SBJ-3 (NP (DT the) (NN reduction)) (PP (IN in) (NP (NN p27Kip1) (NN expression)))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN associated) (NP-3 (-NONE- *)) (PP (IN with) (NP (PRP$ its) (JJ cytoplasmic) (NN relocalization))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-4 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN reported) (NP-4 (-NONE- *)) (PP-LOC (IN in) (NP (NP (JJ human) (NML (NN breast) (NN cancer)) (NNS cells)) (VP (VBG suffering) (NP (NN AKT) (NN hyperactivation))))) (CIT (-LRB- -LRB-) (NNP Liang) (FW et) (FW al.) (CD 2002) (: ;) (NNP Shin) (FW et) (FW al.) (CD 2002) (: ;) (NNP Viglietto) (FW et) (FW al.) (CD 2002) (-RRB- -RRB-)))))))))) (. .)) )
( (S (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN Taken) (NP-1 (-NONE- *)) (ADVP (RB together)))) (, ,) (NP-SBJ (DT this) (NN analysis)) (VP (VBZ supports) (NP (NP (DT a) (NN Pten) (ADJP (NN dose) (HYPH -) (JJ dependent)) (NN model)) (PP (IN with) (NP (NP (JJ progressive) (NNS changes)) (PP (IN at) (NP (DT the) (JJ molecular) (NN level)))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG arguing) (PP (IN against) (NP (NP (DT a) (NML (NN Pten) (NN threshold)) (NN model)) (PP (IN for) (NP (NN tumor) (NN suppression)))))))) (. .)) )
( (S (PP (IN By) (NP (NN contrast))) (, ,) (NP-SBJ-1 (JJ clear) (JJ qualitative) (JJ morphological) (NNS changes)) (VP (VBD were) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN prostate) (NN epithelium))) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBG analyzing) (NP (DT the) (ADJP (NN Pten) (JJ hypomorphic)) (NN series)) (ADVP-TMP-2 (-NONE- *T*))))))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (ADVP-TMP (RB never)) (VP (VBP display) (NP (JJ massive) (JJ prostatic) (NN enlargement))))) (, ,) (NP-SBJ (NP (JJ further) (NN reduction)) (PP (IN to) (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS levels)))) (VP (VBZ leads) (PP (IN to) (NP (NP (DT a) (JJ sharp) (NN increase)) (PP (IN in) (NP (NN prostate) (NN mass)))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (ADVP-TMP (RB never)) (VP (VBP develop) (NP (JJ invasive) (NN CaP)) (, ,) (SBAR-ADV (IN whereas) (S (NP-SBJ (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mice)) (VP (VBP do) (VP (-NONE- *?*))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 6)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT These) (NNS data)) (ADVP (RB clearly)) (VP (VBP support) (NP (NP (DT a) (NN threshold) (NN model)) (PP (IN for) (NP (NP (NML (NN Pten) (NN tumor)) (NN suppression)) (PP (IN at) (NP (DT the) (JJ physiopathological) (NN level))))))) (. .)) )
( (S (ADVP (RB Similarly)) (, ,) (NP-SBJ-1 (JJ qualitative) (JJ morphological) (NNS changes)) (VP (VBP are) (ADVP (RB also)) (VP (VBN caused) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS cells)) (VP (VBG suffering) (NP (JJ complete) (NN Pten) (NN inactivation))))))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN observed) (NP-3 (-NONE- *)) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBG comparing) (NP (NML (NN Ptenpc1) (CC versus) (NN Ptenpc2)) (NNS mice)) (ADVP-TMP-2 (-NONE- *T*)))))))))) (. .)) )
( (S (S (PP-LOC (IN In) (NP (NN Ptenpc2) (NNS mice))) (, ,) (NP-SBJ-1 (NP (NNS signs)) (PP (IN of) (NP (NP (JJ cellular) (NN dysplasia)) (CC and) (NP (JJ irregular) (JJ glandular) (NNS formations))))) (VP (VBD were) (ADVP-TMP (RB frequently)) (VP (VBN observed) (NP-1 (-NONE- *))))) (, ,) (CC but) (S (NP-SBJ (PRP they)) (VP (VBD were) (ADJP-PRD (RB mostly) (JJ absent) (PP (IN from) (NP (NN Ptenpc1) (NNS mutants)))))) (. .)) )
( (S (PP (IN Along) (NP (DT the) (JJ same) (NN tenet))) (, ,) (NP-SBJ-1 (JJ profound) (NN mass) (NN increase)) (VP (VBD was) (ADVP-TMP (RB always)) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-TMP (IN at) (NP (JJ early) (NNS timepoints))) (PP-LOC (PP (IN in) (NP (NN Ptenpc2) (NNS mice))) (, ,) (CONJP (CC but) (RB not)) (PP (IN in) (NP (NN Ptenpc1) (NNS mutants)))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBZ is) (ADVP (RB likely)) (PP-PRD (IN due) (IN to) (NP (NP (DT the) (JJ marked) (NN difference)) (PP (IN in) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NML (NN Pten) (JJ null)) (NNS cells)) (RRC (ADJP-PRD (JJ present)) (PP-LOC (IN in) (NP (NP (DT the) (NN parenchyma)) (PP (IN of) (NP (DT these) (CD two) (NNS models))))) (PP-TMP (IN at) (NP (NN puberty)))))))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG reflecting) (NP (NP (DT the) (JJ different) (NNS levels)) (PP (IN of) (NP (NN Cre) (NN expression))) (PP-LOC (IN in) (NP (DT the) (CD two) (NNS models))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS observations)) (VP (VBP are) (ADVP (RB also)) (ADJP-PRD (JJ consistent) (PP (IN with) (NP (NP (DT a) (NN threshold) (NN model)) (PP (IN for) (NP (NP (NML (NN Pten) (NN tumor)) (NN suppression)) (PP (IN as) (NP (NP (DT a) (NN function)) (PP (IN of) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN Pten) (JJ null) (NNS cells))) (PP-LOC (IN in) (NP (DT a) (JJ given) (NN organ))))))))))))) (. .)) )
( (S (PP (IN From) (NP (DT a) (JJ biological) (NN standpoint))) (, ,) (NP-SBJ (NP (PRP it)) (S-1 (-NONE- *EXP*))) (VP (MD will) (VP (VB be) (ADJP-PRD (JJ challenging)) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (PP-TMP (IN in) (NP (DT the) (NN future))) (SBAR (IN whether) (S (NP-SBJ (DT this) (`` “) (NN field) (NN effect) ('' ”)) (VP (MD would) (ADVP (RB also)) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ natural) (NN history)) (PP (IN of) (NP (JJ human) (NN CaP)))))))))))))) (. .)) )
( (S (PP (IN On) (NP (DT the) (CD one) (NN hand))) (, ,) (NP-SBJ-2 (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (MD could) (VP (VB be) (VP (VBN speculated) (NP-2 (-NONE- *)) (SBAR-1 (SBAR (IN that) (S (NP-SBJ (JJ human) (NN CaP)) (ADVP (RB likely)) (VP (VBZ arises) (PP (IN from) (NP (DT a) (JJ single) (JJ transformed) (NN cell)))))) (CC and) (SBAR (IN that) (ADVP (RB therefore)) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN field) (NNS effects)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NN mouse) (NNS models))))) (VP (MD will) (RB not) (VP (VB be) (NP-PRD (NP (JJ critical) (NNS determinants)) (PP (IN in) (NP (NP (DT the) (JJ natural) (NN history)) (PP (IN of) (NP (DT the) (JJ human) (NN disease))))))))))))))) (. .)) )
( (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP-SBJ (NP (NP (NP (DT the) (JJ multistep) (NN nature)) (PP (IN of) (NP (DT the) (JJ neoplastic) (NN process)))) (-LRB- -LRB-) (CC and) (NP (ADVP (RB hence)) (NP (DT the) (JJ genetic) (NN heterogeneity)) (PP (IN of) (NP (DT the) (NN lesion)))) (-RRB- -RRB-)) (CC and) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP-SBJ-2 (DT the) (NN tumor)) (VP (MD will) (ADVP-TMP (RB eventually)) (VP (VB grow) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (VP (VB form) (NP (NP (`` “) (NNS fields)) ('' ”) (PP (IN of) (NP (JJ neoplastic) (NNS cells))))))))))))) (VP (MD may) (VP (VB suggest) (SBAR (IN that) (S (NP-SBJ (NP (DT these) (NNS effects)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (ADJP (JJ stromal) (CC and) (JJ parenchymal)) (NNS interactions))) (, ,) (VP (VBP are) (NP-PRD (NP (NP (JJ key) (NNS aspects)) (PP (IN of) (NP (DT the) (JJ human) (NN disease)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ (DT the) (NN mouse) (NN model)) (VP (MD can) (VP (VB recapitulate) (NP-1 (-NONE- *T*)))))))))))) (. .)) )
( (S (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN Taken) (NP-1 (-NONE- *)) (ADVP (RB together)))) (, ,) (NP-SBJ (PRP$ our) (NNS findings)) (VP (VBP demonstrate) (NP (NP (NP (DT the) (JJ key) (NN importance)) (PP (IN of) (NP (NN Pten))) (PP (IN in) (NP (NN CaP) (NN tumor) (NN suppression)))) (CC and) (NP (NP (DT the) (JJ dramatic) (NN impact)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ (NP (JJ subtle) (NNS changes)) (PP (IN in) (NP (NP (NN Pten) (NNS levels)) (CC and) (NP (NP (NN extent)) (PP (IN of) (NP (NN Pten) (NN inactivation))))))) (VP (MD may) (VP (VB have) (NP-2 (-NONE- *T*)) (PP (IN on) (NP (NN tumor) (NML (NN initiation) (CC and) (NN progression)))) (PP-LOC (IN in) (NP (DT the) (NN prostate)))))))))) (. .)) )
( (HEADING (NP (NNS Materials) (CC and) (NNS Methods))) )
( (HEADING (NP (NNS Mice))) )
( (S (NP-SBJ-1 (NP (NN Generation) (CC and) (NN characterization)) (PP (IN of) (NP (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (NNS mice)))) (VP (VBP have) (VP (VBN been) (VP (VBN described) (NP-1 (-NONE- *)) (ADVP-TMP (RB perviously)) (CIT (-LRB- -LRB-) (NNP Di) (NNP Cristofano) (FW et) (FW al.) (CD 1998) (, ,) (CD 2001a) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ-1 (NNS Mice)) (VP (VBD were) (VP (VBN genotyped) (NP-1 (-NONE- *)) (PP-MNR (PP (IN by) (NP (NP (NN PCR)) (PP (IN on) (NP (NN tail) (NN DNA))))) (CC or) (PP (IN by) (NP (NNP Southern) (NN blotting)))) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN shown) (NP-2 (-NONE- *))))))) (. .)) )
( (S (S (NP-SBJ-5=4 (JJ Hypomorphic) (NNS mice)) (VP (VBD were) (VP=6 (VBN generated) (NP-5 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN described) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (NN Figure) (CD 1)) (CC and) (NP (NN Figure) (CD 3)))))))))) (CC and) (S (NP-SBJ-3=4 (NN tail) (NN DNA)) (VP=6 (VBN genotyped) (NP-3 (-NONE- *)) (PP-MNR (IN by) (NP (NN PCR))) (PP-PRP (IN for) (NP (NP (NN presence)) (PP (IN of) (NP (DT the) (NML (NML (NN Pten) (SYM −)) (CC and) (NML (NN Ptenhy))) (NNS alleles))))) (-LRB- -LRB-) (UCP (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NNS primers) (NML (CD 1) (CC and) (CD 2))) (PRN (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP (RB below)))) (-RRB- -RRB-)))) (CC or) (PP-MNR (IN by) (NP (NNP Southern) (NN blotting)))))) (. .)) )
( (HEADING (NP (NP (NN Targeting) (NN vector)) (CC and) (NP (NP (NN generation)) (PP (IN of) (NP (ADJP (NN prostate) (HYPH -) (JJ specific)) (ADJP (NN Pten) (HYPH -) (JJ deficient)) (NNS mice)))))) )
( (S (NP-SBJ-1 (DT A) (NML (NN 129) (HYPH /) (NN Sv)) (NN mouse) (JJ genomic) (NN library) (PRN (-LRB- -LRB-) (NP (NP (NNP Stratagene)) (, ,) (NP-LOC (NNP La) (NNP Jolla)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN screened) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT a) (NN mouse) (NN Pten) (NN probe)) (VP (VBG containing) (NP (NNS exons) (NML (NML (CD 4)) (PP (SYM –) (NP (CD 6)))))))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB generate) (NP (DT the) (NN targeting) (NN construct))))) (, ,) (NP-SBJ-1 (NP (NP (DT a) (NML (CD 4.1) (NN Kb)) (NML (NN KpnI) (HYPH –) (NN BamHI)) (NN fragment)) (VP (VBG containing) (NP (NML (CD 5) (SYM ′)) (NN Pten) (JJ genomic) (NN DNA)))) (CC and) (NP (NP (DT a) (NML (CD 2.0) (NN Kb)) (NN XbaI) (NN fragment)) (VP (VBG containing) (NP (NML (CD 3) (SYM ′)) (JJ genomic) (NN DNA))))) (VP (VBD were) (VP (VBN cloned) (NP-1 (-NONE- *)) (PP (IN into) (NP (NN pPNT))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN targeting) (NN construct)) (VP (VBD was) (VP (VP (VBN linearized) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN NotI)))) (CC and) (VP (VBN electroporated) (NP-1 (-NONE- *)) (PP (IN into) (NP (NN CJ7) (NN ES) (NNS cells)))))) (. .)) )
( (S (NP-SBJ-1 (NNS Transfectants)) (VP (VBD were) (VP (VP (VBN selected) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (NN G418) (PRN (-LRB- -LRB-) (NP (NP (CD 350) (NNS μg)) (PP (SYM /) (NP (NN ml)))) (-RRB- -RRB-))) (CC and) (NP (NN gancyclovir) (PRN (-LRB- -LRB-) (NP (CD 2) (NNS μM)) (-RRB- -RRB-)))))) (CC and) (VP (VBN expanded) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NML (NNP Southern) (NN blot)) (NN analysis))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT a) (NML (CD 3) (SYM ′)) (NN probe))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Chimeric) (NNS mice)) (VP (VBD were) (VP (VP (VBN produced) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NN microinjection)) (PP (IN of) (NP (CD two) (ADJP (RB independently) (VBN generated)) (VBN targeted) (NML (NN ES) (NN cell)) (NNS clones))) (PP (IN with) (NP (JJ normal) (NNS karyotypes))) (PP (IN into) (NP (NN E3.5) (NML (NN C57BL6) (HYPH /) (NN J)) (NNS blastocysts)))))) (, ,) (VP (ADVP-TMP (RB then)) (VBN transferred) (NP-1 (-NONE- *)) (PP (IN to) (NP (JJ pseudopregnant) (JJ foster) (NNS mothers)))))) (. .)) )
( (S (S (NP-SBJ-1 (JJ Chimeric) (NNS males)) (VP (VBD were) (VP (VBN mated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NML (NN C57BL6) (HYPH /) (NN J)) (NNS females) (PRN (-LRB- -LRB-) (NP (NP (NNP Jackson) (NNP Laboratory)) (, ,) (NP-LOC (NNP Bar) (NNP Harbor)) (, ,) (NP-LOC (NNP Maine)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))))))) (, ,) (CC and) (S (NP-SBJ-2 (NP (NN germline) (NN transmission)) (PP (IN of) (NP (DT the) (JJ mutant) (NN allele)))) (VP (VBD was) (VP (VBN verified) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NML (NNP Southern) (NN blot)) (NN analysis)) (PP (IN of) (NP (NP (NN tail) (NN DNA)) (PP (IN from) (NP (NN agouti) (ADJP (NN coat) (HYPH -) (VBN colored)) (NN F1) (NN offspring)))))))))) (. .)) )
( (S (ADVP (RB Next)) (S (S (, ,) (NP-SBJ-1 (NML (NML (NN PtenloxP) (HYPH -) (NN neo)) (HYPH /) (SYM +)) (NNS mice)) (VP (VBD were) (VP (VBN mated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NML (NN EIIA) (HYPH -) (NN Cre)) (JJ transgenic) (NNS mice))) (CIT (-LRB- -LRB-) (NNP Lakso) (FW et) (FW al.) (CD 1996) (-RRB- -RRB-))))) (, ,) (CC and) (S (NP-SBJ-2 (NP (NN tail) (NN DNA)) (PP (IN from) (NP (NN offspring)))) (VP (VBD was) (VP (VBN subjected) (NP-2 (-NONE- *)) (PP (IN to) (NP (NML (NNP Southern) (NN blot)) (NN analysis))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NN probe) (CD 6.1)))))))) (. .)) )
( (S (PP (IN Through) (NP (DT these) (NNS crosses))) (, ,) (NP-SBJ (NP (NN mosaic) (NNS mice)) (VP (VBG harboring) (NP (NP (DT a) (NN Pten) (NML (JJ wild) (HYPH -) (NN type)) (NN allele)) (, ,) (NP (NP (DT a) (ADJP (NN Pten) (VBN targeted)) (NN allele)) (-LRB- -LRB-) (NP (NN PtenloxP) (HYPH -) (NN neo))) (-RRB- -RRB-) (, ,) (CC and) (NP (NP (DT a) (JJ floxed) (NN allele)) (-LRB- -LRB-) (NP (NN Ptenloxp)))) (-RRB- -RRB-) (PP-LOC (IN in) (NP (PRP$ their) (NN germline))))) (VP (VBD were) (VP (VBN generated) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (DT These) (NN mosaic) (NNS mutants)) (VP (VBD were) (VP (VBN mated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)) (CC and) (NP (NP (NN tail) (NN DNA)) (PP (IN from) (NP (NP (NN offspring)) (VP (VBN subjected) (NP (-NONE- *)) (PP (PP (IN to) (NP (NP (NML (NNP Southern) (NN blot)) (NN analysis)) (VP (VBG using) (NP (NN probe) (CD 6.1))))) (CC and) (PP (IN to) (NP (NP (NN PCR) (NN analysis)) (VP (VBG using) (NP (NP (NP (NN primer) (CD 1)) (-LRB- -LRB-) (NP (NML (CD 5) (SYM ′)) (HYPH -) (NN AAAAGTTCCCCTGCTGATGATTTGT) (HYPH -) (CD 3) (SYM ′))) (-RRB- -RRB-) (CC and) (NP (NP (NN primer) (CD 2)) (-LRB- -LRB-) (NP (NML (CD 5) (SYM ′)) (HYPH -) (NN TGTTTTTGACCAATTAAAGTAGGCTGTG) (HYPH -) (CD 3) (SYM ′)) (-RRB- -RRB-))))))))))))))) (. .)) )
( (S (NP-SBJ (NN PCR) (NNS conditions)) (VP (VBD were) (NP-PRD (NP (CD 35) (NNS cycles)) (PRN (-LRB- -LRB-) (NP-TMP (NP (NP (CD 30) (NN sec)) (PP (IN at) (NP (CD 95) (NN °C)))) (, ,) (NP (NP (CD 1) (NN min)) (PP (IN at) (NP (CD 55) (NN °C)))) (, ,) (CC and) (NP (NP (CD 1) (NN min)) (PP (IN at) (NP (CD 72) (NN °C))))) (-RRB- -RRB-)) (VP (VBG using) (NP (NP (NNP HotStarTaq) (NNP Master) (NNP Mix) (PRN (-LRB- -LRB-) (NP (NP (NNP Qiagen)) (, ,) (NP-LOC (NNP Valencia)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (, ,) (NP (NN primer) (PRN (-LRB- -LRB-) (NP (CD 0.25) (NNS μM)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN DNA) (PRN (-LRB- -LRB-) (NP (CD 50) (NNS ng)) (-RRB- -RRB-))))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB detect) (NP (DT the) (VBN deleted) (NN allele))))) (, ,) (NP-SBJ-1 (NP (NN primer) (CD 3)) (-LRB- -LRB-) (NP (NML (CD 5) (SYM ′)) (HYPH -) (NN CCCCCAAGTCAATTGTTAGGTCTGT) (HYPH -) (CD 3) (SYM ′)) (-RRB- -RRB-)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (NML (NN PtenloxP) (HYPH /) (NN loxP)) (NNS mice)) (VP (VBD were) (ADVP-TMP (RB next)) (VP (VBN mated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NML (NML (NN PB) (HYPH -) (NN Cre)) (JJ transgenic)) (NNS mice) (CIT (-LRB- -LRB-) (NNP Maddison) (FW et) (FW al.) (CD 2000) (-RRB- -RRB-))) (CC or) (NP (JJ male) (NML (NML (NN PB) (HYPH -) (NN Cre4)) (JJ transgenic)) (NNS mice) (CIT (-LRB- -LRB-) (NNP Wu) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-))))) (PP-PRP (IN for) (NP (JJ conditional) (ADJP (NN prostate) (HYPH -) (JJ specific)) (NN Pten) (NN inactivation))))) (. .)) )
( (HEADING (NP (NN Autopsy) (CC and) (NN histopathology))) )
( (S (S (NP-SBJ-1 (NNS Animals)) (VP (VBD were) (VP (VBN autopsied) (NP-1 (-NONE- *))))) (CC and) (S (NP-SBJ-2 (DT all) (NNS tissues)) (VP (VBD were) (VP (VBN examined) (NP-2 (-NONE- *)) (ADVP (RB regardless) (PP (IN of) (NP (PRP$ their) (JJ pathological) (NN status))))))) (. .)) )
( (S (NP-SBJ-1 (UCP (JJ Normal) (CC and) (NN tumor)) (NN tissue) (NNS samples)) (VP (VBD were) (VP (VBN fixed) (NP-1 (-NONE- *)) (PP (IN in) (NP (NML (CD 10) (NN %)) (VBN buffered) (NN formalin)))) (CC and) (VP (VBN embedded) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN paraffin))))) (. .)) )
( (S (NP-SBJ-1 (NNS Sections) (PRN (-LRB- -LRB-) (NP (CD 5) (NNS μm)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN stained) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NN hematoxylin) (CC and) (NN eosin)) (-LRB- -LRB-) (NP (NN H) (CC &) (NN E)))) (-RRB- -RRB-) (PP-MNR (VBG according) (PP (IN to) (NP (JJ standard) (NNS protocols)))))) (. .)) )
( (HEADING (NP (NNS Cells))) )
( (S (NP-SBJ-1 (NP (JJ Primary) (NNS MEFs)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (CD ten) (NN littermate) (NNS embryos))))) (VP (VBD were) (VP (VBN produced) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBZ follows)))))) (. .)) )
( (S (S (NP-SBJ-1 (NNS MEFs)) (VP (VBD were) (VP (VBN obtained) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG crossing) (NP (NML (NML (NN Ptenhy) (HYPH /) (SYM +)) (CC and) (NML (NN Pten) (SYM +) (HYPH /) (SYM −))) (NNS animals)))))))) (, ,) (S (NP-SBJ-2 (NNS embryos)) (VP (VBD were) (VP (VBN harvested) (NP-2 (-NONE- *)) (PP-TMP (IN at) (NP (CD 13.5) (NNS dpc)))))) (, ,) (CC and) (S (NP-SBJ-4 (JJ individual) (NNS MEFs)) (VP (VBD were) (VP (VP (VBN produced) (CC and) (VBN cultured) (NP-4 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-3 (-NONE- *))))) (CIT (-LRB- -LRB-) (NNP Di) (NNP Cristofano) (FW et) (FW al.) (CD 2001b) (-RRB- -RRB-))) (CC and) (VP (VBN genotyped) (NP-4 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-5 (-NONE- *PRO*)) (VP (VBN described) (NP-5 (-NONE- *)) (ADVP (RB above))))))))) (. .)) )
( (S (PP (IN At) (NP (NN passage) (CD 2))) (, ,) (S (S (NP-SBJ-1=5 (NNS cells)) (VP (VBD were) (VP=4 (VBN harvested) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NP (NN WB) (NN analysis) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VB see) (NP-2 (-NONE- *)) (ADVP (RB below)))) (-RRB- -RRB-))) (CC and) (NP (NN mRNA) (NN extraction)))) (PP-MNR (IN by) (NP (DT the) (NN TRIZOL) (NN method))) (PRN (-LRB- -LRB-) (NP (NN GIBCO) (HYPH –) (NN BRL)) (, ,) (NP (NP (NNP Carlsbad)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))))) (CC and) (S (NP-SBJ-3=5 (NN cDNA)) (VP=4 (VBN produced) (NP-3 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT the) (NNP SuperScript) (NML (JJ First) (HYPH -) (NN Strand)) (NN Kit)))) (PP (IN for) (NP (NN RT) (HYPH –) (NN PCR))) (PRN (-LRB- -LRB-) (NP (NNP Invitrogen)) (, ,) (NP-LOC (NNP Carlsbad)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States)) (-RRB- -RRB-)) (PP-MNR (VBG according) (PP (IN to) (NP (NP (DT the) (NNS manufacturers) (POS ')) (NNS instructions))))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Semiquantitative) (NN PCR)) (-LRB- -LRB-) (VP (VBG yielding) (NP (DT a) (NML (CD 102) (NN bp)) (NN amplicon))) (-RRB- -RRB-)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT a) (NML (NN Pten) (NN exon)) (ADJP (CD 3) (HYPH -) (JJ specific)) (JJ forward) (NML-2 (-NONE- *RNR*)) (PRN (-LRB- -LRB-) (NP (NML (CD 5) (SYM ′)) (HYPH -) (NN TGGATTCAAAGCATAAAAACCATTAC) (HYPH -) (CD 3) (SYM ′)) (-RRB- -RRB-))) (CC and) (NP (DT an) (ADJP (NP (NP (NN exon) (CD 4)) (HYPH -) (CC and) (NP (NN exon) (CD 5))) (HYPH -) (JJ specific)) (JJ reverse) (NML-2 (-NONE- *RNR*))) (NML-2 (NN primer)) (PRN (-LRB- -LRB-) (NP (NML (CD 5) (SYM ′)) (HYPH -) (NN CAAAAGGATACTGTGCAACTCTGC) (HYPH -) (CD 3) (SYM ′)) (-RRB- -RRB-)))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (CD 30) (NNS cycles)) (PP (IN of) (NP (NP (NP (CD 1) (NN min)) (PP (IN at) (NP (CD 95) (NN °C)))) (, ,) (NP (NP (CD 1) (NN min)) (PP (IN at) (NP (CD 55) (NN °C)))) (, ,) (CC and) (NP (NP (CD 1) (NN min)) (PP (IN at) (NP (CD 72) (NN °C))))))) (-RRB- -RRB-) (PP (IN with) (NP (NP (DT the) (NN PCR) (NN optimizer) (NN kit) (PRN (-LRB- -LRB-) (NP (NNP Invitrogen)) (-RRB- -RRB-))) (CC and) (NP (NN buffer) (NN A)))) (PP (VBG according) (PP (IN to) (NP (NP (DT the) (NN manufacturer) (POS 's)) (NNS protocols)))))))) (. .)) )
( (S (S (NP-SBJ-1 (NP (NN PCR) (NN amplification)) (PP (IN of) (NP (DT the) (NNS cDNAs)))) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (NML (CD 25) (, ,) (CD 30) (, ,) (CC and) (CD 35)) (NNS cycles)))))) (, ,) (CC and) (S (NP-SBJ-2 (DT the) (JJ amplified) (NNS products)) (VP (VBD were) (VP (VBN found) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB be) (PP-PRD (IN in) (NP (DT the) (JJ linear) (NN range))) (PP-TMP (IN at) (NP (CD 30) (NNS cycles))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN PCR) (NNS products)) (PP (IN from) (NP (NML (NML (NN hypoxanthine) (NN phosphoribosyltransferase)) (-LRB- -LRB-) (NML (NN HPRT)) (-RRB- -RRB-)) (NN control) (NN amplification))) (PP (IN with) (NP (NML (NML (NML (CD 5) (SYM ′)) (HYPH -) (NN CCTGCTGGATTACATTAAAGCACTG) (HYPH -) (CD 3) (SYM ′)) (CC and) (NML (NML (CD 5) (SYM ′)) (HYPH -) (NN GTCAAGGGCATATCCAACAACAAAC) (HYPH -) (CD 3) (SYM ′))) (NNS primers)))) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN as) (NP (NNS standards))) (PRN (-LRB- -LRB-) (NP (NML (CD 352) (NN bp)) (NN amplicon)) (-RRB- -RRB-)))) (. .)) )
( (S (PP-PRP (IN For) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG measuring) (NP (NP (JJ proliferative) (NNS rates)) (PP (IN of) (NP (DT all) (NN MEF) (NNS genotypes))))))) (, ,) (NP-SBJ-1 (NNS cells)) (VP (VBD were) (VP (VP (VBN seeded) (NP-1 (-NONE- *)) (PP (IN in) (NP (NML (CD 12) (HYPH -) (NN well)) (NNS plates))) (PP (IN at) (NP (NP (CD 3,000) (NNS cells)) (PP (IN per) (NP (NN well))))) (PP (IN in) (NP (NP (NN medium)) (VP (VBG containing) (NP (NML (CD 10) (NN %)) (NN FBS)))))) (CC and) (VP (VBN fixed) (NP (-NONE- *)) (PP (IN at) (NP (NML (CD 2) (HYPH -) (NN d)) (NNS intervals)))))) (. .)) )
( (S (NP-SBJ-1 (NN Analysis) (CC and) (NN quantification)) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-2 (-NONE- *))))) (CIT (-LRB- -LRB-) (NNP Di) (NNP Cristofano) (FW et) (FW al.) (CD 2001b) (-RRB- -RRB-)))) (. .)) )
( (HEADING (NP (NN WB) (NML (NN analysis) (CC and) (NN densitometry)))) )
( (S (S (NP-SBJ-1 (NP (NNS Prostates)) (PP (IN from) (NP (NP (JJ dissected) (NNS animals)) (PP (IN of) (NP (DT all) (NNS genotypes)))))) (VP (VBD were) (ADVP-TMP (RB briefly)) (VP (VBN homogenized) (NP-1 (-NONE- *)) (-LRB- -LRB-) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT a) (NNP Polytron) (NN homogenizer)) (PRN (: ;) (NP (NP (NNP Polytron) (NNP Vertrieb)) (, ,) (NP-LOC (NNP Bad) (NNP Wildbad)) (, ,) (NP-LOC (NNP Germany))) (-RRB- -RRB-))))))) (, ,) (CC and) (S (NP-SBJ-2 (JJ primary) (NNS MEFs)) (VP (VBD were) (VP (VP (VBN harvested) (NP-2 (-NONE- *))) (CC and) (VP (ADVP (RB directly)) (VBN lysed) (NP-2 (-NONE- *)) (PP-MNR (IN in) (NP (NP (NML (CD 50) (NN mM)) (NN Tris) (PRN (-LRB- -LRB-) (NP (NN pH) (CD 7.5)) (-RRB- -RRB-))) (, ,) (NP (NML (CD 150) (NN mM)) (NN NaCl)) (, ,) (NP (NML (CD 1) (NN mM)) (NN EDTA)) (, ,) (NP (NML (CD 0.1) (NN %)) (NN NP) (HYPH -) (CD 40)) (, ,) (NP (NML (CD 1) (NN mM)) (NML (NML (NN sodium) (NN ortho-vanadate)) (-LRB- -LRB-) (NML (NN Na3VO4)))) (-RRB- -RRB-) (, ,) (NP (NML (CD 10) (NN mM)) (NN NaF)) (, ,) (CC and) (NP (NML (NN protease) (NN inhibitor)) (NN cocktail) (PRN (-LRB- -LRB-) (NP (NP (NNP Hoffmann) (HYPH –) (NNP La) (NNP Roche)) (, ,) (NP-LOC (NNP Basel)) (, ,) (NP-LOC (NNP Switzerland))) (-RRB- -RRB-)))))) (CC and) (VP (VBN cleared) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (NN centrifugation))))))) (: ;) (S (NP-SBJ-3 (NNS concentrations)) (VP (VBD were) (VP (VBN determined) (NP-3 (-NONE- *)) (PP-MNR (IN by) (NP (DT the) (NML (NNP Bio) (HYPH -) (NNP Rad)) (NNP Protein) (NNP Assay) (PRN (-LRB- -LRB-) (NP (NP (NNP Bio-Rad) (NNP Laboratories)) (, ,) (NP-LOC (NNP Hercules)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))))))) (: ;) (CC and) (S (NP-SBJ-4 (NNS samples)) (VP (VBD were) (VP (VBN taken) (NP-4 (-NONE- *)) (PP (IN into) (NP (DT an) (NN SDS) (NN sample) (NN loading) (NN buffer))))) (. .))) )
( (S (S (NP-SBJ-5 (NN Blood)) (VP (VBD was) (VP (VBN taken) (NP-5 (-NONE- *)) (PP (IN from) (NP (NP (DT the) (ADJP (JJ retro) (HYPH -) (JJ orbital)) (NN cavity)) (PP (IN of) (NP (VBN anesthetized) (NNS mice)))))))) (, ,) (S (S (NP-SBJ-7=9 (JJ red) (NNS cells)) (VP (VBD were) (VP=6 (VBN lysed) (NP-7 (-NONE- *)) (PP-MNR (IN in) (NP (NN lysis) (NN buffer) (PRN (-LRB- -LRB-) (NP (NML (CD 0.155) (NN M)) (NN NH4Cl)) (, ,) (NP (NML (CD 10) (NN mM)) (NN KHCO3)) (, ,) (NP (NML (CD 1) (NN mM)) (NN EDTA)) (-RRB- -RRB-))))))) (, ,) (CC and) (S (NP-SBJ-8=9 (JJ intact) (NNS cells)) (VP=6 (VBN harvested) (NP-8 (-NONE- *)) (PP-MNR (IN by) (NP (NN centrifugation)))))) (. .)) )
( (S (S (NP-SBJ-1 (NNS PBMCs)) (VP (VBD were) (VP (VBN lysed) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (NN lysis) (NN buffer))) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-2 (-NONE- *))))) (CIT (-LRB- -LRB-) (NNP Di) (NNP Cristofano) (FW et) (FW al.) (CD 2001b) (-RRB- -RRB-))))) (, ,) (CC and) (S (NP-SBJ-3 (NN protein) (NNS concentrations)) (VP (VBD were) (VP (VBN determined) (NP-3 (-NONE- *)) (PP (IN as) (ADVP (RB above)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Equivalents)) (PP (IN of) (NP (NP (CD 50) (NNS μg)) (PP (IN of) (NP (NN lysate))))) (PP (IN per) (NP (NN lane)))) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NML (NML (NN SDS) (HYPH –) (NN PAGE)) (CC and) (NML (NN WB))) (NN analysis))))) (. .)) )
( (S (NP-SBJ-1 (NNS Proteins)) (VP (VBD were) (VP (VBN detected) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT a) (NN rabbit) (JJ polyclonal) (JJ anti-Pten) (NN antibody) (PRN (-LRB- -LRB-) (NP (NML (JJ anti-PTEN) (HYPH /) (NN MMAC) (HYPH -) (CD 1)) (NN Ab) (HYPH -) (CD 2)) (: ;) (NP (NP (NNP NeoMarkers)) (, ,) (NP-LOC (NNP Lab) (NNP Vision) (NNP Corporation)) (, ,) (NP-LOC (NNP Fremont)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (, ,) (NP (NP (NML (NML (JJ anti-actin) (JJ monoclonal) (NN antibody)) (-LRB- -LRB-) (NML (NN mAb))) (-RRB- -RRB-) (NN AC) (HYPH -) (CD 74)) (PRN (-LRB- -LRB-) (NP (NP (NNP Sigma)) (, ,) (NP-LOC (NNP St.) (NNP Louis)) (, ,) (NP-LOC (NNP Missouri)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)) (PP (IN for) (NP (NN normalization)))) (, ,) (CC and) (NP (NP (DT the) (NML (NML (NN Phospho) (HYPH -) (NN Akt)) (NN Pathway) (NN Sampler) (NN Kit)) (NNS antibodies)) (PP (IN against) (NP (NP (NN Akt)) (CC and) (NP (NP (NN phospho) (HYPH -) (NN Serine) (CD 473)) (PP (IN of) (NP (NN Akt)))) (PRN (-LRB- -LRB-) (NP (NP (NNP Cell) (NNP Signaling) (NNP Technology)) (, ,) (NP-LOC (NNP Beverly)) (, ,) (NP-LOC (NNP Massachusetts)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))))) (PP-MNR (VBG following) (NP (NP (DT the) (NNS manufacturers) (POS ')) (NNS instructions))))))) (. .)) )
( (S (PP-TMP (IN After) (NP (NP (NN visualization)) (PP (IN with) (NP (DT the) (NN ECL) (NN system) (PRN (-LRB- -LRB-) (NP (NP (NNP Amersham) (NNP Biosciences)) (, ,) (NP-LOC (NNP Little) (NNP Chalfont)) (, ,) (NP-LOC (NNP United) (NNP Kingdom))) (-RRB- -RRB-)))))) (, ,) (S (S (S (NP-SBJ-1 (NNS films)) (VP (VBD were) (VP (VBN scanned) (NP-1 (-NONE- *))))) (CC and) (S (NP-SBJ-2 (NN band) (NN density)) (VP (VBD was) (VP (VBN quantified) (NP-2 (-NONE- *)))))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NNP MacBas) (NN v2.5) (PRN (-LRB- -LRB-) (NP (NP (NNP Fuji) (NNP Photo) (NNP Film) (NNP Company)) (, ,) (NP-LOC (NNP Tokyo)) (, ,) (NP-LOC (NNP Japan))) (-RRB- -RRB-))) (PP (IN on) (NP (DT a) (NNP Macintosh) (NN computer) (PRN (-LRB- -LRB-) (NP (NP (NNP Apple) (NNP Computer)) (, ,) (NP-LOC (NNP Sunnyvale)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))))))) (. .)) )
( (HEADING (NP (NN IHC))) )
( (S (S (NP-SBJ-1 (NNS Tissues)) (VP (VBD were) (VP (VP (VBN fixed) (NP-1 (-NONE- *)) (PP (IN in) (NP (NML (CD 4) (NN %)) (NN paraformaldehyde)))) (CC and) (VP (VBN embedded) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN paraffin))))))) (, ,) (CC and) (S (NP-SBJ-2 (ADJP (NP (CD 8) (NN μm)) (HYPH -) (JJ thick)) (NNS sections)) (VP (VBD were) (VP (VBN prepared) (NP-2 (-NONE- *))))) (. .)) )
( (S (NP-SBJ-1 (JJ Anti-p27) (NN mouse) (NN mAb) (PRN (-LRB- -LRB-) (NP (NN catalog) (NN #) (CD 610242)) (: ;) (NP (NP (NN BD) (NNP Transduction) (NNP Laboratories)) (, ,) (NP-LOC (NNP San) (NNP Diego)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN at) (NP (NML (NML (CD 0.5) (NN μg)) (PP (SYM /) (NP (NN ml)))) (NN concentration))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN IHC) (NN detection)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT the) (NN MOM) (NN kit)) (PP (IN from) (NP (NNP Vector) (NNP Laboratories) (PRN (-LRB- -LRB-) (NP (NP (NNP Burlingame)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))))))) (. .)) )
( (S (S (NP-SBJ-1 (NML (NN Rabbit) (JJ polyclonal) (NN phospho) (HYPH -) (NN Akt) (PRN (-LRB- -LRB-) (NP (NN Ser) (NN 473)) (-RRB- -RRB-))) (NN antibody) (PRN (-LRB- -LRB-) (NP (NP (NN catalog) (NN #) (CD 9270)) (PP (IN from) (NP (NNP Cell) (NNP Signaling) (NNP Technology)))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN in) (NP (CD 1)))))) (SYM :) (S (NP-SBJ-2 (NP (CD 50) (NN dilution)) (, ,) (CC and) (NP (NP (NML (NN rabbit) (JJ polyclonal) (NN antibody)) (NN PTEN)) (HYPH /) (NP (NN MMAC1) (NN Ab) (HYPH -) (CD 2))) (PRN (-LRB- -LRB-) (NP (NP (NN catalog) (NN #) (NN RB) (HYPH -) (CD 072) (HYPH -) (NN PO)) (PP (IN from) (NP (NNP NeoMarkers)))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN used) (NP-2 (-NONE- *)) (PP (IN at) (NP (QP (CD 1) (SYM :) (CD 200)) (NN dilution)))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN IHC) (NN detection)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT the) (NN ABC) (NN kit)) (PP (IN from) (NP (NNP Vector) (NNP Laboratories))))))) (. .)) )
( (S (NP-SBJ-1 (DT These) (VBG staining) (NNS procedures)) (VP (VBD were) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP-MNR (IN by) (NP (NP (NP (DT the) (JJ automated) (NN staining) (NN processor)) (NP (NNP Discovery))) (PP (IN from) (NP (NNP Ventana) (NNP Medical) (NNP Systems) (PRN (-LRB- -LRB-) (NP (NP (NNP Tucson)) (, ,) (NP-LOC (NNP Arizona)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NML (JJ Anti-Ki) (HYPH -) (CD 67)) (NN antibody) (PRN (-LRB- -LRB-) (NP (NNP Novocastra) (NNP Laboratories) (NNP Ltd.)) (, ,) (NP-LOC (NP (NNP Newcastle)) (HYPH -) (PP (IN upon) (HYPH -) (NP (NNP Tyne)))) (, ,) (NP-LOC (NNP United) (NNP Kingdom)) (-RRB- -RRB-))) (, ,) (NP (JJ anti-Cre) (NN antibody) (PRN (-LRB- -LRB-) (NP (NP (NNP Novagen)) (, ,) (NP-LOC (NNP Madison)) (, ,) (NP-LOC (NNP Wisconsin)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (, ,) (CC and) (NP (JJ polyclonal) (NML (JJ anti-phospho) (HYPH -) (NN mTOR)) (NN antibody) (PRN (-LRB- -LRB-) (NP (NNP Cell) (NNP Signaling) (NNP Technology)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN purchased) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ (JJ Anti-phospho) (HYPH -) (NN FOXO3) (PRN (-LRB- -LRB-) (NP (NN Thr) (CD 32)) (-RRB- -RRB-))) (VP (VBD was) (NP-PRD (NP (DT a) (JJ kind) (NN gift)) (PP (IN from) (NP (NNP Anne) (NNP Brunet) (PRN (-LRB- -LRB-) (NP (NP (NNP Harvard) (NNP University)) (, ,) (NP-LOC (NNP Cambridge)) (, ,) (NP-LOC (NNP Massachusetts)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-1 (NN Paraffin) (NNS sections) (PRN (-LRB- -LRB-) (NP (NML (CD 5) (NN μm)) (NN thickness)) (-RRB- -RRB-))) (VP (VP (VBD were) (VP (VBN fixed) (NP-1 (-NONE- *)) (PP (IN in) (NP (ADJP (NN ice) (HYPH -) (JJ cold)) (NN acetone)))) (CC and) (VP (VBN incubated) (NP-1 (-NONE- *)) (PP (IN in) (NP (NML (CD 0.1) (NN %)) (NN H2O2))) (PP-TMP (IN for) (NP (CD 15) (NN min))))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB inactivate) (NP (JJ internal) (NN peroxidase)))))) (. .)) )
( (S (NP-SBJ-1 (NN Antigen) (NN retrieval)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP (IN in) (NP (NML (CD 10) (NN mM)) (JJ citric) (NN acid))) (PP-TMP (IN for) (NP (CD 15) (NN min))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NN microwave)))))) (. .)) )
( (S (NP-SBJ-1 (NN IHC) (NN staining)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (JJ biotinylated) (JJ secondary) (NNS antibodies)) (VP (VBN followed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NML (NNP Vectastain) (NNP ABC) (NNP Elite)) (NN kit) (PRN (-LRB- -LRB-) (NP (NNP Vector) (NNP Laboratories)) (-RRB- -RRB-)))))))))) (. .)) )
( (HEADING (NP (NN MRI) (NN analysis))) )
( (S (NP-SBJ-1 (NNS Mice)) (VP (VBD were) (VP (VBN assessed) (NP-1 (-NONE- *)) (ADVP (RB individually)) (PP-MNR (IN by) (NP (NN MRI))) (PP-PRP (IN for) (NP (NN tumor) (NN establishment))))) (. .)) )
( (S (NP-SBJ-1 (NNS Images)) (VP (VBD were) (VP (VBN obtained) (NP-1 (-NONE- *)) (PP-MNR (IN on) (NP (DT a) (NN 1.5T) (NML (NNP General) (NNP Electric)) (NML (NNP LX) (NNP Echo) (NNP Speed) (NNP Signa)) (NN scanner) (PRN (-LRB- -LRB-) (NP (NP (NNP General) (NNP Electric) (NNP Medical) (NNP Systems)) (, ,) (NP-LOC (NNP Milwaukee)) (, ,) (NP-LOC (NNP Wisconsin)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (JJ homemade) (NN foil) (NN solenoid) (NNS coils) (PRN (-LRB- -LRB-) (NP (NML (NML (CD 22) (NN mm)) (CC or) (NML (CD 27) (NN mm))) (JJ inner) (NN diameter)) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS mice)) (VP (VBD were) (VP (VBN anesthetized) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN isofluorane))))) (. .)) )
( (S (NP-SBJ-1 (NNS Images)) (VP (VBD were) (VP (VBN acquired) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT a) (ADJP (CD two) (HYPH -) (JJ dimensional)) (NML (NN spin) (HYPH -) (NN echo)) (NN pulse) (NN sequence)))))) (. .)) )
( (S (S (ADVP-TMP (RB Initially)) (, ,) (NP-SBJ-1 (DT the) (NN animal)) (VP (VBD was) (VP (VBN positioned) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN coil))) (PP-LOC (IN in) (NP (DT a) (NN holder)))))) (, ,) (CC and) (S (NP-SBJ-2 (JJ sagittal) (NN scout) (PRN (-LRB- -LRB-) (NP (NP (NP (NN field)) (PP (IN of) (NP (NN view)))) (, ,) (NP (CD 120) (NN mm))) (-RRB- -RRB-)) (NNS images)) (VP (VBN obtained) (NP-2 (-NONE- *)) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN TR)) (VP (SYM =) (NP (CD 300) (NNS ms)))) (, ,) (S-FRM (NP-SBJ (NN TE)) (VP (SYM =) (NP (CD 14) (NNS ms)))) (, ,) (NP (NP (CD one) (NN excitation)) (PP (IN per) (NP (ADJP (NN phase) (HYPH -) (VBG encoding)) (NN step)))) (, ,) (NP (QP (CD 256) (SYM ×) (CD 128)) (NN matrix)) (, ,) (NP (ADJP (NP (CD 3.0) (NN mm)) (HYPH -) (JJ thick)) (NN slice)) (, ,) (NP (NML (CD 1.5) (NN mm)) (NN slice) (NN separation)) (-RRB- -RRB-)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB localize) (NP (NP (DT the) (NN region)) (PP (IN of) (NP (NN interest))))))))) (. .)) )
( (S (ADVP-TMP (RB Subsequently)) (, ,) (NP-SBJ-1 (ADJP (JJ high) (HYPH -) (NN quality)) (ADJP (NN T2) (HYPH -) (VBN weighted)) (NML (NML (JJ fast) (NN spin)) (HYPH -) (NN echo)) (JJ transverse) (NNS images)) (VP (VBD were) (VP (VBN obtained) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN TR)) (VP (SYM =) (NP (QP (CD 3,000) (SYM –) (CD 5,000)) (NN ms)))) (, ,) (S-FRM (NP-SBJ (NN TEeff)) (VP (SYM =) (NP (CD 102) (NNS ms)))) (, ,) (S-FRM (NP-SBJ (NML (NN echo) (NN train)) (NN length)) (VP (SYM =) (NP (CD 12)))) (, ,) (NP (NP (QP (CD 6) (SYM –) (CD 12)) (NNS excitations)) (PP (IN per) (NP (ADJP (NN phase) (HYPH -) (VBG encoding)) (NN step)))) (, ,) (NP (ADJP (NP (CD 1.5) (NN mm)) (JJ thick)) (NN slice)) (, ,) (S-FRM (NP-SBJ (NP (NN field)) (PP (IN of) (NP (NN view)))) (VP (SYM =) (NP (CD 40) (NN mm)))) (, ,) (NP (NML (CD 0.5) (NN mm)) (NN slice) (NN separation)) (, ,) (PP (IN in) (NP (NP (NN plane) (NN resolution)) (PP (IN of) (NP (NP (QP (CD 156) (SYM ×) (CD 156)) (NN μm)) (CC or) (NP (QP (CD 156) (SYM ×) (CD 208)) (NN μm)))))) (-RRB- -RRB-)))) (. .)) )
( (HEADING (NP (JJ Statistical) (NN analysis))) )
( (S (NP-SBJ-1 (NN Survival)) (VP (VBD was) (VP (VBN calculated) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT the) (NML (NNP Kaplan) (HYPH –) (NNP Meier)) (NN method)))))) (. .)) )
( (S (NP-SBJ-1 (NN Log) (NN rank) (NNS tests)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB compare) (NP (NNS groups)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT the) (NML (NNP SPSS) (CD 10)) (NN software) (NN package) (PRN (-LRB- -LRB-) (NP (NP (NNP SPSS) (NNP Incorporated)) (, ,) (NP-LOC (NNP Chicago)) (, ,) (NP-LOC (NNP Illinois)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))))))))))) (. .)) )
( (HEADING (NP (NNS Acknowledgements))) )
( (S (NP-SBJ (PRP We)) (VP (VP (VBP thank) (NP=2 (NP (NNP Peter) (NNP Scardino)) (CC and) (NP (NNP Howard) (NNP Scher))) (PP=1 (IN for) (NP (NN advice) (CC and) (NNS discussions)))) (: ;) (VP (NP=2 (NNP Zhenbang) (NNP Chen)) (PP=1 (IN for) (NP (NP (NN help)) (PP (IN with) (NP (NP (NN genotyping) (CC and) (NN characterization)) (PP (IN of) (NP (DT the) (NN Pten) (JJ hypomorphic) (NNS mutants)))))))) (: ;) (VP (NP=2 (NNP Lisette) (NNP Anne) (NNP Maddison)) (PP-PRP=1 (IN for) (NP (NP (DT the) (NN genotyping)) (PP (IN of) (NP (DT the) (NML (NN PR) (HYPH -) (NN Cre)) (JJ transgenic) (NNS mice)))))) (: ;) (VP (NP=2 (NP (NNP Katia) (NNP Manova)) (CC and) (NP (NNP Craig) (NNP Farrell))) (PP-PRP=1 (IN for) (NP (NP (NN assistance)) (PP (IN with) (NP (DT the) (JJ automated) (NN IHC) (NNS procedures)))))) (: ;) (VP (NP=2 (NNP Maria) (NNP Socorro) (NNP Jiao)) (PP-PRP=1 (IN for) (NP (NP (NN assistance)) (PP (IN with) (NP (JJ pathological) (NN analysis)))))) (: ;) (CC and) (VP (NP=2 (NP (NNP Mihaela) (NNP Lupu)) (CC and) (NP (NNP Cornelia) (NNP Matei))) (PP-PRP=1 (IN for) (NP (NP (NN assistance)) (PP (IN with) (NP (DT the) (NN MRI) (NN analysis))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN study)) (VP (VBD was) (VP (VBN supported) (NP-1 (-NONE- *)) (, ,) (PP (IN in) (ADJP (JJ part))) (, ,) (PP (PP (IN by) (NP-LGS (NML (NML (NNP National) (NNP Cancer) (NNP Institute)) (-LRB- -LRB-) (NML (NNP NCI))) (-RRB- -RRB-) (NNS grants) (PRN (-LRB- -LRB-) (NP (NP (NN SPORE) (CD 92629)) (PP (IN in) (NP (NN Prostate) (NN Cancer)))) (, ,) (NP (NP (NN MMHCC) (NN CA) (HYPH -) (CD 84292)) (, ,) (CC and) (NP (NN RO1) (NN CA) (HYPH -) (CD 82328))) (-RRB- -RRB-)))) (CC and) (PP (IN by) (NP (DT the) (NML (NML (NNP I.T.) (NNP Hirschl)) (SYM /) (NML (NNP M.) (NNP Weill) (HYPH –) (NNP Caulier))) (NNP Foundation)))) (PP (IN to) (NP (NP (NNP PPP)) (CC and) (NP (NNP CC) (HYPH -) (NNP C)))))) (. .)) )
( (S (NP-SBJ-1 (NN Imaging) (NN analysis)) (VP (VBD was) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NNP NCI) (NN grant) (NN R24CA83084)) (CC and) (NP (NP (DT an) (NN MSKCC) (NNP NCI) (JJ Core) (NN Grant)) (PP (IN to) (NP (NNP JAK)))))))) (. .)) )
( (HEADING (NP (NNS Abbreviations))) )
( (NP (NP (NN AP)) (: -) (NP (JJ anterior) (NN prostate))) )
( (NP (NP (NN BPH)) (: -) (NP (JJ benign) (JJ prostatic) (NN hyperplasia))) )
( (NP (NP (NN CaP)) (: -) (NP (NP (NN cancer)) (PP (IN of) (NP (DT the) (NN prostate))))) )
( (NP (NP (NN ES)) (: -) (NP (JJ embryonic) (NN stem))) )
( (NP (NP (NN H) (CC &) (NN E)) (: -) (NP (NN hematoxylin) (CC and) (NN eosin))) )
( (NP (NP (NN HPRT)) (: -) (NP (NN hypoxanthine) (NN phosphoribosyltransferase))) )
( (NP (NP (NN IHC)) (: -) (NP (NN immunohistochemistry))) )
( (NP (NP (NN mAb)) (: -) (NP (JJ monoclonal) (NN antibody))) )
( (NP (NP (NN MEF)) (: -) (NP (NN mouse) (JJ embryonic) (NN fibroblast))) )
( (NP (NP (NN MRI)) (: -) (NP (JJ magnetic) (NN resonance) (NN imaging))) )
( (NP (NP (NN Neo)) (: -) (NP (NN neomycin))) )
( (NP (NP (NN PB)) (: -) (NP (NN Probasin))) )
( (NP (NP (NN PBMC)) (: -) (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NN cell))) )
( (NP (NP (NN PI3K)) (: -) (NP (NN phosphoinositide) (CD 3) (HYPH -) (NN kinase))) )
( (NP (NP (NN PIN)) (: -) (NP (JJ prostatic) (JJ intraepithelial) (NN neoplasia))) )
( (NP (NP (NN PIP3)) (: -) (NP (NN phosphatidylinositol) (NML (CD 3) (, ,) (CD 4) (, ,) (CD 5)) (HYPH -) (NN trisphosphate))) )
( (NP (NP (NN PTEN)) (: -) (NP (NP (NML (NN phosphatase) (CC and) (NN tensin)) (NN homolog)) (VP (VBN deleted) (NP (-NONE- *)) (PP-LOC (IN on) (NP (NN chromosome) (CD 10)))))) )
( (NP (NP (NN RNAi)) (: -) (NP (NN RNA) (NN interference))) )
( (NP (NP (NN siRNA)) (: -) (NP (JJ small) (VBG interfering) (NN RNA))) )
( (NP (NP (NN WB)) (: -) (NP (NNP Western) (NN blot))) )
( (HEADING (NP (NNS Figures) (CC and) (NNS Tables))) )
( (HEADING (NP (NN Figure) (CD 1))) )
( (HEADING (NP (NP (NN Production) (CC and) (NN Analysis)) (PP (IN of) (NP (DT a) (NN Pten) (JJ Hypomorphic) (NN Mouse) (NN Series))))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (JJ Schematic) (NN representation)) (PP (IN of) (NP (NP (DT the) (UCP (NML (JJ wild) (HYPH -) (NN type) (PRN (-RRB- -LRB-) (NML (SYM +)) (-RRB- -RRB-))) (, ,) (ADJP (JJ hypomorphic) (PRN (-LRB- -LRB-) (NP (NN hy)) (-RRB- -RRB-))) (, ,) (CC and) (ADJP (JJ null) (PRN (-LRB- -LRB-) (ADJP (SYM −)) (-RRB- -RRB-)))) (NNS alleles)) (PP (IN of) (NP (NN Pten))))) (. .))) )
( (CAPTION (S-IMP (-LRB- -LRB-) (PP (IN For) (NP (DT a) (JJ detailed) (NN view))) (, ,) (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 3A))) (. .) (-RRB- -RRB-))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NP (NN Breeding) (NN scheme)) (VP (VBN used) (NP (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (DT a) (NN Pten) (JJ hypomorphic) (NN mouse) (NN series))))))) (CC and) (NP (NP (VBN predicted) (NN hierarchy)) (PP (IN of) (NP (NN Pten) (NN expression) (NNS levels)))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP-SBJ (NP (NN WB) (NN analysis)) (PP (IN of) (NP (NP (NN MEF) (NNS lysates)) (PP (IN from) (NP (NP (CD ten) (NN littermate) (JJ primary) (NN cell) (NNS cultures)) (VP (VBN obtained) (NP (-NONE- *)) (PP (IN from) (NP (DT a) (JJ single) (NN cross)))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN indicated) (NP-1 (-NONE- *)) (PP (IN in) (NP (-LRB- [) (NN B))))) (-RRB- ]) (-RRB- -RRB-))))))) (VP (VBZ confirms) (NP (NP (NP (NP (JJ predicted) (NML (NN Pten) (NN expression)) (NN hierarchy)) (PP (IN in) (NP (DT the) (JJ hypomorphic) (NN series)))) (CC and) (NP (ADJP (RB inversely) (VBN related)) (NML (NN Akt) (NN phosphorylation)) (NN status) (PRN (-LRB- -LRB-) (NP (NN top)) (-RRB- -RRB-)))) (, ,) (NP-ADV (NP (DT both)) (VP (VBN verified) (NP (-NONE- *)) (PP-MNR (IN by) (NP (NP (JJ densitometric) (NML (NN analysis) (CC and) (NN plotting))) (PP (IN of) (NP (NP (DT the) (NN Pten) (HYPH /) (NN actin)) (CC and) (NP (NML (NML (NN phospho) (HYPH -) (NN Akt)) (HYPH /) (NN Akt)) (NNS ratios)))) (PRN (-LRB- -LRB-) (NP (NN bottom)) (-RRB- -RRB-)))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP-SBJ-1 (NN MEF) (NN cDNA)) (VP (VBD was) (VP (VBN amplified) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (JJ semiquantitative) (NN PCR)) (PP (IN with) (NP (UCP (NML (NN exon) (CD 3) (PRN (-LRB- -LRB-) (ADJP (JJ forward)) (-RRB- -RRB-))) (CC and) (ADJP (NP (NP (NN exon) (CD 4)) (PP (SYM –) (NP (CD 5)))) (VBG spanning) (PRN (-LRB- -LRB-) (ADJP (JJ reverse)) (-RRB- -RRB-)))) (NNS primers))))) (PP (IN for) (NP (NN Pten))))) (. .))) )
( (CAPTION (S (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (ADJP-PRD (JJ Consistent) (PP (IN with) (NP (NP (DT the) (NN concept)) (PP (IN of) (NP (NP (JJ transcriptional) (NN interference)) (PP-LOC (IN at) (NP (DT the) (NN Pten) (NN locus))))))))) (, ,) (NP-SBJ-1 (NP (NN Pten) (NN mRNA) (NNS levels)) (PP (IN in) (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS MEFs)))) (VP (VBP are) (ADVP (RB clearly)) (PP-PRD (IN below) (NP (NP (DT the) (NN level)) (VP (VBN observed) (NP (-NONE- *)) (PP (IN in) (NP (NN heterozygosity))))))) (. .))) )
( (CAPTION (S (NP-SBJ (JJR Lower) (NNS panels)) (VP (VBP show) (NP (NP (NP (DT the) (NN quantification)) (PP (IN of) (NP (NN Pten)))) (ADJP (JJ relative) (PP (IN to) (NP (NN Hprt) (NN amplification)))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 3))) )
( (HEADING (NP (NP (JJ Conditional) (NN Knockout)) (PP (IN of) (NP (DT the) (NN Pten) (NN Gene))) (PP-LOC (IN in) (NP (NN Mouse) (NN Prostate))))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NP (NN Map)) (PP (IN of) (NP (NP (NML (JJ wild) (HYPH -) (NN type)) (NN Pten) (NN locus) (PRN (-LRB- -LRB-) (NP (NN top)) (-RRB- -RRB-))) (, ,) (NP (NN targeting) (NN construct) (PRN (-LRB- -LRB-) (ADJP (JJ second) (PP (IN from) (NP (NN top)))) (-RRB- -RRB-))) (, ,) (NP (JJ predicted) (JJ targeted) (NN locus) (PRN (-LRB- -LRB-) (ADJP (JJ third) (PP (IN from) (NP (NN top)))) (-RRB- -RRB-))) (, ,) (NP (NP (NN Pten) (NN locus)) (PP (IN after) (NP (NP (ADJP (NN Cre) (HYPH -) (VBN mediated)) (NN excision)) (PP (IN of) (NP (DT the) (NN Neo) (NN resistance) (NN cassette))) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG crossing) (PP (IN with) (NP (DT an) (NML (NN EIIA) (HYPH -) (NN Cre)) (NN mouse)))))))) (PRN (-LRB- -LRB-) (NP (NP (JJ fourth)) (PP (IN from) (NP (NN top)))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN Pten) (NN locus)) (PP (IN after) (NP (NP (ADJP (NN Cre) (HYPH -) (VBN mediated)) (NN excision)) (PP (IN of) (NP (DT the) (JJ floxed) (NNS exons) (NML (CD 4) (CC and) (CD 5)))) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG crossing) (PP (IN with) (NP (DT a) (NML (NML (NN PB) (HYPH -) (NN Cre)) (CC or) (NML (NN PB) (HYPH -) (NN Cre4))) (JJ transgenic) (NN mouse)))))))) (PRN (-LRB- -LRB-) (ADJP (JJ bottom)) (-RRB- -RRB-)))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (JJ genomic) (NN sequence)) (VP (VBZ is) (VP (VBN depicted) (NP-1 (-NONE- *)) (PP-MNR (IN as) (NP (DT a) (JJ black) (NN line))) (, ,) (PP (IN with) (S-NOM (NP-SBJ (JJ black) (NNS boxes)) (VP (VBG representing) (NP (NNS exons) (NML (CD 4) (CC and) (CD 5)))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ (ADJP (JJ Pink) (CC and) (JJ yellow)) (NNS boxes)) (VP (VBP represent) (NP (NP (DT the) (NN Neo) (NN resistance)) (CC and) (NP (NP (DT the) (NN HSV) (NN thymidine) (NN kinase) (NN cassette)) (-LRB- -LRB-) (NP (NN TK))) (-RRB- -RRB-)))) (CC and) (S (NP-SBJ (ADJP (RB light) (JJ blue)) (NNS triangles)) (VP (VBP represent) (NP (DT the) (NN loxP) (NN site)) (, ,) (ADVP (RB respectively)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (DT The) (NN Pten) (JJ genomic) (NNS fragments)) (VP (VBN used) (NP (-NONE- *)) (PP-MNR (IN as) (NP (DT a) (NN probe))) (PP-PRP (IN for) (NP (NNP Southern) (NN blot) (NN analysis))))) (VP (VBP are) (VP (VBN shown) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (NP (NML (CD 3) (SYM ′)) (NN probe)) (CC and) (NP (NN probe) (CD 6.1))) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (S (S (NP-SBJ (JJ Solid) (NNS arrows)) (VP (VBP represent) (NP (NP (JJ expected) (NNS fragments)) (PP (IN following) (NP (NP (NN hybridization)) (PP (IN with) (NP (DT the) (NML (CD 3) (SYM ′)) (NN probe))) (PP-TMP (IN upon) (NP (NN digestion))) (PP (IN with) (NP (NN EcoRI)))))))) (, ,) (CC and) (S (NP-SBJ (JJ dashed) (NNS arrows)) (VP (VBP represent) (NP (JJ expected) (NNS fragments)) (PP (VBG following) (NP (NP (NN hybridization)) (PP (IN with) (NP (DT the) (NN probe) (CD 6.1))) (PP-TMP (IN upon) (NP (NN digestion))) (PP (IN with) (NP (NN XbaI))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NNS Locations)) (PP (IN of) (NP (NP (NN PCR) (NNS primers)) (SBAR (WHNP-2 (-NONE- *0*)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (TO to) (VP (VB detect) (NP (NP (NML (JJ wild) (HYPH -) (NN type)) (, ,) (JJ floxed) (NN allele)) (-LRB- -LRB-) (NP (NN PtenloxP))) (-RRB- -RRB-) (, ,) (CC and) (NP (JJ deleted) (NN allele))))))))) (VP (VBP are) (VP (VBN shown) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NML (NML (NN XbaI)) (NML (-LRB- -LRB-) (NN X) (-RRB- -RRB-))) (, ,) (NML (NML (NN KpnI)) (NML (-LRB- -LRB-) (NN K) (-RRB- -RRB-))) (, ,) (NML (NML (NN BamHI)) (NML (-LRB- -LRB-) (NN B) (-RRB- -RRB-))) (, ,) (CC and) (NML (NML (NN EcoRI)) (NML (-LRB- -LRB-) (NN E) (-RRB- -RRB-))) (NNS sites)) (VP (VBP are) (VP (VBN shown) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NN Genotyping)) (PP (IN of) (NP (NNS mice))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Lanes) (NML (CD 1) (CC and) (CD 2))) (VP (VBP show) (NP (NP (NML (NNP Southern) (NN blot)) (NN analysis)) (PP (IN of) (NP (NN ES) (NN cell) (NNS clones))) (PP (IN with) (NP (NP (NML (CD 3) (SYM ′)) (NN probe)) (PP (IN of) (NP (NP (UCP (NN control) (PRN (-LRB- -LRB-) (NP (NNS lanes) (CD 2)) (-RRB- -RRB-)) (CC and) (JJ recombined)) (NNS clones)) (CC and) (NP (SYM #) (CD 176) (PRN (-LRB- -LRB-) (NP (NN lane) (CD 1)) (-RRB- -RRB-))))))) (PP-TMP (IN after) (NP (NP (NN digestion)) (PP (IN with) (NP (NN EcoRI)))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG showing) (NP (NP (DT a) (NML (CD 6) (NN kb)) (NML (JJ wild) (HYPH -) (NN type)) (NN band)) (-LRB- -LRB-) (NP (NN WT)) (-RRB- -RRB-)) (CC and) (NP (NP (DT a) (NML (CD 2.5) (NN kb)) (JJ targeted) (NN band)) (-LRB- -LRB-) (NP (NN R)) (-RRB- -RRB-))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Lanes) (NML (CD 3) (CC and) (CD 4)) (PRN (-LRB- -LRB-) (NP (NN control)) (-RRB- -RRB-))) (VP (VBP represent) (NP (NP (NML (NNP Southern) (NN blot)) (NN analysis)) (PP (IN of) (NP (NP (NN mouse) (NN tail) (NN DNA)) (PP (IN of) (NP (NN offspring))))) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG crossing) (NP (NP (NN F1) (NN mouse)) (VP (VBN generated) (NP (-NONE- *)) (PP (IN from) (NP (SYM #) (CD 176))))) (PP (IN with) (NP (DT an) (NML (NN EIIA) (HYPH -) (NN Cre)) (NN mouse))) (PP-MNR (IN with) (NP (NN probe) (CD 6.1))) (PP-TMP (IN after) (NP (NP (NN digestion)) (PP (IN with) (NP (NN XbaI))))))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG showing) (NP (NML (JJ wild) (HYPH -) (NN type)) (, ,) (ADJP (ADJP (VBN targeted) (PRN (-LRB- -LRB-) (NP (NN PtenloxP) (HYPH -) (NN neo)) (-RRB- -RRB-))) (, ,) (CC and) (ADJP (JJ floxed) (PRN (-LRB- -LRB-) (NP (NN PtenloxP)) (-RRB- -RRB-)))) (NN locus) (NNS bands))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Lanes) (NML (NML (CD 5)) (, ,) (NML (CD 6) (PRN (-LRB- -LRB-) (NP (NN control)) (-RRB- -RRB-))) (, ,) (CC and) (NML (CD 7)))) (VP (VBP represent) (NP (NP (NML (NNP Southern) (NN blot)) (NN analysis)) (PP (IN of) (NP (NP (NML (NN mouse) (NN tail)) (NN DNA)) (PP (IN of) (NP (NN offspring))))) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG crossing) (NP (NP (DT the) (NN mouse)) (PP (IN of) (NP (NN lane) (CD 3)))) (PP (IN with) (NP (DT a) (NML (JJ wild) (HYPH -) (NN type)) (NN mouse))) (PP-MNR (IN with) (NP (NN probe) (CD 6.1))) (PP-TMP (IN after) (NP (NP (NN digestion)) (PP (IN with) (NP (NN XbaI)))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Lanes) (NML (NML (CD 8)) (PP (SYM –) (NP (CD 14))))) (VP (VBP show) (NP (NP (NN PCR) (NN analysis)) (PP (IN of) (NP (NP (NN tail) (NN DNA)) (PP (IN of) (NP (NN offspring))))) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG crossing) (NP (DT a) (NML (NN PB) (HYPH -) (NN Cre4) (-LRB- -LRB-) (SYM +) (-RRB- -RRB-)) (, ,) (NML (NN PtenloxP) (HYPH /) (SYM +)) (NN male)) (PP (IN with) (NP (DT a) (NML (NN PtenloxP) (HYPH /) (SYM +)) (NN female))) (PP-MNR (IN with) (NP (NNS primers) (NML (CD 1) (CC and) (CD 2))))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ (NNS Lanes) (NML (CD 8) (, ,) (CD 9) (, ,) (CC and) (CD 14))) (VP (VBP indicate) (NP (NN PtenloxP) (HYPH /) (SYM +)))) (, ,) (S (NP-SBJ (NNS lanes) (NML (CD 10) (CC and) (CD 13))) (VP (VBP indicate) (NP (NN Pten) (SYM +) (HYPH /) (SYM +)))) (, ,) (CC and) (S (NP-SBJ (NNS lanes) (NML (CD 11) (CC and) (CD 12))) (VP (VBP indicate) (NP (NN PtenloxP) (HYPH /) (NN loxP)))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Lanes) (NML (NML (CD 15)) (PP (SYM –) (NP (CD 17))))) (VP (VBP show) (NP (NP (NN PCR) (NN analysis)) (PP (IN of) (NP (NP (NN tail) (NN DNA)) (PP (IN of) (NP (NN offspring))))) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG crossing) (NP (DT a) (NML (NN Ptenloxp) (HYPH /) (SYM +)) (NN male)) (PP (IN with) (NP (NP (DT a) (NML (NN PB) (HYPH -) (NN Cre4) (-LRB- -LRB-) (SYM +) (-RRB- -RRB-)) (, ,) (NML (NN PtenloxP) (HYPH /) (SYM +)) (NN female)) (PP (IN with) (NP (NNS primers) (NML (CD 1) (, ,) (CD 2) (, ,) (CC and) (CD 3))))))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ (NN Lane) (CD 15)) (VP (VBZ indicates) (NP (NN PtenloxP) (HYPH /) (SYM +)))) (, ,) (S (NP-SBJ (NN lane) (CD 16)) (VP (VBZ indicates) (NP (NN Pten) (SYM +) (HYPH /) (SYM +)))) (, ,) (CC and) (S (NP-SBJ (NN lane) (CD 17)) (VP (VBZ indicates) (SBAR (IN that) (S (NP-SBJ (DT the) (VBN deleted) (NN allele)) (VP (VBZ exists) (PP-LOC (IN in) (NP (NP (NN tail) (NN DNA)) (PP (IN of) (NP (DT this) (NN offspring)))))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (NP (NN Representation)) (PP (IN of) (NP (VBG crossing) (NN scheme)))) (VP (VBN used) (NP (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB generate) (NP (ADJP (NN prostate) (HYPH -) (JJ specific)) (NN Pten) (JJ conditional) (NNS mutants)))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NML (NN PtenloxP) (HYPH /) (NN loxP)) (NNS mutants)) (VP (VBD were) (VP (VBN crossed) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NML (NN PB) (HYPH -) (NN Cre)) (JJ transgenic) (NNS mice)) (CC or) (NP (NML (NN PB) (HYPH -) (NN Cre4)) (JJ transgenic) (NNS mice)))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 2))) )
( (HEADING (S (NP-SBJ (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS Mice)) (VP (VBP Display) (NP (NP (JJ Massive) (NN Hyperplasia)) (CC and) (NP (JJ Invasive) (NN CaP)))))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ (NP (NN IHC)) (PP (IN on) (NP (NP (JJ preneoplastic) (NML (NML (JJ anterior) (NN prostate)) (-LRB- -LRB-) (NML (NN AP))) (-RRB- -RRB-) (NN tissue)) (PP (IN of) (NP (ADJP (NP (CD 2) (HYPH -) (NN mo)) (HYPH -) (JJ old)) (NN littermate) (NNS mice)))))) (VP (VBZ shows) (NP (VBG decreasing) (NN Pten) (NN protein) (NNS levels)) (PP-LOC (IN in) (NP (DT the) (JJ hypomorphic) (NN series)))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (S (NP-SBJ-1 (NP (NN WB) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NN prostate) (NNS lobes)) (PP (IN from) (-LRB- -LRB-) (NP (NN A)))))) (-RRB- -RRB-) (VP (VBZ is) (VP (VBN shown) (NP-1 (-NONE- *)) (PP-LOC (IN on) (NP (DT the) (NN left)))))) (CC and) (S (NP-SBJ-2 (PRP$ their) (NN quantification)) (VP (VBZ is) (VP (VBN shown) (NP-2 (-NONE- *)) (PP-LOC (IN on) (NP (DT the) (NN right)))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP-SBJ (NP (NN MRI)) (PP (IN of) (NP (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mice)) (ADJP (VBN aged) (NP (QP (CD 6) (SYM –) (CD 8)) (NN mo)))))) (VP (VBZ shows) (NP (NP (NP (NP (JJ pathologic) (NNS structures)) (-LRB- -LRB-) (VP (VBN encircled) (NP (-NONE- *)) (PP-MNR (IN by) (NP (JJ dashed) (NNS lines)))) (-RRB- -RRB-)) (ADJP (JJ adjacent) (PP (IN to) (NP (NP (JJ seminal) (NNS vesicles)) (-LRB- -LRB-) (NP (NN SV)) (-RRB- -RRB-))))) (VP (VBG coinciding) (PP (IN with) (NP (NP (NN displacement)) (PP (IN of) (NP (NP (DT the) (NN bladder)) (-LRB- -LRB-) (NP (NN Bl)) (-RRB- -RRB-))))))) (, ,) (S-ADV (NP-SBJ-1 (NNS features)) (ADVP (RB typically)) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (JJ massive) (NN prostate) (NNS tumors) (PRN (-LRB- -LRB-) (ADJP (JJ right)) (-RRB- -RRB-))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT These) (NNS features)) (VP (VBD were) (ADVP-TMP (RB never)) (VP (VBN found) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NML (NN Pten) (SYM +) (HYPH /) (SYM +)) (CC or) (NML (NN Pten) (SYM +) (HYPH /) (SYM −))) (NNS mice))) (PRN (-LRB- -LRB-) (ADJP (JJ left)) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP-SBJ (NP (JJ Macroscopic) (NN view)) (PP (IN of) (NP (DT the) (NML (NN Ptenhy) (HYPH /) (SYM −)) (NN mouse))) (PP (IN from) (-LRB- -LRB-) (NP (NN C)))) (-RRB- -RRB-) (VP (VBZ confirms) (NP (NP (NP (JJ massive) (NN enlargement)) (PP (IN of) (NP (DT the) (NN AP) (NNS lobes)))) (, ,) (CC but) (NP (ADJP (JJ normal) (HYPH -) (JJ sized)) (JJ seminal) (NNS vesicles)))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS E) (-RRB- -RRB-)) (NP (NN Quantification)) (PP (IN of) (NP (NP (NN WB) (NN analysis)) (PP (IN on) (NP (NML (NN AP) (NN lobe)) (JJ total) (NNS lysates))))) (PP (IN from) (NP (NP (DT the) (NML (NN Ptenhy) (HYPH /) (SYM −)) (NN animal)) (VP (VBN shown) (NP (-NONE- *)) (PP (IN in) (-LRB- -LRB-) (NP (NN C)))))) (-RRB- -RRB-) (PP (VBN compared) (PP (IN to) (NP (NP (JJ preneoplastic) (NN AP)) (PP (IN of) (NP (NP (JJ same) (NN genotype)) (PP (IN from) (-LRB- -LRB-) (NP (NP (NN A) (-RRB- -RRB-) (CC and) (-LRB- -LRB-) (NN B)) (-RRB- -RRB-) (, ,) (VP (VBN labeled) (NP-1 (-NONE- *)) (S-CLR (NP-SBJ-1 (-NONE- *PRO*)) (NP-PRD (NP (CD 8) (NNS mo)) (CC and) (NP (CD 2) (NNS mo)))) (, ,) (ADVP (RB respectively)))))))))) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Note) (SBAR (IN that) (S (PP-LOC (IN in) (NP (DT the) (VBN enlarged) (JJ hyperplastic) (NN prostate))) (, ,) (NP-SBJ-1 (NN Pten) (NN protein) (NN expression)) (VP (VBZ is) (VP (VBN retained) (NP-1 (-NONE- *)))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS levels)) (VP (VBP are) (VP (VBN expressed) (NP-2 (-NONE- *)) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ relative) (PP (IN to) (NP (DT the) (JJ corresponding) (NML (JJ wild) (HYPH -) (NN type)) (NNS animals)))))))) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS F) (-RRB- -RRB-)) (NP-SBJ (NP (NN Histopathology) (PRN (-LRB- -LRB-) (NP (NN H) (CC &) (NN E)) (-RRB- -RRB-))) (PP (IN of) (NP (NN AP) (NNS lesions))) (PP-TMP (IN at) (NP (CD 8) (NN mo)))) (VP (VBZ reveals) (NP (NP (NN transition)) (PP (IN from) (NP (NML (ADJP (JJ low) (HYPH -) (PP (IN to) (ADJP (JJ high)))) (HYPH -) (NN grade)) (NN PIN) (CC and) (NN invasion))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NP (NN infiltration)) (PP (IN of) (NP (JJ stromal) (NN tissue)))) (VP (VBZ is) (VP (VBN indicated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NNS arrows)))))) (-RRB- -RRB-))) (PP-LOC (IN in) (NP (NN Ptenhy) (HYPH /) (SYM −))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (ADJP (NN age) (HYPH -) (VBN matched)) (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (NN tissue)) (ADVP (RB only)) (VP (VBZ shows) (SBAR (-NONE- *0*) (S (NP-SBJ (NP (JJ hyperplastic) (NNS features)) (CC and) (NP (NML (NN Pten) (SYM +) (HYPH /) (SYM +)) (NN tissue))) (VP (VBZ is) (ADJP-PRD (JJ unaffected))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Bars)) (VP (VBP are) (NP-PRD (CD 50) (NNS μm))) (. .))) )
( (HEADING (NP (NN Figure) (CD 5))) )
( (HEADING (NP (NP (NP (JJ Molecular) (NNS Effects)) (PP (IN of) (NP (NP (NN Loss)) (PP (IN of) (NP (NN Pten)))))) (CC and) (NP (NP (JJ Biological) (NN Comparison)) (PP (IN of) (NP (DT All) (VBN Generated) (NN Mouse) (NNS Models)))))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ (NP (NML (NN Ki) (HYPH -) (CD 67)) (NN staining)) (PP (IN of) (NP (NN AP) (NN lobe) (NNS sections)))) (VP (VBZ illustrates) (NP (VBG increasing) (NN proliferation)) (PP-MNR (IN with) (NP (VBG decreasing) (NN Pten) (NNS levels) (PRN (-LRB- -LRB-) (S (S (NP-SBJ (NNS numbers)) (VP (VBP are) (NP-PRD (NP (ADJP (NP (NN Ki) (HYPH -) (CD 67)) (HYPH -) (JJ positive)) (NNS cells)) (PP (IN per) (NP (NP (CD 300) (NNS cells)) (VP (VBN counted) (NP (-NONE- *)) (PP (IN in) (NP (NN percent))))))))) (: ;) (S (NP-SBJ (NNS bars)) (VP (VBP are) (NP-PRD (CD 50) (NNS μm))))) (-RRB- -RRB-))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP-SBJ-2 (DT The) (NML (NML (NN phospho) (HYPH -) (NN Akt)) (HYPH /) (NML (NN Akt))) (NN ratio)) (VP (VBZ is) (ADVP (RB sharply)) (VP (VBN increased) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (NNS prostates)) (PP (IN of) (NP (ADJP (NP (CD 10) (HYPH -) (NN wk)) (HYPH -) (JJ old)) (NN Ptenpc2) (NNS animals))))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN shown) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (JJ densitometric) (NN quantification)) (PP (IN of) (NP (NN WB) (NN analysis)))))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP-SBJ (NP (NN AP) (NN staining)) (PP (IN with) (NP (NML (JJ anti-phospho) (HYPH -) (NN Akt)) (NNS antibodies)))) (VP (VBZ reveals) (NP (NP (NP (JJ strong) (NML (NN plasma) (NN membrane)) (NN localization)) (PP (IN of) (NP (NN phospho) (HYPH -) (NN Akt)))) (CC and) (NP (NP (JJ apparent) (NN reduction)) (PP (IN of) (NP (NN p27) (NN protein) (NN detection))))) (, ,) (SBAR-ADV (IN whereas) (S (NP-SBJ (NML (NML (NN phospho) (HYPH -) (NN mTOR)) (CC and) (NML (NN phospho) (HYPH -) (NN threonine) (HYPH -) (NN FOXO3))) (NNS antibodies)) (VP (VBP show) (NP (JJ increased) (NN staining)) (PP-LOC (IN in) (NP (NML (NML (NN Ptenpc2)) (CC versus) (NML (JJ wild) (HYPH -) (NN type))) (NN mouse) (NNS prostates))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Bars)) (VP (VBP are) (NP-PRD (CD 50) (NNS μm))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP (NML (NNP Kaplan) (HYPH –) (NNP Meier)) (NN curve)) (VP (VBG showing) (NP (NN prostate) (NN enlargement)) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN visualized) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN MRI))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (JJ Progressive) (NNS rates)) (PP (IN of) (NP (NP (NN mass) (NN increase)) (PP (IN for) (NP (NML (NML (NN Ptenpc2) (PRN (-LRB- -LRB-) (NP (NP (JJ median) (NN age)) (, ,) (NP (CD 4) (NNS mo))) (-RRB- -RRB-))) (, ,) (NML (NN Ptenhy) (HYPH /) (SYM −) (PRN (-LRB- -LRB-) (NP (NP (JJ median) (NN age)) (, ,) (NP (CD 7) (NNS mo))) (-RRB- -RRB-))) (, ,) (CC and) (NML (NN Ptenpc1) (PRN (-LRB- -LRB-) (NP (NP (JJ median) (NN age)) (, ,) (NP (CD 16) (NNS mo))) (-RRB- -RRB-)))) (NNS mice)))))) (VP (VBP are) (VP (VBN found) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-1 (DT no) (JJ prostatic) (NN size) (NNS irregularities)) (VP (VBD were) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NML (NN Pten) (SYM +) (HYPH /) (SYM +)) (CC or) (NML (NN Pten) (SYM +) (HYPH /) (SYM −))) (NNS mice))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS E) (-RRB- -RRB-)) (NP (NN Incidence)) (PP (IN of) (NP (JJ invasive) (NN CaP))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (JJ Invasive) (NN CaP)) (VP (VBD was) (VP (VBN defined) (NP-1 (-NONE- *)) (PP-MNR (IN as) (S-NOM (NP-SBJ (NN tumor) (NNS cells)) (VP (VP (VBG disrupting) (NP (NP (DT the) (JJ basal) (NN membrane)) (PP (IN of) (NP (JJ prostatic) (NNS glands))))) (CC and) (VP (VBG growing) (PP-DIR (IN into) (NP (DT the) (VBG surrounding) (NN stroma))))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (JJ Full) (NN penetrance)) (VP (VBD was) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (PP (IN in) (NP (CC both) (NN Ptenpc1) (NNS mice))) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (NN Ptenpc2) (NNS mice)))))) (. .))) )
( (CAPTION (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mice)) (PP (IN with) (NP (NP (DT a) (NN follow) (HYPH -) (NN up)) (PP (IN of) (NP (QP (JJR more) (IN than) (CD 6)) (NNS mo)))))) (VP (VBD displayed) (NP (NP (NML (QP (RB only) (CD 25)) (NN %)) (NN incidence)) (PP (IN of) (NP (JJ invasive) (NN CaP))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 4))) )
( (HEADING (S (NP-SBJ (NN Ptenpc2) (NNS Mice)) (VP (VBP Develop) (NP (JJ Invasive) (NN CaP))))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NN Histopathology) (NN analysis)) (PP (IN of) (NP (NML (NML (JJ wild) (HYPH -) (NN type)) (, ,) (NML (NN Ptenpc1)) (, ,) (CC and) (NML (NN Ptenpc2))) (NNS mice))) (ADVP-TMP (RB prior) (PP (IN to) (NP (NN tumor) (NN onset)))) (. .))) )
( (CAPTION (S (NP-SBJ (ADJP (NP (NN H) (CC &) (NN E)) (HYPH -) (VBN stained)) (NN AP) (PRN (-LRB- -LRB-) (NP (NN top)) (-RRB- -RRB-))) (VP (VBZ shows) (NP (NP (DT the) (NN difference)) (PP (IN in) (NP (NP (CC both) (NP (DT the) (NN morphology)) (CC and) (NP (JJ proliferative) (NNS rates))) (PP (IN of) (NP (DT the) (JJ prostatic) (NN epithelium)))))) (PP (IN in) (NP (DT these) (CD two) (NNS models)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NN IHC) (NN staining)) (PP (IN with) (NP (JJ anti-Pten) (NN antibody) (PRN (-LRB- -LRB-) (NP (NN bottom)) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP (IN on) (NP (NML (NML (JJ wild) (HYPH -) (NN type)) (, ,) (NML (NN Ptenpc1)) (, ,) (CC and) (NML (NN Ptenpc2))) (NNS mice))))) (. .))) )
( (CAPTION (S (PP-PRP (IN In) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))) (, ,) (NP-SBJ-1 (JJ strong) (JJ cytoplasmic) (NN staining)) (VP (VBD was) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (JJ epithelial) (NNS cells))) (PRN (-LRB- -LRB-) (NP (NNS arrowheads)) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (S (PP-LOC (IN In) (NP (NN Ptenpc1) (NNS mice))) (, ,) (NP-SBJ (NN staining)) (VP (VBD was) (ADVP (RB generally)) (ADJP-PRD (JJ weak)) (, ,) (SBAR-ADV (IN whereas) (S (PP-LOC (IN in) (NP (NN Ptenpc2) (NNS mice))) (, ,) (NP-SBJ (NN staining)) (VP (VBD was) (ADJP-PRD (RB completely) (JJ absent)) (PP-LOC (IN in) (NP (DT the) (JJ prostatic) (NN epithelium))))))) (. .))) )
( (CAPTION (NP (NP (JJ Original) (NN magnification)) (, ,) (NP (QP (CD 400) (SYM ×))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP-SBJ (NN MRI) (PRN (-LRB- -LRB-) (NP (NN top)) (-RRB- -RRB-))) (VP (VBZ shows) (NP (NP (NP (NP (JJ massive) (NN prostate) (NN tumor)) (-LRB- -LRB-) (VP (VBN surrounded) (NP (-NONE- *)) (PP-MNR (IN by) (NP (VBN dashed) (NN line))))) (-RRB- -RRB-) (PP-LOC (IN in) (NP (NN Ptenpc2) (NNS mice))) (-LRB- -LRB-) (PP-TMP (IN at) (NP (CD 6) (NN mo)))) (-RRB- -RRB-) (CC and) (NP (NP (DT no) (JJ detectable) (NN difference)) (PP (IN between) (NP (NP (DT the) (NNS prostates)) (PP (IN of) (NP (NML (NML (NN Ptenpc1)) (CC or) (NML (NN Pten) (SYM +) (HYPH /) (SYM +))) (NNS mice))) (-LRB- -LRB-) (PP-TMP (IN at) (NP (CD 12) (NN mo))) (PRN (: ;) (NP (NNS arrowheads)) (-RRB- -RRB-))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NP (NN Bladder)) (-LRB- -LRB-) (NP (NN Bl)) (-RRB- -RRB-)) (CC and) (NP (NP (JJ seminal) (NNS vesicles)) (-LRB- -LRB-) (NP (NN SV)) (-RRB- -RRB-))) (VP (VBP are) (VP (VBN indicated) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (JJ Macroscopic) (NN view) (PRN (-LRB- -LRB-) (NP (NP (JJ second)) (PP (IN from) (NP (NN top)))) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (JJ same) (NNS animals)))) (VP (VP (VBZ confirms) (NP (NP (JJ massive) (NN enlargement)) (PP (IN of) (NP (DT both) (NNS APs)))) (PP-LOC (IN in) (NP (NN Ptenpc2)))) (CC and) (VP (VBZ reveals) (NP (NP (DT the) (ADJP (RB slightly) (JJ enlarged)) (NN AP)) (PP (IN of) (NP (NN Ptenpc1) (NNS mice)))) (PRN (-LRB- -LRB-) (ADJP (VBN encircled)) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NML (NN H) (CC &) (NN E)) (NN staining) (PRN (-LRB- -LRB-) (NP (NN bottom)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (DT the) (NN prostate)) (PP (IN from) (NP (NN Ptenpc1) (NNS mice)))))) (VP (VBD was) (VP (VBN characterized) (NP-1 (-NONE- *)) (PP (PP (IN by) (NP-LGS (NP (JJ multiple) (NNS foci)) (PP (IN of) (NP (NN PIN) (NNS lesions))))) (CC and) (PP (IN by) (NP-LGS (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ prostatic) (NN adenocarcinoma)))))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT These) (NNS lesions)) (VP (VP (VBD contained) (NP (ADJP (RB well) (HYPH -) (VBN differentiated)) (JJ neoplastic) (NNS cells))) (CC and) (VP (VBD showed) (NP (NP (JJ focal) (NNS areas)) (PP (IN of) (NP (NN invasion)))) (PRN (-LRB- -LRB-) (NP (NNS arrowheads)) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NML (NN H) (CC &) (NN E)) (NNS stainings)) (PP (IN of) (NP (NP (NNS prostates)) (PP (IN from) (NP (NN Ptenpc2) (NNS mice)))))) (VP (VBD showed) (NP (JJ diffuse) (, ,) (JJ invasive) (NN CaP)) (PP (IN with) (NP (NP (ADJP (JJ large) (, ,) (JJ undifferentiated)) (NN tumor) (NNS cells)) (VP (VBG growing) (PP-DIR (IN into) (NP (JJ stromal) (NNS areas))))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 6))) )
( (HEADING (S (NP-SBJ (NN Pten) (NN Dose)) (VP (VBZ Affects) (NP (NML (NN Prostate) (NN Tumor)) (NN Progression))))) )
( (CAPTION (S (NP-SBJ (NML (NN Pten) (SYM +) (HYPH /) (SYM −)) (NNS mice)) (VP (VBP develop) (NP (NP (NN hyperplasia)) (, ,) (NP (NN dysplasia)) (, ,) (CC and) (NP (ADJP (JJ low) (HYPH -) (NN grade)) (NN PIN)))) (. .))) )
( (CAPTION (S (S (NP-SBJ (NML (NN Ptenhy) (HYPH /) (SYM −)) (NNS mice)) (VP (VBP develop) (PP-TMP (IN at) (NP (JJ complete) (NN penetrance))) (NP (ADJP (JJ high) (HYPH -) (NN grade)) (NN PIN)) (PP-TMP (IN at) (NP (DT a) (JJ young) (NN age) (PRN (-LRB- -LRB-) (NP (QP (CD 8) (SYM –) (CD 10)) (NNS wk)) (-RRB- -RRB-)))))) (CC and) (S (NP-SBJ (QP (RB roughly) (CD 25)) (NN %)) (VP (VBP present) (NP (JJ invasive) (NN CaP)) (PP-TMP (IN around) (NP (CD 8) (NNS mo))))) (. .))) )
( (CAPTION (S (NP-SBJ (NN Ptenpc) (NNS mice)) (VP (VBP develop) (NP (JJ invasive) (NN CaP)) (PP-TMP (IN at) (NP (JJ complete) (NN penetrance)))) (. .))) )
( (CAPTION (S (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB See) (NP (NN Discussion)) (PP-PRP (IN for) (NP (DT a) (JJ detailed) (NN description))))) (. .) (-RRB- -RRB-)) (NP-SBJ (NML (NN p27Kip1) (SYM −) (HYPH /) (SYM −)) (NNS mice)) (, ,) (PP (IN on) (NP (DT the) (NN contrary))) (, ,) (VP (VBP develop) (NP (RB only) (NN BPH))) (. .))) )
( (CAPTION (FRAG (NP (NP (NP (NNS Possibilities)) (PP (IN for) (NP (JJ human) (JJ therapeutic) (NN intervention)))) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (PRP$ our) (NNS findings))))) (: :) (S (PP (IN in) (NP (NP (NN addition)) (PP (IN to) (NP (NP (NN inactivation)) (PP (IN of) (NP (NP (NN PI3K) (HYPH /) (NN AKT)) (CC and) (NP (NN mTOR) (JJ enzymatic) (NNS activities)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (NP (NN PTEN) (NN loss)) (PP (IN of) (NP (NN heterozygosity) (NN condition))))) (-RRB- -RRB-)))))))) (, ,) (NP-SBJ-2 (NP (NN monitoring) (CC and) (NN elevation)) (PP (IN of) (NP (NP (NN PTEN) (NN expression) (NNS levels)) (PP (IN of) (NP (DT the) (VBG remaining) (NN allele)))))) (VP (VP (MD could) (CONJP (RB not) (RB only)) (VP (VB prevent) (NP (NP (NN formation)) (PP (IN of) (NP (NN PIN) (NNS lesions) (PRN (-LRB- -LRB-) (PP-LOC (IN in) (NP (NML (NN PTEN) (SYM +) (HYPH /) (SYM −)) (NNS individuals))) (-RRB- -RRB-))))))) (, ,) (CC but) (VP (MD could) (ADVP (RB importantly)) (ADVP (RB also)) (VP (VB be) (VP (VBN used) (NP-2 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB counteract) (NP (NP (DT the) (NN progression)) (PP (IN to) (NP (JJ invasive) (NNS phenotypes)))) (PRN (-LRB- -LRB-) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN Ptenhy) (HYPH /) (SYM −)) (NN mouse) (NNS mutants)))))) (-RRB- -RRB-)))))))))) (. .))) )
( (HEADING (NP (NNS Footnotes))) )
( (HEADING (NP (NP (NNS Conflicts)) (PP (IN of) (NP (NN Interest))) (. .))) )
( (S (NP-SBJ (DT The) (NNS authors)) (VP (VBP have) (VP (VBN declared) (SBAR (IN that) (S (NP-SBJ (NP (DT no) (NNS conflicts)) (PP (IN of) (NP (NN interest)))) (VP (VBP exist)))))) (. .)) )
( (HEADING (NP (NN Author) (NNS Contributions) (. .))) )
( (S (NP-SBJ (NP (NNP LCT)) (, ,) (NP (NNP MN)) (, ,) (NP (NNP ZAD)) (, ,) (NP (NNP JAK)) (, ,) (NP (NNP AD)) (, ,) (NP (NNP AX)) (, ,) (NP (NNP TVD)) (, ,) (NP (NNP CC) (HYPH -) (NNP C)) (, ,) (CC and) (NP (NNP PPP))) (VP (VBD conceived) (CC and) (VBD designed) (NP (DT the) (NNS experiments))) (. .)) )
( (S (NP-SBJ (NNP LCT) (, ,) (NNP MN) (, ,) (NNP ZAD) (, ,) (NNP JAK) (, ,) (NNP AD) (, ,) (CC and) (NNP AX)) (VP (VBD performed) (NP (DT the) (NNS experiments))) (. .)) )
( (S (NP-SBJ (NP (NNP LCT)) (, ,) (NP (NNP MN)) (, ,) (NP (NNP ZAD)) (, ,) (NP (NNP JAK)) (, ,) (NP (NNP AD)) (, ,) (NP (NNP AX)) (, ,) (NP (NNP ASBK)) (, ,) (NP (NNP TVD)) (, ,) (NP (NNP CC) (HYPH -) (NNP C)) (, ,) (CC and) (NP (NNP PPP))) (VP (VBD analyzed) (NP (DT the) (NNS data))) (. .)) )
( (S (NP-SBJ (NP (NNP PR) (HYPH -) (NNP B)) (, ,) (NP (NNP NMG)) (, ,) (NP (NNP TVD)) (, ,) (CC and) (NP (NNP PPP))) (VP (VBD contributed) (NP (NP (NNS reagents)) (HYPH /) (NP (NNS materials)) (HYPH /) (NP (NN analysis) (NNS tools)))) (. .)) )
( (S (NP-SBJ (NNP LCT) (, ,) (NNP MN) (, ,) (NNP ZAD) (, ,) (CC and) (NNP PPP)) (VP (VBD wrote) (NP (DT the) (NN paper))) (. .)) )
( (NP (NP (JJ Academic) (NN Editor)) (: :) (NP (NP (NNP Nicholas) (NNP Hastie)) (, ,) (NP-LOC (NML (NML (NNP Medical) (NNP Research)) (NNP Council)) (NML (NNP Human) (NNP Genetics)) (NNP Unit)) (, ,) (NP-LOC (NNP Western) (NNP General) (NNP Hospital)))) )
